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SUMMARY
Osteo-densitometry has some well defined roles in the 
management of osteoporosis. This thesis examined the role of a 
new technique, peripheral quantitative computed tomography 
(pQCT) at the ultra-distal radius, which quantifies trabecular 
and cortical bone mineral density (BMD) separately through a 
volumetric measurement. Comparison was made with dual energy X- 
ray absorptiometry (DXA), and calcaneal ultrasound attenuation 
(BUA) and velocity (VOS) in some studies.
The precision [expressed as the co-efficient of variation (CV)] 
of pQCT in young females was 1.24%, 1.33%, 1.58% and 1.88% for 
total (Qtot), trabecular (Qtrab), subcortical (Qscort) and 
cortical (Qcort) BMD respectively. The precision was improved 
to these figures by minimising the difference in voxel numbers 
between repeat scans, a strategy which was thereafter utilised 
to aid repositioning in follow-up scans. The corresponding CV s 
were higher in women with vertebral fractures, or rheumatoid 
arthritis. There were small, and insignificant differences in 
BMD between dominant and non-dominant forearms. To minimise the 
variance in measurements, the non-dominant forearm was always 
scanned unless contra-indicated.
Normative pQCT data were derived from 332 normal females aged 
18-90 years. Differences compared to the manufacturers 
reference data were noted, stressing the importance of creating 
a normal range from the local population. Age (all 
measurements), postmenopausal status (Qtot, Qscort) and height 
(Qtot, Qtrab) were negatively, and weight (Qtot, Qtrab, Qcort) 
was positively related to radial BMD. A cubic regression model 
best fitted all pQCT BMD’s as a function of age for the whole 
population. pQCT BMD was effectively stable in premenopausal 
women. In postmenopausal women, estimated rates of change in
Y
BMD (derived from best fit, non-linear regression models as a 
function of years postmenopause) were greatest for Qtot, Qscort 
and Qcort at 20 years postmenopause (-1.36%/yr - -1.39%/yr),
which were greater than those for Qtrab throughout the 
postmenopausal years (-0.53%/yr - -0.76%/yr). Significant
annualized rates of change in Qscort (-1.35%/yr,p=0.024) and 
Qtot (-1.04%/yr,p=0.027), but not Qtrab (-0.19%/yr) or Qcort (- 
0.95%/yr) were observed in 23 late premenopausal women studied 
longitudinally. Bearing in mind precision values, these results 
suggest a 3 year interval between scans would be necessary to 
detect clinically significant individual changes in BMD. 
Perimenopausal differences (between 79 late premenopausal and 
40 early postmenopausal women) were smaller for pQCT [BMD (T- 
score difference, p-value): Qscort(-0.58,0.018), Qtot(-
0.54,0.013), Qtrab(-0.35,0.098), Qcort(-0.29,0.174)] than for 
DXA lumbar spine (LS:-0.61,0.003), and femoral neck (FN:- 
0.76,<0.001), trochanter (FT:-0.81,0.001) and Ward's (FW : - 
0 . 77,<0.001) . These observed and estimated rates of change in 
pQCT BMD, and the differences between late premenopausal and 
early postmenopausal women, are contrary to the accepted theory 
of accelerated trabecular bone loss immediately following the 
menopause, at least at the radius. Rather they suggest 
remodelling, with trabecularisation of endosteal cortical bone.
In 216 perimenopausal women, correlations of Qtot, Qtrab and 
Qscort with DXA LS and hip measurements were moderate (r : 0 .35- 
0.53), and poorer with BUA (r: 0.24-0.31) and VOS (r: 0.1-0.17) . 
Corresponding figures for Qcort were even poorer. Consequently, 
pQCT would be of no value in pre-selecting perimenopausal women 
for axial DXA assessment. To detect all potential LS or FN 
osteopenia based upon a pQCT measurement, 98.6%-100% of the 
perimenopausal population would require a pQCT scan.
BMD in female vertebral and hip fracture populations, and the
vi
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power of pQCT compared to DXA and ultrasound in fracture 
discrimination was studied. There were significant differences 
in Qtrab [ (Z-score difference, p-value); -1.35,<0.001], Qtot (- 
0.94,0.001), LS (-1.37,<0.001), FN (-1.08,0.003), FT (-
1.03,0.006) and FW (-0.64,0.023), but not Qscort (-0.71,0.063) 
or Qcort (-0.24,0.2) between vertebral fracture (n=39) and non­
fracture (n=30) groups. Qtrab was superior (numerically, but 
not statistically) to other pQCT and axial DXA measurements in 
discriminating vertebral fractures [Area under the Receiver 
Operator Curve (AUC): 0.853]. There were statistically
significant differences in all pQCT (Z-score differences : -0.48 
to -0.73), DXA hip (-0.64 to -1.04) and ultrasound (-0.64 to - 
0.91) measurements between hip fracture (n=165) and non­
fracture (n=45) groups. FN (AUC:0.796) was superior 
(numerically and statistically) to all pQCT measurements and 
BUA, but not VOS (AUC:0.783) in discriminating hip fractures. 
Corresponding AUC's for pQCT measurements (except Qcort) were 
greater in the vertebral than hip fracture study, suggesting 
that pQCT may have a greater role in the prediction of 
vertebral fractures.
Osteo-densitometry has a recognised role in monitoring response 
to drug therapy. Changes in pQCT BMD were compared to DXA hip 
and spine BMD during treatment for 1 year with HRT (n=ll) and 
cyclical etidronate (ETD:n=10) in postmenopausal women. In both 
groups, the greatest increase after 1 year was found at LS 
(HRT:+6.6%,p<0.001; ETD:+5.2%,p=0.013), with significant change 
detected after only 4 months (HRT :+3.3%,p=0.02 ; ETD:+3.8%, 
p=0.01). In both groups, pQCT BMD remained virtually unchanged, 
suggesting that routinely, response to HRT and ETD in best 
detected by monitoring LS BMD. An adverse effect of warfarin on 
BMD was observed in a cross-sectional study. 40 men requiring 
longterm warfarin for cardiovascular disease, were matched for 
underlying disease with 40 controls. All pQCT and axial DXA BMD
vii
' - ...r:-,.-.   _ _ _ _ _ _   ___
vm
measurements were lower in the warfarin group, reaching 
statistical significance for LS (-10.4% difference,p=0.003) and 
Qtrab (-9% difference,p=0.024).
BMD is reduced in patients with rheumatoid arthritis (RA) . The 
pathogenesis is complex, and the contribution of low dose 
corticosteroid therapy controversial. pQCT was compared to 
axial DXA and ultrasound in 75 postmenopausal women, of which 
29 were controls, 21 non-steroid treated and 25 steroid treated 
RA patients. There was no significant steroid effect on any BMD 
measurement. Qtrab (p=0.001), Qscort (p=0.009) and Qtot
(p=0.016), were significantly lower in the RA groups, as were 
both ultrasound measurements (p=0.001) and all DXA hip 
measurements (p=0.012-0.002). Differences in LS and Qcort were 
insignificant. The principle determinant of Qtot, Qtrab and 
ultrasound measurements was the degree of radiological damage 
(Larsen score). pQCT and ultrasound measurement sites are 
periarticular, and may be of value in assessing RA disease I 
. .activity and response to therapy.
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CHAPtER 1 î
INtRODUCtION
This thesis examines the clinical role of peripheral 
quantitative computed tomography (pQCT) in the expanding field 
of osteoporosis. pQCT is a relatively new method of measuring 
bone mineral density (BMD) at appendicular sites, and when the 
work for this these was undertaken, there was very little
■ipublished work on its use. It is a technique which offers
was to evaluate pQCT in relevant areas of clinical care for 
those suffering from osteoporosis, in an attempt to define a 
niche for its use.
Understanding the fundamentals of bone pathophysiology and 
biomechanics ; osteoporosis - its definition and aetiologies; 
and osteo-densitometry - particularly present day techniques 
and defined roles, was essential in planning the work
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potential advantages over existing methods by assessing 
trabecular and cortical bone compartments independently at an 
easily accessible peripheral site. This facility is important 
as trabecular and cortical bone behave differently depending
upon the prevailing circumstances. In addition, pQCT 
measurements are truly volumetric, and therefore reflect true 
BMD, unlike many other techniques which "correct" bone mineral 
content for the projected area. While several peripheral sites 
are accessible to pQCT, work for this thesis was limited 
purely to the ultra-distal radial site. Osteoporosis is 
recognised as a huge clinical problem and a considerable drain 
upon NHS resources. Delivery of effective health care for 
those suffering from osteoporosis includes provision of 
facilities to measure BMD (1.1). The purpose of this thesis
"Si
presented hereafter. The remainder of the introduction sets 
out present day knowledge of these matters.
1.1. Bone
1.1.1 Normal Cellular Function
Bone is the living tissue that forms the skeleton, providing 
a mechanical framework of support. Skeletal growth occurs 
during childhood and adolescence, and involves bone modelling 
by either endochondral or intramembranous ossification. During 
adult life, bone undergoes the continuous process of
remodelling in response to the changing needs of an
individual. Remodelling comprises or a series of complex 
interactions between cells and the extracellular matrix. Two 
processes are responsible for remodelling - bone resorption 
where osteoclasts remove bone, and bone formation where 
osteoblasts lay down bone. The opposing functions of
osteoclasts and osteoblasts are closely linked by a phenomenon 
known as "coupling", with resorption then formation occurring 
in discrete areas known as "basic multicellular units" 
(BMU) . The process of coupling within a BMU is depicted in 
figure 1.1. Arrival of osteoclasts on the bone surface signals 
the initiation of bone remodelling. Osteoclasts are derived 
from haematopoietic granulocyte-macrophage fibroblast colony- 
forming units (1.2,1.3) which also produce monocytes and 
macrophages. The point at which they become committed to the 
osteoclast lineage is not clear, but osteoclast progenitors 
migrate from bone marrow to bone through the circulation or by 
direct migration (1.3). Having arrived on the bone surface, 
osteoclasts remove a quantum of bone leaving a "resorption 
pit". This is achieved through the expression of many features 
of the macrophage (1.3). Bone resorpting agents are secreted
into the extracellular space and bone is broken down. 
Internalization of the products occurs through phagocytosis 
before being further processed (1.2). The process of coupling 
attracts osteoblasts into the resorption cavity. Osteoblasts 
are derived from the pluripotent mesenchymal stem cells of the 
bone marrow (1.2,1.3), which can differentiate into 
fibroblasts, chondrocytes, adipocytes, and muscle cells. The 
progenitors which produce these cell lineages are known as 
fibroblast colony-forming units (1.3). The main function of 
osteoblasts is secretory. Deposition of the extracellular 
matrix occurs within the resorption cavity that is 
subsequently mineralised. The synthesis, deposition and 
mineralization of the extracellular matrix require the orderly 
expression of several genes, their correct expression being 
prerequisite for the next (1.4) . Type I collagen is the major 
matrix component secreted by the osteoblast and the main 
structural protein of bone. Its expression occurs early, 
during the proliferative phase of osteoblast function. 
Synthesis of many other non-collagenous proteins occurs. To 
name but a better known few, alkaline phosphatase and 
osteopontin are expressed later during the osteoblast matrix 
maturation phase. Osteocalcin is expressed even later during 
its mineralization phase (1.4). Filling of the resorption 
cavity is achieved with completion of osteoblast function. The 
surface is then covered with flattened cells that line the 
surface of all bone that is quiescent (1.2), Remodelling 
occurs continuously throughout the skeleton during adult life. 
Inspection of the surface of a section of bone reveals several 
resorption hollows at different stages surrounded by areas of 
quiescent bone. The control of osteoclast and osteoblast 
function and its coupling is extremely complex, involving
cellular interplay, the interaction of many cytokines and 
hormones, and local mechanical factors (1.2,1.3).
Properties
Division of bone is possible into two distinct types 
cortical and trabecular.
Î
1.1.2. Bone types, Skeletal Distributions and Biomechanical
ICortical bone makes up approximately 80% of the skeleton. It 
consists of a series of irregularly spaced, overlapping 
cylindrical structures known as Haversian systems, each 
comprising a central canal surrounded by concentric layers of 
bony tissue. Remodelling of cortical bone occurs at periosteal 
and endosteal surfaces, and within the Haversian canals. 
Increased Haversian system resorption will cause increased 
porosity of cortical bone, while increased periosteal and 
endosteal resorption results in increased numbers of surface
'BMU'8 (1.5). The proportion of cortical and trabecular bone 
varies within individual bones and according to skeletal site. 
Cortical bone is found primarily in the diaphyseal region of 
long bones in the appendicular skeleton, with metaphyseal 
areas containing a smaller proportion. With increasing age, 
endosteal exceeds periosteal resorption resulting in
progressive cortical thinning, an increased intramedullary ;
Space and a small increase in the diameter of the bone
(1.5,1.6). There is considerably less cortical bone in the i
■3iaxial skeleton, where trabecular bone predominates. However, ÿ
within the clinically important vertebrae, the vertebral body 
has a thin envelope of cortical bone, and the posterior 
elements are predominantly cortical bone (1.5,1.7), 
contributing significantly to antero-posterior lumbar spine I
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bone mass assessments - 53% in women and 44% in men (1.7).
Trabecular bone comprises approximately 20% of the skeleton, 
and consists of a meshwork of interconnecting trabeculae. It 
is found predominantly in the axial skeleton within the 
vertebral bodies and flat bones, and within the metaphyseal 
region of lone bones in the appendicular skeleton (1.2,1.5). 
Due to the greater surface area to volume ratio of trabecular 
bone, it is metabolically more active and responds more 
quickly to stimuli than cortical bone (1.2,1.3,1.5,1.8). 
Consequently, about 25% of trabecular, compared to 3% of 
cortical bone is remodelled each year during adulthood 
(1.3,1.9). Of great importance is the effect of the menopause 
upon bone quantity and quality. Ovarian failure and reduced 
levels of circulating oestrogen in women results in increased 
activation of BMU's, with increased bone resorption and a 
deficit in bone formation within each BMU (1.10,1.11) , The net 
effect is bone loss, which preferentially effects trabecular 
bone. Not only is the BMU activation frequency increased, but 
the depth of resorption cavity is also increased (1.11,1.12). 
This results in increased perforation of trabecular plates, 
decreased connectivity and disruption of the trabecular 
lattice structure, and subsequent reduction in load carrying 
capacity (1.11,1.13).
Also of importance is the presence of bone marrow, which is in 
close proximity to trabecular bone within the medullary 
cavities of bone. During childhood and adolescence, red or 
haemopoietic marrow is present in all bones. By the age of 20, 
marrow in the long bones has become inactive, being replaced 
by fat, which is then known as yellow marrow (1.14) . This
  .■  ■.  ,  ■ , ■' "/I.  I" ■
occurs in all long bone with the exception of the upper femur 
and humerus. In addition to the upper humerus and femur, 
haemopoietic marrow persists in the axial skeleton. However, 
marrow fat increases by about 7% per decade in the vertebral 
body (1.15). Consequently, the proportion of active marrow in 
elderly females with vertebral fractures is as low as 25% 
(1,5) . This age related change in the distribution and type of 
bone marrow may have important implications for the
measurement of BMD, and the response of bone to different
stimuli.
In this thesis, the radius, lumbar spine, proximal femur and
os calcis are the main skeletal sites studied, and the
proportion of cortical and trabecular bone varies with
skeletal site. At the radius there is variation in the
proportion of cortical and trabecular bone along the radial 
length. Four common measurement sites are encountered in the 
literature, these being denoted by the percentage of the total 
radial length, proximal to the most proximal point of the
radio-carpal joint that the measurement occurs. The most
distal measurement site is the 4% "ultra-distal" site where 
typically 50-55% of bone is trabecular (1.16,1.17). pQCT 
measurements occur at this site. At the 8-10% "distal" site, 
characteristically 25% of the bone mass is trabecular, and 
less than 10% at the 33% "1/3", and 50% measurement sites
(1.16) . The radius has been the subject of extensive study 
previously, mainly using single photon absorptiometry (SPA). 
This technique and others are discussed in greater detail 
later in this chapter (see section 1.3). It is worth stating 
at this point however, that SPA measurements occur at the 
distal, 1/3 and 50% measurement sites where the proportion of
trabecular bone is much lower than that found at the ultra- 
distal "4%" site. It is also worth noting that there are 
dramatic changes in the proportion of cortical and trabecular 
bone within the distal radius, which occur within small 
distances (1.16,1.17,1.18,1,19). The proportion of trabecular 
bone in the lumbar vertebral body is about 65% (1.2,1.5,1.20). 
In the proximal femur, the proportion is about 25-3 0% at the 
femoral neck (1.2,1.5,1.20), increasing to approximately 50% 
within the trochanteric region (1.20). The proportion at the 
os calcis is 90-95% (1.21).
Bone mineral density contributes about 75-85% of bone strength
(1.22), with both cortical and trabecular components being 
important (1.22), A decline in bone mass results in a 
disproportionately greater decrease in bone strength
(1.9.1.22). Bone mass of the spine (1.9,1,13,1,23,1.24,1.25), 
proximal femur (1.26,1.27,1.28) and distal radius (1.29,1.30) 
is strongly related to bone strength. For trabecular bone, 
both bone density (1.13,1.31,1.32,1.33) and structure
(1.9,1,22) are important in determining its strength. Halving 
the cross-sectional area of a vertical trabecular column, or 
doubling the effective vertical length of the column through 
loss of horizontal support reduces its carrying capacity by 
75% (1.22). Although trabecular bone is of great importance,
cortical bone at the spine (1.31,1.34), femoral neck 
(1.26,1.35) and radius (1.36) are also important in 
determining the overall strength of bone. More pertinent in
the context of this thesis, both cortical shell geometry and
trabecular BMD at the ultra-distal radial site (1.36), and 
cortical BMD and thickness at the distal 1/3 site (1,37) as 
assessed by pQCT, is related to fracture force.
1.1.3 Normal Age Related Bone Mass Changes
A simple graphic representation of gender and age related 
changes in BMD is shown in figure 1.2. Skeletal growth and 
bone mass increases during childhood (1.38,1.39,1.40,1.41). 
During puberty, there is rapid skeletal growth matched by an 
increase in bone density (1.41,1.42,1.43,1.44,1.45). Marked 
accumulation occurs at the lumbar spine during puberty
(1.43,1.44), while a more linear increase has been found at 
the radius (1.40), albeit assessed by SPA. It is possible that 
accretion of cortical and trabecular BMD during childhood and 
adolescence may differ. This issue cannot be adequately
addressed using measurement techniques which measure areal 
BMD, such as SPA and DXA. Maximum accretion of bone mass 
occurs during early adulthood, and the maximum potential in an 
individual is known as peak bone mass (PBM).
PBM is an important concept in the pathogenesis of
osteoporosis, as fracture risk in later life is considered 
(although not yet proven) to be dependent upon PBM, and the 
rate of subsequent bone loss in later life (1.46,1.47,1.48). 
PBM in men is generally accepted as being greater than that 
in women. While this is accepted at the radius 
(1.40,1.49,1.50,1.51,1.52), it is more controversial at the 
spine, some having found greater bone mass in males
(1.53,1.54), others having found no gender difference 
(1.52,1.55,1.56). It is thought that areal BMD measurements 
acquired using dual energy x-ray absorptiometry (DXA) and dual 
photon absorptiometry (DPA), rather than volumetric BMD 
measurements using QCT may account for in part these 
discrepancies, as the greater bone size in males results in an 
overestimation of areal BMD gender differences (1.57).
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However, even data acquired using volumetric measurements have 
been conflicting (1.53,1.54,1.55,1.56). PBM is predominantly 
influenced by genetic factors, which account for about 80% of 
the population variance (1.58,1.59). Other factors such as 
parity and lactation, oral contraceptive use, diet, physical 
activity and smoking have been shown to have an inconsistent 
and variable effect upon PBM (1.49,1.60). There is controversy 
regarding the timing of PBM (1.46). Based upon older, cross- 
sectional data, the consensus was that PBM was attained by the 
end of the third decade (1.46,1.51). Recent cross-sectional 
(1.44,1.60,1.61,1.62,1.63,1.64) and longitudinal (1.45,1.65) 
studies with greater numbers of subjects suggest that PBM is 
achieved by the end of the second decade.
After acquisition of PBM, bone mass is generally considered to 
be maintained until the latter part of the fifth decade, 
after which continuous trabecular and cortical bone loss occur 
at all skeletal sites, in all individuals of both sexes
(1.47,1.49,1.51,1.64,1.66,1.67,1.68,1.69,1.70,1.71,1.72,1.73) . 
Following the menopause, women experience a phase of 
accelerated bone loss which preferentially effects trabecular 
bone (1.49,1.64,1.66,1.67,1.74,1.75,1.76,1.77). This lasts 
approximately ten years and is caused by ovarian failure and 
oestrogen deficiency. There is controversy regarding the 
timing of bone loss at different skeletal sites. Most would 
agree that radial BMD is stable until the end of the fifth 
decade, or until the onset of the menopause
(1.50,1.51,1.63,1.68,1.69,1.70,1.78,1.79), although others 
have shown bone loss in premenopausal women in a longitudinal 
study (1.80). The issue is less clear at axial sites, where
some cross-sectional studies have documented reductions in BMD
at the hip (1.68,1.72,1.81) and spine (1.51,1.74) earlier than 
the fifth decade, as have longitudinal studies at the spine 
(1.70,1.82,1.83). If premenopausal bone loss does occur, it is 
considerably less than postmenopausal loss, and much less 
important (1.84).
Controversy also exists about bone loss in the elderly. Some 
work has suggested that bone loss may cease or actually 
increase at the spine, hip and radius (1.73,1.85). This 
assumption however, has been called into question. Several 
factors such as selection of a fracture free population, 
secular trends in BMD, mortality of fracture patients, and 
accuracy errors of BMD measurements due to concomitant 
osteoarthritis and marrow fatty changes, confound the study of 
the elderly. All these confounding factors (except marrow 
changes) will lead to an over-estimatation of BMD, and an 
under-estimatation of the rates of bone loss in the elderly 
(1 .86).
1.1.4 Describing BMD Measurements: t-Score and Z-Score
IIt is important to describe BMD values in such a way that is easy to understand, and that gives as much information as 
possible without being misleading (1.87,1.88). There are
several approaches to this.
1. The absolute BMD value. This alone has limitations as 
there are age and sex related differences in absolute 
BMD.
2. The percentage of the expected age and sex matched value. 
Although easy to understand, it has limitations and can 
be misleading. With ageing the mean value decreases, and
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hence a decreasing denominator results in a wider range 
of percentage values representing the normal range. This 
is especially important if serial measurements are 
expressed as a percentage relative to the age related 
normal mean (not to be confused with expressing the 
percentage change relative to the baseline measurement). 
The percentile of the expected age and sex matched value. 
This is also easily understood, does not depend upon a 
normal distribution of data, and is not misleading in 
comparison to age matched controls or serial 
measurements. Unfortunately, expression of BMD as a 
percentile make age related comparisons difficult, and at 
present, they are not widely used by the manufacturers of 
osteo-densitometer.
A unit of standard deviation (SD) from the normal mean. 
Data has to be normally distributed to allow BMD 
expression in this manner. Data not distributed normally 
require appropriate transformation. Population studies 
have demonstrated a Gaussian distribution of BMD values 
at all ages, in both sexes, at all skeletal sites when 
large enough numbers of subjects are studied. Comparison 
with other age groups is convenient and not misleading, 
but many clinicians are not familiar with data expression 
in SD units. Two different scores are commonly used. 
These are described below and graphically represented in 
figure 1.2.
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Z-score this value is the number of SD's above or below 
the sex and. age related normal mean.
t-score this value is the number of SD's above or below 
the mean value of young normals.
These values are now frequently used, and as discussed 
later in this chapter (chapter 1.2.1), the T-score is 
central to the definition of osteoporosis.
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1.2 Os teoporos i s
1.2.1 History and Definition of Osteoporosis
Only in recent years has osteoporosis received attention from 
the medical profession, and achieved public awareness that it 
warrants. The term "osteoporosis" was introduced to the 
medical literature in the 18th century (1.89). Its use implied 
a histological diagnosis of "porous bone" which was later 
refined to signify a reduced quantity of bone which was 
normally mineralised. This formed the basis for the first 
modern attempt to redefine osteoporosis using population based 
bone mass measurements performed by newer osteo-densitometers . 
Osteoporosis was thus defined as a BMD less than two standard 
deviations (SD) below the mean of young normal women i.e. a T- 
score less than -2 (1.90). This definition is solely dependent 
upon reduced bone mass, yet is it clear the structural 
deterioration in bone tissue is also of great important in 
determining bone strength. Moreover, few would argue that the 
most important end point of reduced bone mass, is fracture. 
This also is neglected in the above definition. Subsequently, 
the definition of osteoporosis was changed in 1991 to the 
following:
Osteoporosis is a disease that is characterized by 
abnormalities in the amount and architectural arrangement 
of bone tissue, which lead to impaired skeletal strength 
and an increased susceptibility to fracture (1.91).
Although this definition encompasses all the important 
concepts of osteoporosis, its clinical and research 
application is limited by being purely qualitative. To 
overcome this problem, the World Health Organisation recently
I
devised an operational definition which is based upon BMD and 
fracture occurrence (1.92).
OStEOPENIA
BMD more than 1 SD below the young normal mean, but less 
than 2.5 SD below.
i.e. -1.0 > t-score > -2.5
OStEOPOROSIS
BMD more than 2.5 SD below the young normal mean, without 
fracture.
i.e. t-score < -2.5 (no fracture)
SEVERE OStEOPOROSIS
BMD more than 2.5 SD below the young normal mean, with 
fracture.
i.e. t-score < -2.5 (plus fracture)
However, limitations persist even for these definitions. 
Structural considerations have been omitted, and the diagnoses 
of osteopenia and osteoporosis (without fracture) are 
dependent upon BMD measurement. Osteo-densitometry is 
therefore essential for the diagnosis of osteoporosis without 
fracture, a service not readily available to all at the 
present time in the UK. A further problem in definition is 
posed by intra-individual variation in BMD. Due to this, an 
individual can be classified as osteoporotic according to BMD 
at one skeletal site, yet not based upon another.
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Consequently, the prevalence of osteoporosis in Caucasian 
women varies from 16% to 3 0% depending upon the number of 
skeletal sites assessed (1.92). Inspite of these limitations,
this is the definition of osteoporosis which prevails at the
present time.
Some idea of the magnitude now posed by osteoporosis has been 
shown by the applications of these definitions to a local 
American population in Rochester, with subsequent 
extrapolation nationwide. It has been estimated that 16.8 
million (54%) postmenopausal white American women have 
osteopenia, and a further 9.4 million (30%) have osteoporosis 
from this calculation (1.93). Comparable figures from other 
populations (notably the UK) are not yet available, but these 
figures serve to illustrate the magnitude of the problem posed 
by osteoporosis.
1.2.2 Osteoporotic Fractures
Osteoporotic fractures are characterised by incidence rates
greater in females than males, rates which increase steeply 
with age, and a tendency to occur in skeletal sites richer in 
trabecular bone (1.94). The sites which are typically affected 
are the hip, thoracolumbar spine and distal radius, although 
fractures of the proximal humerus and distal femur also have 
the above characteristics (1.95). There are considered to be 
two distinct types of osteoporosis, leading to different 
fracture types (1.67). Type I osteoporosis (and fracture) is 
caused by ovarian failure, reduced levels of circulating 
oestrogen and increased bone loss. Trabecular bone is 
preferentially effected and greater bone loss occurs at 
skeletal sites richer in this bone type - namely the spine and
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Idistal radius. Ultimately, this predisposes to vertebral and 
Colles' fractures (1.67). Type II osteoporosis (and fractures) 
results from age related reduction in both cortical and 
trabecular bone. This affects all individuals of both sexes, 
and predisposes to hip fractures (1.67). Graphic 
representation of the age and gender related incidence of hip, 
vertebral and distal forearm fracture is shown in figure 1.3.
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Caucasian women and men have a lifetime fracture risk of 17.5% 
and 6% respectively for hip fracture, 15.6% and 5.6% for
clinically diagnosed vertebral fracture, and 16% and 2.5% for 
distal forearm fractures (1.96), Determining the exact 
prevalence and incidence of vertebral fracture is complicated 
by asymptomatic events, and the application of differing 
fracture criteria (1.97). This is discussed in greater detail 
in section 1.2.2.2. However, from the age of 50 years onwards, 
the life-time risk for any of the three fractures is 39.7% for 
women and 3.1% for men (1.96). Consequently, in the UK around 
50,000 hip fractures, 40,000 clinically diagnosed vertebral 
fractures and 50,000 distal forearm fractures will occur 
annually in women (1.12), costing the National Health Service 
an estimated £740 million (1.1). With an increasingly aged 
population, these figures are set to rise (1.98). Specific 
osteoporotic fractures are discussed briefly below.
1.2.2.1 Hip Fracture
Hip fracture is the most serious of the osteoporotic 
fractures. Its incidence rises exponentially with age, and 
above the age of 50 there is a females to male ratio of 2:1 
(see figure 1.3) . The lifetime age and sex related hip 
fracture rates are higher in Caucasian compared to Black or 
Asian populations (1.99), the female predilection also being
rt.i --Ji" i L is-:. ■■
absent in the latter populations (1.95). There are also 
regional differences in hip fracture incidence between 
(1.95,1.100,1.101), and within countries (1.95). There is 
significant morbidity and mortality associated with hip 
fracture, with the relative survival rate at 5 years being 
0.8 3 (1.94). The majority of deaths occur within 6 months of 
fracture, and are related to concomitant illnesses (1.102), 
although some are due to complications of the fracture or its 
surgical management (1.103) . Aetiological factors in the 
pathogenesis of hip fracture are discussed further in chapter 
8 .
1.2.2.2 Vertebral Fracture
Inspite of being synonymous with the diagnosis of 
osteoporosis, information on the epidemiology of vertebral 
fracture remains scanty. This is in part due to clinically 
silent fractures, which necessitates clarification of the 
distinction between "fracture" and "deformity". "Fracture" 
applies to morphometric abnormalities detected as a 
consequence of symptoms, usually back pain or loss of height. 
"Deformity" refers to abnormalities detected from morphometric 
studies which have been performed regardless of clinical 
symptoms (1.95). Gathering of epidemiological information has 
also been hindered by the lack of universal agreement on the 
definition of a vertebral fracture. There are many differing 
definitions based upon vertebral body morphology 
(1.104,1.105,1.106,1.107,1.108,1.109). There are two main 
methods of determining deformities/fractures at the present 
time. Quantitative method relies solely upon vertebral height 
measurements. Semi-quantitative methods require inspection of 
the x-ray by a radiologist as well as measurement of vertebral
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heights. Semi-quantitative methods have the advantage of 
allowing differentiation of change due to conditions other 
than osteoporosis (such as Schuermanns disease) from true 
vertebral fracture. However, it is also highly dependent upon 
the experience of the radiologist, and reproducibility can be 
a problem, especially if criteria are not laid down. As each 
vertebral body has characteristic dimensions (1.104), probably 
the most widely accepted definitions incorporate a 
distribution of vertebral body dimensions for each spinal 
level, with cut-off values defining a fracture 
(1.95,1.106,1.107). However, to date there is no agreement as 
to which of these numerous methods of defining a vertebral 
fracture is best.
The incidence of clinically diagnosed vertebral fractures is 
shown in figure 1.3. In men the incidence rate increases 
exponentially, whilst in women there is a more linear 
increase. The most common spinal level for fracture is the 
lower thoracic and upper lumbar spine (1.95), most occurring 
as a result of minimal trauma. It has long been appreciated 
that morbidity is associated with vertebral fracture. Now 
there is recognised to be significant associated mortality, 
with a relative survival rate of 0.82 (1.110).
1.2.2.3 Distal Fore-arm Fracture
The incidence pattern of this type of fracture differs from 
that of hip and vertebral fractures (see figure 1.3) . In 
women, the incidence rate increases linearly between the ages 
of 40 and 65 years before stabilising. In men, there is a 
linear increase from the age of 20 to 80 years. The majority 
of fractures occur in females (females:male ratio of 4:1).
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Although morbidity arises from this fracture, there is no 
associated mortality (1.95) .
1.2.3.1 Risk Factors and Causes of Secondary Osteoporosis
The importance of ageing in type 2 osteoporosis, and the 
menopause, ovarian failure and hypoestrogenaemia in type 1
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::osteoporosis has already been eluded to in the preceding 
sections of the introduction. Table 1.1 lists the large 
numbers of lifestyle factors, concomitant diseases and drugs 
which adversely affect bone and predispose to osteoporosis 
(1.11,1.49,1.111). They are too numerous to discuss in detail 
in the introduction of this thesis, although some are 
discussed in greater detail in the relevant chapters of this 
thesis. Worthy of further discussion at this point however, is 
corticosteroid induced osteoporosis which is probably the 
commonest cause of secondary osteoporosis. Unfortunately, it 
was not possible to study its effect on bone per se, although 
its was studied in patients with rheumatoid arthritis, work 
which is presented in chapter 11. Corticosteroid induced 
osteoporosis is therefore discussed below.
1.2.3.2 Corticosteroid Induced Osteoporosis.
Direct Bone Effects.
Corticosteroids uncouple bone metabolism in favour of 
resorption, at least early in the course of therapy. 
Osteoblast function and precursor differentiation are directly 
inhibited, whilst the rate of mineral apposition is reduced 
resulting in inhibition of bone formation (1.112). Conversely, 
bone resorption is probably increased, although the evidence 
supporting this is less convincing and there is no convincing 
evidence that corticosteroids directly stimulate osteoclasts.
However, increased numbers of osteoclasts have been 
demonstrated histomorphometrically (1,113), It is thought that 
the increased osteoclast activity is a consequence of mild 
secondary hyperparathyroidism induced by depressed intestinal 
calcium absorption (1.114) and increased urinary calcium 
excretion (1.115). Thus the overall effect of corticosteroid 
is to reduce bone formation and probably increase bone 
resorption resulting in net bone loss (1.116).
Indirect Hormonal Effects
Adequate levels of oestrogen and testosterone are necessary 
for healthy bone. Corticosteroids have been shown to reduce 
circulating oestrogen levels by blunting the LHRH dependant 
pituitary release of LH (1.117), and the FSH dependant gonadal 
release of oestrogen (1.118,1.119) and testosterone 
(1.120,1.121). Likewise, there is evidence that adrenal 
androgens are important in maintaining bone density, with low 
dehydroepiandrosterone (DHEA) levels predicting reduced 
femoral BMD in post menopausal females (1.122,1.123). 
Corticosteroids cause ACTH suppression and adrenal atrophy, 
reducing androstenedione and oestrogen levels (1.124).
Vitamin D plays an important role in calcium homeostasis and 
bone metabolism, but as yet its role in corticosteroid induced 
osteoporosis in unclear. The inhibition of intestinal 
absorption would appear to be independent of Vitamin D status 
(1.125,1.126). The importance of mild secondary 
hyperparathyroidism has already been eluded to, net calcium 
loss through decreased intestinal absorption and increased 
renal excretion being the stimulus (1.114,1.115). 
Normocalcaemia is usual, and although conflicting levels of
20
PTH (normal or high) have been demonstrated, bone biopsies 
showing increased osteoclast activity(1.113) and increased 
nephrogenic cAMP measurements(1,127) support the contention 
that corticosteroids induce a state of mild secondary 
hyperparathyroidism. Thus corticosteroids have a profound 
effect on a variety of hormones involved in bone metabolism 
with changes favouring bone loss.
Effects upon Bone Mineral Density and Fracture.
High dose corticosteroid therapy can cause annual bone loss of 
5-15% (1.128,1.129,1.130). However, not all patients lose bone 
(1.129,1.130), and recovery after cessation is possible 
(1.131) . Although both trabecular and cortical bone are 
adversely effected, greater loss occurs from the former 
(1.128,1.132,1.133,1.134). The long term consequences of this 
is an increased fracture rate of femoral neck, rib and 
particularly thoracolumbar spine (1.116,1.135). The true 
incidence of fracture at this latter site has not been 
accurately defined, because painless fractures often escape 
detection.
Bone loss occurs most rapidly during the first few months of 
corticosteroid therapy, with subsequent slower, but continued 
bone loss(1.128,1.136,1.137). Low dose therapy (less than 
7. 5mg/ day prednisolone) may have less effect on premenopausal 
than postmenopausal women or men(1.138) . Larger doses however, 
affect all population groups irrespective of age, menopausal 
status, sex or racial origin, with evidence suggesting that 
children and postmenopausal women lose bone especially 
quickly(1.139). The latter group are most at risk of fracture 
presumably due to the additive effect of oestrogen deficiency.
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The cumulative dose has been found by most investigators to 
relate to the amount of bone loss, although a threshold value 
over which this becomes critical has not been established. 
Alternate day dosing offers no protection against bone 
loss(1.139), and all corticosteroids affect bone adversely 
although, equipotent doses of Deflazacort have been shown to 
have a less detrimental effect than other synthetic steroids 
(1.140). Corticosteroid induced bone loss occurs irrespective 
of the underlying condition being treated. Recent interest has 
focused on the effect of inhaled steroids used in the § 
management of asthma on bone. Evidence is mounting that even 
this small dose may adversely affect bone(1.141,1.142). The 
longterm importance of this is yet to be established.
Through quantification of trabecular bone, pQCT would be 
ideally suited to monitor the effects of corticosteroid. #
Ruegsegger et al (1.139, 1.143) have studied a small numbers 
of asthmatics treated with corticosteroid for 1 year and found 
dose related reductions in trabecular BMD at the radius up to 
17.5%, while cortical BMD was unaffected. Beyond these small, 'Iinitial studies there is a paucity of data examining the use #
of pQCT in monitoring the effect of corticosteroid on bone.
At the present time, axial DXA BMD assessments are indicated 
for the management of patients likely to be treated with 
corticosteroid for more than one year (1.144,1.145,1.146). 
Further work is necessary to establish whether pQCT has a role 
in the management of corticosteroid induced osteoporosis.
a
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1.3 techniques Used to Assess Bone Mass
Development of methods to assess bone mass has contributed 
immensely to the recent increased awareness of osteoporosis as 
a serious health issue. Clinicians and the public alike, are 
now informed that there are methods available to assess bone 
mass, albeit some more than others. These methods must satisfy 
several criteria before they can be utilised clinically. They 
must be accurate (reflect true bone mass), precise 
(reproducible) in the short and longterm, acceptable to the 
patient and safe in terms of radiation exposure. A number of 
methods exists to assessing bone mass, some more readily 
available than others. These have been reviewed extensively 
before (1.88,1.147-1.154). Techniques such as neutron 
activation analysis (1.147, 1.155),compton scattering (1.147) 
and proton activation (1.147) are not routinely used. A new 
area of interest, which is still very much a research tool is 
quantitative magnetic resonance imaging. This may reveal 
information about trabecular bone microstructure as well as 
density (1.147,1.152,1.153,1.154). The following section is 
a summary of the commonly used, present day methods of 
assessing bone mass.
1.3.1 Radiographs
A plain x-ray can detect fracture, but is not sensitive enough 
to accurately assess BMD (1.5,1.156). Structural analyses of 
radiographs have been developed in an attempt to improve the 
diagnostic ability of x-rays.
The pattern of trabeculae in the proximal femur can be graded, 
and is known as the Singh index (1.157). With age related 
trabecular thinning, the grade changes from VI to I. Although
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the index is lower in women with hip, vertebral of Colles |
i;]fractures, it has been criticised by some {1.155,1.156), but 
not others (1.159) for its subjectivity and high inter­
observer variability. It has a low sensitivity but high 
specificity for diagnosing low bone mass, with a large overlap 
in BMD between grades (1.158,1.159). It may have a adjuvant 
role in conjunction with BMD, geometric or morphometric 
assessments in fracture prediction, but this requires further
study.
conditions. Less frequently the radius, humerus, clavicle.
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Radiogrammetry is a technique where a high quality antero- 
posterior x-ray of the hand is performed under standard
tibia and femur have been studied. In the hand, numerous 
measurements from the metacarpal (usually the second) are used ||
to calculate various indices. As a technique of assessing bone
3mass, it is limited to peripheral site, is time consuming, 
requires skilled personnel, assesses only cortical bone, 
detects only advanced osteoporosis and is therefore not lï:routinely used today (1.5,1.155).
I,g:
Radiographic absorptiometry, which was previously known as 1
photodensitometry, is a technique where an x-ray of a 
peripheral bone (usually phalanges, less commonly radius or 
tibia) is obtained under standard conditions together with an $
aluminium reference wedge. The density of bone on x-ray is I
then derived by comparison with the wedge using an optical
densitometer. There has been some resurgence of interest in gS'
photodensitometry (1.160), with computer enhanced analysis 
and improved performance. Precision has improved to 1.5-2% #
(1.161,1.162) which is comparable with other scanning
modalities such as DXA. It is a readily available technique of 
low cost and low radiation dose. It correlates well with in 
vivo radial BMD as measured by SPA (1.161) and DXA
(1.162,1.163), and moderately with axial hip and spine BMD as
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measured by DP A (1.161) and DXA (1.162,1.163,1.164). An age 
related decrease in the metacarpal index (one of the 
calculated parameters) has been documented (1.163), and 
evidence exists that it provides an estimate of vertebral and 
hip fracture risk (1.160,1.165). It may prove to be of value 
as a population screening tool, bearing in mind that DXA in 
not universally available.
1.3.2 Single Photon Absorptiometry (SPA)
SPA was developed in the I960's. A highly collimated photon 'beam from a single energy radiation source (usually ^^ I^) is used
■to measure photon attenuation at the measurement site. Its use 
is limited to scanning peripheral sites as the scan site 
requires to be immersed in water to ensure uniform absorption 
of the single energy radiation from the surrounding tissues.
The cortical rich radius is most commonly scanned, although 
the exact site can be varied to increase the proportion of 
trabecular bone. The distal femur and calcaneus can also be
scanned. Precision is 1-3%, accuracy 5%, scan duration 15 mins
with a radiation dose of 0.5-1.0 ptSv. A recent development has 
been the replacement of the ^^ I^ source with a mini X-ray tube, 
giving the advantage of a stable photon source with improved 
longterm precision. This variation is known as single energy 
x-ray absorptiometry. ;
1.3.3 Dual Photon Absorptiometry (DPA)
DPA overcomes the problems of soft tissue composition and
Î
water immersion encountered by SPA, by using a double energy 
source which emits two different photons energies. These 
photon energies have different bone and soft tissue
attenuation properties which can be subtracted from each other 
allowing the BMD of axial sites such as the proximal femur and 
lumbar spine to be quantified. Total body scans can also be 
performed. Initially two isotopes (iodine: ^^ I^, and
americanium: ^^ A^m) were used, before the single isotope
gadolinium (^ ^^ Gd) , with dual emission energies of 44 and 
lOOkeV, became the standard. Typically, precision values are 
2-4%, accuracy 4-10%, scan duration 20 mins (45 mins for total 
body scans) and the radiation dose is around 1 ^Sv. Decay of 
the radiation source requires its replacement after
approximately 18 months which can become expensive and further 
adversely affect precision. This lead to the replacement of 
isotopes by an X-ray source giving dual energy X-ray
absorptiometry.
1.3.4 Dual Energy X-ray Absorptiometry (DXA)
DXA is now probably the most widely used scanning technique, 
and was introduced commercially in 1987. The radionucleotide 
source used in SPA and DPA was replaced with an x-ray tube. 
Two distinct energy level beams are generated by one of two 
methods. One method (used in Hologic scanners) uses rapid 
switching of the x-ray generator between high and low voltage 
settings. The other (used by Norland and Lunar scanners) 
produces a beam from a constant voltage, which is then
filtered into two different energy beams. Measurements using 
DXA are possible at almost any skeletal site. Sites most 
commonly scanned are the antero-posterior and lateral lumbar 
spine, proximal femur, whole body, radius and calcaneus. At
26
27
S
the hip a number of different measurements are recorded. The 
femoral neck and trochanter areas have differing trabecular 
contributions as detailed in chapter 1.1.2. Ward's area is a 
derived region of maximum trabecular bone content in the 
proximal femur. For AP scanning of the lumbar spine, precision
.is less than 1%, and 2-3% at the hip. Accuracy is 5-10%, scan 
duration is less than 10 mins (20 mins for total body scans) 
and the radiation dose 0.1-0.4 ^Sv. Recently fan beam (rather 
than pencil beam) DXA scanner have been developed and are now 
commercially available. These scanners quantify BMD in the 
thoracolumbar spine, and the images produced also allow 
vertebral body morphometric analysis. This development is 
known as morphometric x-ray absorptiometry (MXA).
DXA is now considered to be the benchmark method of measuring 
BMD. There are however limitations worthy of discussion. DXA, 
like DPA and SPA provide planar, two dimensional BMD 
measurements, which are expressed as g/cm^. Such BMD 
measurements are influenced by skeletal size, and can be 
underestimated in small individuals (1.88). Although the 
lumbar spine is considered to be a trabecular rich site, 
antero-posterior scanning incorporates the posterior elements 
of the spinal column which is predominantly cortical bone 
(1.5, 1.7), and contribute 53% of BMD in women, and 44% in men 
(1.7) . This can be minimised by using a lateral projection, 
but at the expense of poorer precision and accuracy, a smaller 
region of interest and a radiation dose 5 times greater. Both 
spinal and hip DXA measurements are influenced by marrow fat 
content (1.86,1.166,1.167). Increasing amounts of fatty marrow 
with age underestimates the actual BMD, and overestimates the 
rate of age related bone loss (1.86). Spinal measurements can ■I
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also be falsely elevated by aortic calcification 
(1.168,1.169,1.170) or degenerative changes secondary to 
lumbar spondylosis (1.171-1.177), both of which are common 
with increasing age. There is also evidence that spinal 
osteoarthritis is related to an increased BMD secondary to 
changes in bone metabolism, not merely a consequence of 
osteophytosis (1.174,1.178,1.179), which can have a 
generalised effect upon BMD (1.177). AP spine Scanning of the 
hip is less plagued by confounding factors, although smaller 
regions of interest and rotation during positioning does 
affect data acquisition (1.180), resulting in poorer precision 
compared to that of the lumbar spine.
1.3.5 Ultrasound
Ultrasound was first used to measure properties of bone in the 
1960's, but was not widely employed until much more recently. 
Ultrasound use in the context of bone analysis is based upon 
the interaction of sound waves with bone tissue. Two 
ultrasonic properties are altered with transmission through 
bone: 1) wave velocity, and 2) wave amplitude. Alterations in 
amplitude are known as attenuation, which is highly dependent 
upon the frequency of ultrasound used. With low frequency 
ultrasound, the attenuation is almost linear, whereas with 
higher frequencies, it is non-linear. For this reason, low 
frequency ultrasound (0.2 - 0.6MHz) is used . Ultrasound
measurements occur at peripheral sites, most commonly the 
calcaneus, less commonly at the tibia, patella or phalanges. 
In this thesis, only calcaneal measurements were done. This is 
a weight bearing, trabecular rich site with flat, parallel 
surfaces, at which overlying soft tissue is limited even in 
obese subjects, which has been extensively studied before.
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Ultrasound measurements in this thesis were done using the 
McCue CUBA Clinical machine, the methodology of which is 
described in chapter 3. Two measurements are produced. 
Broadband ultrasonic attenuation (BUA) which is measured in 
dB/MHz, and velocity (VOS) which is measured in m/s. There are 
several slightly different variants of the velocity 
measurement. "True velocity" is the velocity of sound through 
bone tissue only. "Heel velocity" is the velocity of sound 
through bone and soft tissue. It is this measurement which is 
used throughout this thesis. Lastly, "time of flight" is the 
velocity of sound through coupling media, soft tissue and 
bone. The precision of BUA is 1-3.8%, and that for velocity 
0.1-1.2%. Both BUA and velocity measurements are considered to 
reflect not only bone density, but bone structure (1.181- 
1.184), although the importance of this property has been 
questioned (1.185). The major advantages of ultrasound are 
that it is a low cost, easily portable, radiation free 
technique, with a rapid scan time of less than 5 minutes. 
There are however several troublesome features of calcaneal 
ultrasound worthy of further comment. Precision of BUA remains 
poorer than other scanning techniques such as DXA. This may be 
related to the inhomogeneous nature of calcaneal trabecular 
bone, which in turn can influence the measurement depending 
upon the region of interest studied (1.186). Recent concern 
has also been expressed that the present generation scanners 
are inherently inaccurate (1.187). BUA does not scale linearly 
with bone size (1.188) (although this would not be a problem 
unless very large or very small bones were being scanned), or 
with high BMD values (1.184).
1.3.6 Quantitative Computed tomography (QCt)
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Quantitative computed tomography was introduced in the mid 
1970's, and measures true volumetric BMD, which is therefore 
expressed as g/cm^. It is also the only method which allows 
separate quantification of cortical and trabecular BMD. Spinal 
QCT has been used extensively. Accuracy of single energy 
spinal QCT is rather poor at 5-15% due to the effects of 
marrow fat (which increases with age) which falsely reduces 
BMD, especially in elderly osteoporotic women. Dual energy QCT 
is now available which improves accuracy to 5% but at the 
expense of a higher radiation dose and poorer precision (3-5% 
compared to 1-3% for single energy QCT), Scan time is about 10 
mins, but radiation dose is high at 20-200 ^Sv, which limits 
its use in repeat scanning.
There are several area of recent development with QCT 
(1.149,1.150). The use of stacked-slice and spiral CT scans 
allow a greater volume to be measured with improved precision. 
A more detailed analysis of spinal trabecular and cortical 
compartments is possible with respect to the regional effects 
of ageing and therapy, the relative contributions to bone 
strength, and fracture discrimination. Such a method of 
scanning also permits separate analysis of proximal femur 
trabecular and cortical bone, as well as providing detailed 
information on geometry. This is not possible with planar 
methods, such as DXA and DPA, or conventional QCT scanning due 
to its complex architecture, and rapid three dimensional 
variation in density and composition. Also being developed is 
high resolution QCT which allows assessment of trabecular 
micro-architecture at both axial and appendicular sites. This 
can be considered as being equivalent to a non-invasive bone 
biopsy. These are all areas of future study.
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1.3.7 Peripheral Quantitative Computed tomography (pQCt)
QCT applied to peripheral measurement sites was introduced in 
the mid 1970's (1.189). Radionucleotide sources (usually ^^ I^) 
were used initially, but found to be restrictive. Long scan 
times introduced movement artifact, and only small diameter 
sites could be scanned (1.190). To overcome these problems, 
modern pQCT scanners use an x-ray source 
(1.50,1.75,1.78,1.190). There are approximately 700 pQCT 
scanners worldwide, mostly in Europe (1.150). Most of these 
commercially available systems, which are manufactured by 
Stratec (including the one used for this thesis), perform a 
single axial slice of 2.5mm thickness at 4% of the ulnar 
length from the distal radial cortical endplate. The scanning 
procedure is discussed further in chapter 3. A smaller number 
of scanners, produced by Densiscan, perform multi-slice, high 
resolution scans, with improved precision (1.75,1.149). 
Although the ultra-distal radius is the site most commonly 
scanned, measurements at the tibia are also possible (1.149). 
pQCT performs a true volumetric measurement of BMD, results 
being expressed in g/cm^.
In-vitro accuracy of pQCT has recently been determined from 
the study of 7 cadaveric forearms (1.19). The correlation 
between pQCT total bone mineral content and ashed weight at 
the standard measurement site was 0.87, with an accuracy error 
of 15.5%. The precision of pQCT is discussed further in 
chapter 3. It varies according to the scanner used, with in- 
vivo precision values for trabecular BMD using the multi­
slice, high resolution scanner being about 0.35% (1.75),
compared to 1-2% for its single slice counterpart 
(1.19,1.50,chapter 3).
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Rapid, scan time of 10-15 minutes, forearm radiation dose of 
only 3 jLtSv and negligible whole body exposure, easy of use at 
readily accessible sites, and separate assessment of cortical 
and trabecular bone make pQCT a potentially attractive 
technique worthy of further study.
1.4 Clinical Indications for BMD Measurement
At the present time, measurement of BMD is the best way of 
defining fracture risk (1.1,1.88,1.101). There is almost an 
exponential rise in fracture risk with decreasing BMD. 
Consequently, a small change in BMD of the 
osteopenic/osteoporotic individual results in large changes in 
fracture risk. Data from many studies (1.101,1.191) have shown 
that the risk of fracture increases between 1.5 and 3.1 times 
for each standard deviation decrease in BMD. The gradient of 
fracture risk for each standard deviation decrease in BMD is 
largely similar between fracture types and between measurement 
sites. However, the gradient of risk is generally greater when 
a site specific measurement for each fracture type is 
performed - i.e. the optimum measurement site to determine hip 
fracture risk is the hip (1.192).
There are many indications for BMD assessment 
(1.1,1.145,1.146), and these are listed in table 1.2. Previous 
fragility fracture of hip, spine of forearm should result in 
BMD assessment. Although hip fracture is a late consequence of 
osteoporosis, the same is not true of Colles fracture. Modest 
(5-8%) reductions in hip and spinal BMD have been found in 
patients with Colies fracture (1.193), which should be 
regarded at a risk factor for future, more serious fracture. 
Monitoring the effect of drugs which have an adverse effect on 
bone (such as corticosteroids) or those which are used to 
prevent or treat osteoporosis [Hormone Replacement Therapy 
(HRT), bisphosphonates] is advisable. Radiological evidence of 
osteopenia is an indication for BMD assessment, because as 
discussed above, a standard x-ray gives only a crude measure 
of BMD which is easily misinterpreted. Vertebral deformity
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warrants BMD assessment, as old traumatic vertebral fractures 
may not be associated with low BMD. Other findings, risk 
factors and conditions which are deserving of BMD assessment 
are shown in table 1.2.
.'is:
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1.5 Screening for Osteoporosis
At the present time there is great debate as to whether 
population based screening for the prevention of osteoporosis 
should be implemented. This issue has recently been discussed 
at some length by a worldwide panel of experts, from which a 
WHO report was produced (1.101). Another important report was 
published in 1992 (1.194). Although funded by the Department
of Health (DOH), this report was not an official doh 
publication. Based upon these publications and recent papers, 
the important issue of screening is discussed in the following 
section.
If screening were found to be feasible, uptake is likely to be 
in the region of 70-80% (1.101,1.195,1.196). Several methods 
have been proposed, none of them tested, all shrouded in 
controversy. A single BMD measurement to assess fracture risk 
has been proposed. The present day scanners fulfill the 
requirements necessary to be applied to screening. As 
discussed above, they are comfortable, accurate, precise 
machines which scan rapidly and are capable of predicting 
future fracture. Importantly, they are of low radiation dose 
(spinal QCT less so). Prospective fracture prediction data on 
pQCT is not yet available, and although there is good 
prospective data for ultrasound in hip fracture, it is limited 
for other fracture types. Based upon the relationship of 
increasing fracture risk and decreasing BMD, the best site of 
measurement depends upon which osteoporotic fracture is being 
predicted. Hip fracture is best predicted by DXA of the hip, 
while any osteoporotic fracture is predicted equally well by 
radial SPA or axial DXA. Regarding the timing of a single 
measurement, there are two schools of thought. One supports
;
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measurement during the perimenopausal years as there is 
profound bone loss following the menopause, and peak bone mass 
is considered important in determining future fracture risk. 
The other supports a measurement around the age of 65 years. 
This option seem more favoured at the present time 
{1.101,1.197) as bone loss (another important determinant of 
fracture risk) has had a substantial effect on bone mass, the 
incidence of hip fracture is still low, and it appears more 
cost effective to target intervention at this age compared to 
the age of 50 years.
Another propose method of screening is the use of repeat BMD 
measurements. Fast bone losers will more quickly reach a 
critical bone mass at which fracture is likely to occur. A 
second BMD measurement 5 years following the initial 
perimenopausal would be considered adequate to assess the rate 
of bone loss for screening purposes (although an earlier 
measurement is advisable to assess treatment response), but 
only improves the estimate of ultimate bone mass by about 50%. 
Peak bone mass (PBM) is considered to be of greater importance 
in determining fracture risk up to the age of 70, but 
thereafter the relative importance of rate of loss and PBM 
equates. It should be borne in mind however that the precision 
of repeat measurements worsens in older age, so that a smaller 
proportion of BMD variance will be related to bone loss. 
Allied to the concept of assessing rates of bone loss is the 
use of markers of bone metabolism. There is now a plethora of 
such tests, some indicating bone formation (bone iso-enzyme 
alkaline phosphatase, osteocalcin, collagen propeptides 
markers - PINP, PICP), other resorption (hydroxy-proline, 
pyridinoline, de-oxypyridoline, collagen degradation markers -
36
1-CTP, 1-NTP). Analysis of a panel of such markers is useful 
in characterising the rate of bone loss over many years. This 
in conjunction with a baseline BMD assessment is the third 
method of screening proposed. The development of more accurate 
and precise measures of BMD, and more specific markers of bone 
turnover may increase the predictive power of these proposed 
methods in the future.
Several criteria should be met before population based 
screening is accepted (1.101,1.194). Ideally a randomised 
controlled study should be performed which shows that 
screening reduces fracture rates - no such study yet exists. 
Failing this, several other criteria have to be considered. 
Firstly, the social burden of the disease should be great 
enough to warrant screening. As described above, osteoporotic 
fractures undoubtedly fulfil this criteria, being a major 
social and financial burden. Secondly, effective therapy must 
be available. HRT has been shown to reduce fracture incidence, 
but there was lack of data showing its longterm benefit in the 
elderly population. More recent studies shows longterm 
protection against vertebral and forearm fracture by HRT in 
the elderly (1.198,1.199). Also, conventional prescription of 
HRT is for a maximum of 10 years, after which bone loss 
resumes and fracture protection diminishes. The major benefits 
of HRT are to reduce cardiovascular morbidity and mortality, 
which weakens the case for targeting HRT treatment based upon 
BMD. However, BMD assessment may have a role if the result 
showed an individual to be at high risk, and they were willing 
to take HRT. BMD results have been shown to influence the 
prescription (1.200) and uptake (1.201,1.202) of HRT.
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Conversely there is no indication to screen for low BMD if the 
individual is either intending to take HRT irrespective of the 
result, or would not consider HRT if low BMD was found. Non- 
HRT treatments are increasing available, and the increasing 
acceptance of their use should increase the justification for 
screening. Thirdly, the screening BMD measurement should 
adequately define future fracture risk. Although this has been 
shown to be the case, with hip fracture, the overlap in BMD 
between fracture and non-fracture patients is considered to be 
too great for screening purposes. Additionally, fracture 
prediction has been most extensively studied in older 
postmenopausal females. There is only early, preliminary data 
to suggest that a measurement during the perimenopausal years 
can predict future fracture (1.203,1.204). However, the follow 
up period reported is only 2 years, and the number of hip and 
vertebral fractures reported were small (1.203) or absent 
(1.2 04) . Lastly, the result of the screening test would have 
to encourage longterm HRT use. Although uptake of HRT has been ; 
shown to be influenced by a BMD result (1.201,1.202), its 
longterm use has not.
II
ftBearing in mind the above points, the consensus of opinion is 
that population based screening cannot yet be justified 
(1,101,1.194). However, gathering of hitherto lacking 
information, and advances in densitometry and available 
therapies will require this to be reviewed. Present day policy
encourages case finding rather than population screening, 
whereby patient with suitable risk factors should be offered 
BMD measurements. There are many conditions which predispose 
to low bone mass, as detailed in table 1.1. However, it is
only those individuals with "strong" risk factors, as detailed
f
in table 1.2, who should routinely undergo BMD assessment, 
although clinical judgement must also influence this decision. 
It is noteworthy however, that clinical risk factors do not 
adequately predict BMD (1.205,1.206,1.207) and perform even 
worse in predicting fractures (1.207,1.208,1.209). As such 
they cannot be considered as a replacement for BMD measurement 
and fracture risk prediction, only a rough guide for further 
assessment.
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1.6 Rational behind thesis Work
The central issue regarding pQCT is independent quantification 
of trabecular and cortical bone, the behaviour of which 
differs depending upon the prevailing conditions. Ultrasound 
is the other newly developed technique of assessing BMD which 
has received alot of attention in recent years. Ultrasound 
measurements are therefore compared to pQCT in a number of 
chapters. The preceding sections of chapter 1 lay the 
foundation of the thesis. Chapter 2 largely describes the 
methodology of the different densitometry techniques used, 
concentrating on pQCT. The precision of an osteo-densitometer 
is of great importance. Chapter 3 describes the measures taken 
during scanning to ensure the best possible precision for 
pQCT. More especially, the hypothesis that the difference in 
scan voxel numbers between repeat scans influences the 
precision of pQCT is investigated. Chapter 4 examines the 
effect of dominance upon pQCT BMD measurements. It is 
important to document this effect and develop a policy 
regarding scanning, as even small differences could assume 
greater clinical importance when changes related to treatment, 
or differences between groups are being sought. Lack of such 
a scanning policy may increase the variance of measurements 
and reduce the chance of finding significance. Osteo- 
densitometers usually have pre-loaded normative data which is 
used to create T and Z scores. In the case of the pQCT scanner 
used in this thesis, the normative data was based upon a 
German population. Differences in normal ranges are known to 
exist between countries, hence it is important to develop a 
normal range derived from the local population. Chapter 5 
describes the creation of a normal female range from the local 
population. The relationships of important anthropometric
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variables to different pQCT BMD measurements within this
population are also investigated in this chapter. It is
recognised that BMD at one site may not reflect that of
another. Chapter 6 examines the relationship between pQCT BMD 
measurements, and measurements at other sites using different 
scanning modalities. It also touches on the potential use of 
pQCT should a screening program ever be implemented. In
chapter 7, cross-sectional age related changes in pQCT BMD's 
are determined from the population described in chapter 5. 
Perimenopausal change in BMD is considered to be profound, and 
preferentially affect trabecular bone. Differences in pQCT BMD 
between late premenopausal and early postmenopausal women are 
therefore examined, and compared to axial DXA differences in 
a cross-sectional study. Also in chapter 7, observed annual 
rates of change in pQCT BMD are compared to axial DXA changes 
in longitudinal studies of late premenopausal, and 
postmenopausal women. Of immense importance in the field of 
osteo-densitometry is the role of fracture prediction, and no 
work would be complete without addressing this issue. 
Prospective, fracture prediction studies require many years, 
which is outwith the timescale of this thesis. Discriminatory 
studies have demonstrated almost the same relationship between 
specific sites of BMD assessment and fracture risk as 
subsequent prospective studies, and are within a feasible 
timescale. The discriminatory power of pQCT in hip and 
vertebral fracture, was therefore compared to modalities known 
to discriminate and predict both these types of fracture 
respectively, the results of which are presented in chapter 8. 
There are now effective treatments for osteoporosis, although 
not all individuals respond adequately. Another very important 
role for osteo-densitometry is monitoring the response to
41
therapies such as HRT and bisphosphonates. Both these 
therapies preferentially increase trabecular BMD, and one 
could hypothesise that the pQCT trabecular BMD measurement may 
be particularly valuable in monitoring therapeutic response. 
The potential role of pQCT in monitoring response to HRT and 
etidronate is therefore examined in chapter 9, and compared to 
axial DXA measurements. The effect of warfarin on adult bone 
has received little attention. Chapter 10 describes the effect 
of longterm warf arinisation upon axial DXA BMD and 
appendicular pQCT BMD. The relative contribution of the 
inflammatory aspects of rheumatoid arthritis (RA), its 
inevitable effect on mobility and the use of low dose 
corticosteroid on appendicular and axial BMD remains 
controversial. Also, peripheral BMD measurements are being 
cited as potentially useful tools in monitoring disease 
progression and treatment response in RA. In chapter 11, these 
issues are addressed using pQCT, with comparison with axial 
DXA, and ultrasound measurements. The concluding chapter draws 
together the important findings from the previous 
investigative chapters, highlights potential areas of clinical 
use, and proposes potential explanations for the apparent 
difference in behaviour of axial and appendicular bone.
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Table 1.2 Indications for assessment of bone mineral density
Radiological evidence of osteopenia, or vertebral deformity 
Previous fragility fracture of forearm, spine or hip 
Significant loss of height or thoracic kyphosis 
Monitoring therapy for osteoporosis 
Strong risk factors
Early menopause (<45 years)
Prolonged secondary amenorrhoea 
Primary hypogonadism 
Corticosteroid therapy 
Conditions associated with osteoporosis 
Anorexia nervosa 
Malabsorption
Primary hyperparathyroidism 
Hyperthyroidism 
Cushings syndrome
. : iTransplantation 
Chronic renal failure 
Multiple myeloma
Prolonged immobility
44
;;i-
Osteogenesis imperfecta
I
i
Ï
•H •H
-H
■H
•H
tH
O
U
I—I
XJ
■H -Hi—I
XJ
•HtHiH -H CHen Q.
fH
•H i—I
XJ
XJ•HXJI—IH rH •H
XJ
O-HH
-H
I—! IM rHHXJ
rH iH
______
CQ
t3C(0
D)
aQ>
I
OJQ
l«M0)"Oc0>
JZ
Q .SC7)4-»fO)
Q. g WQ)
"OcCO
g g
8 
iëTO■O 0) Q)%0
OcOsc8
Q .m
o
ZQ .C8
O  O)
c4
T“
£3O)
E
■op sXJ
XJ
O) ~ s
XI o
■O
8U)
o
I&
o
iD
r §11.
O(£>
O
8
O
i
<%)G )
sse|/\| auog
gICO
1
Ü"Ucvs
2 jQ
g
d!cI
8C0>■OÜc
o
&U)0)
<
o
£3O)LL
a.
8
oo§ §os oo<o
a
a
o
8 3 8oo o
£
I
2I
8
sjeeA-uosiad OOOOOL aouapfoui
CHAPtER 2
MEtHODOLOGY
2.1 Introduction
Osteo-densitometry has many roles in the management of 
metabolic bone disease. In the investigation of a new bone 
scanner, it would be impossible to address such a multitude of 
important issues in one study. Therefore, for the purposes of 
this thesis, a number of studies were designed to examine the 
role of pQCT in areas of clinical importance. The study 
designs, the numbers of patients recruited, the methods of 
recruitment and the statistical analyses are discussed in the 
appropriate chapters. The remainder of this chapter deals 
largely with the different methods used to quantify BMD, with 
the emphasis being placed on the description of pQCT.
2.2 Peripheral Quantitative Computed tomography (pQCt)
2.2.1 the Osteo-densitometer
pQCT measurements were made of the ultra-distal radius using 
the Stratec XCT-960 scanner (Stratec Medizintechnik, 
Birkenfeld, Germany). It produces a narrow fan beam by means of 
a single energy X-ray tube with heavy filtering (45 kilovolts). 
The detector unit comprises 6 semiconductor detectors with 
amplifiers. Movement of the source-detector unit occurs in 3 
different directions (longitudinal, transverse and rotational) 
and is controlled by microcontrollers. Patient forearm 
radiation dose is 0.3 /^ Sv for each of the scout and measurement 
scans (see below). Leakage and scatter results in total body 
exposure of less than 0.1 /^Sv/hr to patient and operator. The 
operator radiation exposure can be reduced at least by a factor 
of 4 by simply standing Im from the x-ray source, such that 
external radiation protection is unnecessary for both patient 
and operator. The total time for scanning and data acquisition 
is approximately 12 minutes. An individual being scanned using
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the Stratec XCT-960 is shown in figure 2.1.
2.2.2 Scanning Method
The patient's forearm length is measured with a millimetre 
ruler from the ulnar styloid process to the point of the 
olecranon before the arm is positioned for scanning. This 
measurement is used to set an elbow support in front of the 
scanning aperture to ensure the distal forearm and carpus is in 
the scanning field. The upper limb is then positioned with the 
elbow in its support, the fingers resting on a finger rest at 
the back of the scanner with the thumb dangling comfortably 
below.
Scanning then takes place in two stages. Firstly a coronal scan 
provides an image of the distal forearm and carpus, and is 
known as the "scout scan". This allows accurate repositioning 
of the scanner for the "measurement scan", by positioning a 
cross-sectional cursor at the distal end of the radius. The 
measurement scan then occurs at 4% of the previously documented 
length of forearm, proximal to the cross-sectional cursor (see 
Fig 2.2). From the measurement scan, 15 tomograms are merged to 
create an axial slice of 2.5mm thickness, which is depicted on 
a monitor screen (see figure 2.2). The reconstructed image is 
comprised of thousands of cubes of uniform dimension but 
differing density, which are known as "voxels". The density is 
colour coded on the screen, with high density areas depicted as 
white/yellow, medium density areas as red, and low density 
areas as blue/black. This allows visual identification of the 
radius and ulna within the image. A thresholding algorithm 
between 0 and 100 is then applied to the image. Bone with a 
linear attenuation co-efficient (and density) lower than the 
threshold is defined as trabecular bone, and that above as 
cortical bone. The default threshold setting is 50, which was 
not changed in standard scanning. Subsequently the radius is
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isolated as the region of interest (ROI), from which several 
BMD measurements are obtained as described below (chapter 
2.2.3). The number of voxels within the ROI is also 
automatically calculated (typically 900-1000 for a female). As 
the voxel dimensions and measurement slice width remain 
constant, the number of voxels in any given ROI is directly 
proportional to its size.
2.2.3 Bone Mineral Density (BMD) measurements acquired by
pQCt
4 different BMD measurements are recorded and shown in Fig 2.2. 
These are truly volumetric measurements so the resultant BMD 
values are expressed in g/cm^.
1) tOtAL BMD (Qtot) is the overall measurement of radial 
BMD at the measurement site.
2) tRABECULAR BMD (Qtrab). From the cross-sectional image, 
the outer 55% of the radial area is concentrically removed 
by the computer software. This leaves a central core of 
purely trabecular bone which is then quantified giving 
trabecular BMD. The default setting for the peeling 
process is 55%, but this can be altered if, in the rare 
occurrence, cortical bone (white colour) persists after 
peeling of the outer area.
3) SUBCORtICAL BMD (Qscort) is the density of bone in the 
outer 55% of voxels which are removed. It is mainly 
cortical bone with a small rim of trabecular bone.
4) CORtICAL BMD (Qcort) is calculated from the outer 55% 
area which has been removed. The computer software defines 
bone with a high density, eliminating less dense bone 
through the further use of thresholding algorithms. This 
process occurs automatically for any chosen threshold used
50
(50 by default) in the overall analysis.
The precision of pQCT measurements is discussed in Chapter 3. 
The non-dominant forearm was scanned in all individuals to 
excluded any potential effect of mechanical loading on BMD 
measurements. The effects of dominance is discussed further in 
Chapter 4. In the rare occurrence of a previous Colles fracture 
of the non-dominant arm, the dominant arm was scanned, as 
previous fracture distorts the anatomy at the scan site, and 
post-fracture radial BMD is known to be reduced (2.1).
2.3 Dual Energy X-ray Absorptiometry (DXA)
The technique of scanning using DXA has been described in 
chapter 1.3,4, and in detail elsewhere (1.153,1.154). DXA 
scanning was mainly performed using a single Norland XR26-Mark 
II bone densitometer (Norland Corporation, Port Atkinson, USA). 
Figure 2.3 shows a woman undergoing DXA scanning of the lumbar 
spine and proximal femur. The following measurements were made 
using an antero-posterior projection, with representative scans 
being shown in figures 2.4-2.6.
1. Lumbar spine [L2-4: (LS) ]
2. Left hip [femoral neck (FN), trochanter (Ft) and Ward's 
area (FW)]
3. Whole body [bone mineral density (WB-BMD)].
The in-vivo short-term precision expressed as the coefficient 
of variation is 0.9%, 2.8%, 1.3%, 4.9% and 1.5% for lumbar
spine, femoral neck, trochanter and Ward’s area, and whole body 
BMD measurements respectively (2.2,2.3). To prevent unnecessary 
repetition throughout the thesis, use of the term "DXA hip" 
measurements will encompass femoral neck, trochanter and Ward’s 
BMD measurements.
A small proportion of patients with vertebral fractures
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described in chapter 8, were scanned using a Lunar DPX-a 
densitometer. The scanning procedure is the same as that for 
the Norland XR26-Mark II, with the subject lying comfortably on 
the scanner base which is padded. Data acquisition differs 
between Norland and Lunar scanners with slight disparity of BMD 
results. This is dealt with further in chapter 8.
2.4 Ultrasound (CUBA)
The technique of scanning using ultrasound has been described 
previously (1.154). Ultrasound was performed using the McCue 
CUBA Clinical (McCue Ultrasound, Winchester, UK) , which is 
shown in figure 2.7. The non-dominant foot is placed in the 
foot recess of the ultrasound machine, and two silicone rubber 
faced transducers applied to either side of the heel. K-Y jelly 
is applied to eliminate air from between the contact surfaces. 
Two measurements are recorded: broadband ultrasound attenuation 
(BUA), and velocity of sound (VOS), results being expressed in 
dB/MHz and m/s respectively. The in-vivo shorterm precision for 
these measurements is 3.8% and 1.4% respectively (based upon 
paired measurements in 16 healthy premenopausal individuals 
with the foot removed from the machine between measurements). 
To prevent unnecessary repetition of information throughout the 
thesis, "calcaneal ultrasound" measurements will refer to both 
BUA and VOS.
Although pQCT was performed in all studies, DXA and ultrasound 
measurement were not. The measurements performed in specific 
studies are detailed in each of the appropriate chapters.
2.5 Statistical Analyses
The statistical analyses used in the various studies differ and 
are discussed in each of the chapters. The normality of data 
distribution was verified using normality plots and Shapiro- 
Wilks statistics. Data which violated normality criteria were 
compared using non-parametrie tests.
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2.6 Ethics and Consent
All patients participated in studies approved by the local 
Ethical Committee, and gave informed, written consent.
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Figure 2.2. the top image is a graphic representation of the 
"scout scan" showing the distal forearm and proximal carpus. 
the cross-sectional cursor (solid line) is placed at the distal 
end of the radius and the measuement scan takes place at the 
"4% measurement site", across the dotted line. the 2nd from top 
image is a graphic representation of the cross-sectional image 
of the distal forearm produced by the measurement scan. the 
radius is identified as the region of interest (within the 
hatched area) and the voxel number indicates the number of 
packets of bone in the cross-sectional radial image (voxel 
number). the total BMD (Qtot) is derived from this image. the 
bottom two images indicate how the remaining trabecular BMD 
(Qtrab), subcortical BMD (Qscort) and cortical BMD (Qcort) 
measurements are derived from the region of interest.
ÎE2E.
SCOUTS SCAN 
(LongirjJLnaJ Image)
4% Measurement site 
Cursor placed at the distal 
end of ndius
M EASUREM ENT SCAN 
(Cross-sectional Measurement Image)
t o t a l  BMD  
(Qtot)
c r o s s - s e c t io n a l  a r e a  of radius(Voxel Number)
t r a b e c u l a r  BMD (Qtrab) 
SUBCORTICAL BMD (Qscort)
C O R TIC A L BMD (Qcort)
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Figure 2.3. A woman undergoing DXA scanning of the lumbar spine 
(above) and proximal femur (below) using the Norland XR26-Mark 
II.
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Figure 2.4. DXA scan of the lumbar spine using the Norland 
XR26-Mark II. the region of interest (L2-4) is selected for 
analysis. the BMD is shown in the box below the spinal image, 
with associated t and Z scores in the box on the right.
H AP Spine 19/12/96 Sequence 1
Bone Image not for diagnosis
1.500
0.587
L2 - L4 CAUCASIAN 
SCOttISH
l.QEL
25 AGE
19/12/96 0.899
% Young Ref. 60.1
t - Score -1.93
% Age Matched 99.2
Z - Score -0.05
Manual Positioning
BMD BMC LENGtH AREA
g/cm2 g cm cm2
L2 0.782 10.92 3.30 13.96L3 0.952 15.02 3.45 15.78L4 0.950 14.85 3.15 15.63
L2 - L4 0.899 40.79 9.90 45.37
StD CVs for L2-L4 BMD 1.0 BMC; 1.5 See Guide for other CVs.
5 X 1.5 mm, 60 mm/s, 12. 00 cm Rev. 2.5.2 / 1.3. 1 Calib. 19/1
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Figure 2.5. DXA scan of the left proximal femur using the 
Norland XR26-Mark II. the regions of interest are shown: 
femoral neck (FN), femoral trochanter (Ft) and femoral Ward's 
area (FW) . the BMD values are shown in the box below, with 
associated t and Z scores for FN in the box on the right.
H Left Hip 19/12/96 Sequence 2
FW
Bone image not for diagnosis
1.210
Fern Neck CAUC* 
SCOttISH - NEW
0.461
"T- —WWW'#"*'
% Young R#f. *3%0
t - Seor* -1,37% Age Matched 100,3Z - Score 0,03
25 AGE 80
19/12/96 0.806
BMD BMC LENGtH AREA
g/cm2 g cm cm2Fern Neck 0.806 3.903 1.50 4.85
troch 0.618 8.923 14.44
Wards tri 0.553 0.553 1.00 1.00
StD CVs for Neck BMD: 1.2 BMC: 1.7 See Guide for other CVs.
1.0 X 1.0 mm, 45 mm/s, 9.00 cm Rev. 2.5.2 / 1.3.1 Calib. 19/12/96
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Figure 2.6. A whole body DXA scan using the Norland XR26-Mark
II. In this instance, the left upper limb has also been 
selected as an additional region of interest (ROI) . the medial 
border of the selected ROI passes through the glenohumeral 
joint and excludes all other bony area. the associated BMD 
values are shown in the boxes below, and to the right of the 
whole body image.
LEFT
ARM
R.0.1.
total BMD (g/cm ) : 
total BMC (g)
total Lean Mass(g) 
total Fat Mass (g) 
total Fat %
Siri UWE Fat % 
Brozek UWE Fat % 
Soft tissue Fat %
% tBMC/FFM
0.827
1498
29520
13092
29.7 
25.4
24.7
30.7 
4.8
Bone image not for diagnosis
DEtAILED RESULtS
BMD BMC AREA LENGtH WIDtH LEAN MASS FAt MASSg/cm2 g cm2 cm cm g gHead 1.370 346.7 253.1 2889 628.4trunk 0.818 462.2 564.9 14365 5082Abdomen 0.924 183.7 198.7 7459 2213Arms 0.477 131.7 276.1 3125 1548Legs 0.777 557.2 717.4 9141 5834total 0.827 1498 1811 29520 13092Left Arm 0.670 99.97 149.2 63.70 13.00 1162 1622
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CHAPtER 3
tHE PRECISION OF pQCt AND HOW It IS IMPROVED USING SCAN VOXEL 
NUMBERS
3,1. Introduction
3.1.1 Precision
Precision, which is the reproducibility of measurement 
results, is an important concept in osteo-densitometry. The 
standard value quoted in the literature is the coefficient of 
variation (CV). The better the precision of a scanner (ie the 
lower the CV) , then the greater its potential for detecting 
small but significant age, drug or disease related BMD changes. 
It is also important to evaluate precision in different age 
groups, as factors in the elderly, such as low BMD and movement 
artifact, may influence precision.
3.1.2 Voxel Numbers and "trending".
With repeat measurements of the ultra-distal radius, it is 
vitally important to scan at the same anatomical site, as the 
cross-sectional area and proportion of trabecular and cortical 
bone changes dramatically over short distances (1.17,1.19). 
Ensuring standardised scanning technique will minimise inter 
and intra-operator variability, and improve precision.
sectional area of the radius.
The Stratec 960 has a "trending" function which allows an
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a.
If the cross-sectional area of a repeat scan in an individual 
is similar to the original, this should ensure a comparable 
measurement site, and improved precision. The cross-sectional 
area of the radius in the ROI is quantified by a "voxel number : 
(VN) " (Fig 2.2). This could be a useful surrogate measure of 
area, and therefore a marker of anatomical site in any given 
individual, assuming there is no real change in the cross-
• ■; ;
additional measurement scan to be performed if the site of the 
first follow up measurement scan is too far removed from the 
original. "Trending" utilises the difference in voxel numbers 
to make small adjustments to the scanner position for a further 
measurement scan. We were advised by the manufacturer to accept 
a difference in voxel numbers of 50 or less between repeat 
measurements. Typically there are approximately 900-1000 voxels 
per measurement slice in a female subject. Our initial 
experience suggested that the precision of the scanner using 
this cut off value was poorer than we would have expected. The 
effect upon the CV of reducing this value to 3 0 was therefore 
examined, then applied to a group of postmenopausal females 
with vertebral fractures, and another group of postmenopausal 
females with rheumatoid arthritis.
3.2 Methods
Each individual underwent two consecutive scans at one visit, 
the arm being removed from the scanner between scans. In 
addition to BMD data, the VN in each ROI was recorded as was 
the difference in voxel numbers between scans (vox-diff).
3.3 Statistical Analysis
Continuous variables are expressed as median with ranges. Mean 
BMD values are also shown as the CV is dependent upon the mean 
and the SD of measurements. The CV was calculated for each BMD 
measurement.
3.4 Study Populations
Group A comprised 14 men and 12 women. All women were young 
healthy volunteers. 13 of the men were volunteers with various 
cardiovascular diseases participating in a study examining the 
effects of warfarin on BMD (see chapter 10) , whilst the 
remaining man was young and healthy. None were known to have 
suffered an osteoporotic fractures. Group A was subdivided 
according to vox-diff: (Group A-Sl: vox-diff  ^30; Group A-S2 :
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vox-diff > 30). Group B comprised 6 postmenopausal females with ■at least 1 osteoporotic vertebral fracture documented on x-ray 
(see chapter 8). Group C comprised 8 postmenopausal females who 
had suffered from rheumatoid arthritis for at least 1 year t(see chapter 11). The vox-diff in groups B and C was  ^ 30 for 
all females,
3.5 Results
Demographic, BMD, VN and vox-diff data for each of the groups |
are shown in table 3.1. The age, gender mix and BMD data for |,
the subgroups of group A were comparable. The VN was greatest §
in group A-S2, and smallest in group C. By design, the vox-diff
is less in subgroup A-Sl than in A-S2. The vox-diff in groups
mlB and C is comparable to group A-Sl, although they are all ||| 
females and older. All BMD values are lower in groups B and C.
The C V s  for each group for each BMD measurement are shown in 
table 3.2. By reducing the vox-diff to 3 0 of less, and 
comparing group A-Sl with A-S2, the CV is lowered for all BMD 
measurements. When the vox-diff is comparable (^  30), the CV 
is higher in groups B and C than in group A-Sl for each of the 
BMD measurements with the exception of Qscort in group B.
3.6 Discussion
The precision of an osteo-densitometer is of great importance 
and care should be taken to ensure high reproducibility of BMD 
measurements. The following technical aspects of pQCT scanning 
must be standardised to improve reproducibility. The ulnar #
length should be measured in an identical manner by all 
operators. This determines the scanner position for the "4% i 
measurement site". The forearm, hand, fingers and thumb must be 
positioned in the scanner in a similar manner as forearm 
rotation influences localisation of the region of interest 
(radius) from the measurement scan. Localisation of the distal 
end of the radius on the scout scan has to be defined to ensure 
uniform positioning of the cross-sectional cursor. To aid
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relocation of the same measurement site in repeat measurements, 
the scout scan from previous measurements (eg the baseline scan 
in a longitudinal study) can be recalled. This permits the 
baseline cross-sectional cursor and measurement site to be 
referred to during subsequent scanning. Standardising the above 
procedural elements will minimise operator variation in 
scanning technique.
Voxel numbers can be used to further improve precision. If the 
number of voxels between consecutive measurement scans is 
greater than a predetermined threshold, fine-tuning of the scan 
site is possible though the "trending" function on the Stratec 
960-XCT pQCT. Repositioning then occurs, the scanner moving a 
tiny distance towards the original scan site. An additional 
measurement scan (without scoutscan) then takes place at the 
new site within close proximity of the original scan. This is 
of vital importance in repeat radial measurements as there are 
marked changes in the proportion of cortical and trabecular 
bone over short distances (1.17, 1.18,1.19).
By reducing the difference in voxel number between repeat scans 
to 30 rather than 50, an improvement in precision was achieved 
as seen by comparing the C V s  of subgroups 1 and 2 of group 
with C V S  of 1.24%, 1.33%, 1.58% and 1.88% for Qtot, Qtrab,
Qscort and Qcort respectively in subgroup 1 of group A. This 
compares well with the precision of other osteo-densitometers 
in our centre (see chapter 2), and other centres (1.153,1.154) . 
They are also comparable to in-vivo precision values published 
for the same pQCT scanner at other centres (1.50,3.1).
The precision of pQCT is poorer in the groups with vertebral 
osteoporotic fractures (group B) and RA (group C), even when 
the vox-diff was 30 or less. These results can be explained by 
the fact that the median (and mean) BMD values are lower in 
these two groups compared to Group A. As the CV is determined
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by dividing the standard deviation of the difference between 
measurements by the mean of the measurements, even if the 
errors between groups are similar, the lower mean value will 
ensure a higher CV (3,2) . Another contributory factor could be 
movement artifact in the scan images of the older individuals 
in groups B and C, which falsely elevates the scan voxel 
number. Older individuals find it more difficult to prevent 
forearm movement during scanning, particularly when the 
"trending" function is needed and the scan time increases. 
Consequently, the repeat measurement site may not be so close 
to the original as the voxel number suggests, resulting in 
greater between scan BMD differences. There were however no 
gross movement artifacts in any of the scans analysed. Also, 
the median voxel numbers in groups B and C were lower than in 
subgroup 1 of group A. A difference of 3 0 is therefore 
relatively greater in these groups (B & C), resulting in poorer 
proximity of the follow-up scans. Although the precision in the 
RA group is poorer, the use of voxel numbers is probably more 
useful for repeat measurements in this population. The 
destructive change which occurs at the radio-carpal joint in RA 
can make it indistinct during the pQCT scout scan. This 
anatomical landmark is essential for the correct positioning of 
the scanner for any measurement scan. When this is less well 
defined, scan voxel numbers are invaluable in repositioning the 
follow up scan ensuring proximity to the original measurement 
site.
Whilst the improvements in the precision values between the 
subgroups of group A are obvious, there are some confounding 
factors. The mean BMD values of subgroup 1 were slightly 
greater than the corresponding values in subgroup 2, with the 
exception of Qscort. This could result in a bias towards better 
results in subgroup 1. Also the median voxel number of the 
scans in subgroup 1 was slightly lower than that in subgroup 2. 
This work could be repeated using a cadaveric radius and ulna
65
mounted in resin, obtained from a normal individual, an 
osteoporotic individual, and an individual who suffered from 
rheumatoid arthritis. This would eliminate in-vivo movement 
artifact and fatigue factors. The effect of reducing the 
difference in voxel numbers upon the CV could be studied, and 
a threshold determined below which there is no further 
improvement in the CV. #
I
ÎIt became our policy to do a further measurement scan using the 
"trending" function when the difference in voxel numbers ®
exceeded 3 0 in repeat measurements. This ensured close |
anatomical proximity of follow up and baseline measurement 
sites which is reflected in the improved CV figures. However, 
there is a large difference in the cross-sectional area, and |
therefore voxel numbers, of the radius between individuals. It 
would therefore be better to specify the threshold for a 
further scan using the trending function, as a percentage of ,i|
the original scan voxel number rather than an absolute value.
A percentage difference of 3% would appear to be appropriate.
This figure could be validated or adjusted using the cadaveric i
iradius studies as suggested above. i
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CHAPtER 4
tHE EFFECt OF DOMINANCE ON RADIAL pQCt BMD MEASUREMENtS
4.1 Introduction
The effect of mechanical stimulation and exercise upon BMD at 
appendicular and axial sites is controversial (4.1). This is 
due to differing exercise and loading regimes being studied in 
varying population groups, at different skeletal sites where 
bone composition varies. With regard to the radius, upper limb 
exercise and mechanical loading has been shown to have a 
beneficial effect upon radial bone mass in both cross-sectional 
( 4 . 2 , 4.3,4.4,4 . 5 ) and longitudinal studies
(4.6,4.7,4.8,4.9,4.10). When the issue of dominance was 
addressed in some of these studies, bone mass in the dominant 
forearm was uniformly found to be greater than its non-dominant 
counterpart (4.2,4.3,4.4,4.9). However these studies examined 
the effects of regularly playing tennis or specific upper limb 
exercises, neither of which typically prevail in the normal 
population. They do however suggest that at the radius, 
mechanical loading and dominance is of some importance, 
although the magnitude of this in the general population is 
poorly defined. The influence of dominance upon radial BMD in 
the general population was therefore investigated.
4.2 Patient Recruitment and Methods
Dominant and non-dominant forearms were scanned using pQCT on 
the same day in 31 individuals. 10 individuals (5 males: 5
females) were volunteers participating in a study comparing the 
precision of DXA scanners in 3 different Scottish centres 
(2.3). In addition there were 12 men participating in the study 
discussed in chapter 10, and 9 females participating in the 
study discussed in chapter 8. 2 of the 31 individuals were left 
handed.
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4.3 Statistical Analyses
Continuous variables are expressed as the mean and standard 
deviation. Comparison between the dominant and non-dominant BMD
,values was performed by the paired t-test, and differences 
expressed as percentages.
%4.4 ResultsThe BMD measurements of dominant and non-dominant forearms with 
percentage differences are shown in table 4.1. Considering all 
individuals as a single group, there was a trend for all BMD 
measurements to be greater in the dominant radius, although 
this failed to reach significance: percentage differences of 
1.6%, 1.1%, 1.2%and 0.6% for Qtot, Qtrab, Qscort and Qcort
respectively. BMD values of the dominant forearm were slightly
.higher than the non-dominant forearm with the exception of 
Qtrab in the male subgroup, and Qscort and Qcort in the female 
subgroup. None of the differences were statistically 
significant. BMD values in the male subgroup were higher than 
the corresponding values in the female subgroup, although they 
were not age matched. Ï
4.5 Discussion
'These data suggest that there is no statistically significant 
effect of dominance upon any radial BMD measurement in either 
males of females, although there was a trend for BMD to be 
slightly higher in the dominant arm. Although not statistically 
significant, the differences may be clinically important. The 
differences were largely in the region of 1-2%, which is 
similar to the precision error for the different BMD 
measurements. Introducing a further 1-2% variation in BMD 
measurements would limit the ability of pQCT to differentiate 
osteopenic/osteoporotic populations from normals, to detect 
rates of change and to monitor response to drugs.
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A previous study examining the effect of dominance upon radial 
BMD using pQCT in normal sedentary individuals found cortical 
and total, but not trabecular BMD to be significantly greater 
in the dominant forearm, the differences being 11%, 10% and 6% 
respectively (4.11) . The disparity with our findings is 
difficult to explain as the study populations seemed comparable 
in their level of physical activity (no elite athletes), and 
the same pQCT scanner was used.
Small, and statistically insignificant differences between DXA 
BMD of opposing proximal femora have also been documented
(4.12,4.13). Infrequently however, considerable individual 
variations have also been noted (4.12,4.13), and thought to be 
due largely to local factors such as previous fracture or hip 
osteoarthritis (4.12). 7-8% variation in ultrasound attenuation 
(BUA) measurements between opposing os calces have previously 
been found which was unrelated to stated handedness. The 
conclusion of the authors was that the same site should always 
be measured, particularly in longitudinal studies (4.14).
In summary, dominance and local mechanical stimulation do 
appear to have a mild influence on radial BMD, which may be of 
clinical importance without achieving statistical significance. 
Although only small and insignificant differences were found 
between radii in this work, the numbers studiW^were relatively 
small. Greater differences have been recorded previously in the 
general population (4.11), and in those undertaking specific 
upper limb exercises (4.2,4.3,4.4,4.9). Bearing in mind that 
even small percentage differences would be clinically 
important, it is important to remove the influence of dominance 
as a confounding factor in pQCT BMD measurements. Consequently 
it was our policy to always scan the non-dominant forearm, 
unless an individual had suffered a previous Colies fracture, 
when the contralateral forearm was scanned. In longitudinal
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studies the same forearm was always scanned
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Table 4.1, pQCT BMD measurements for the dominant (DOM) and |
non-dominant (NON-DOM) forearms in the whole study population |
(whole pop), and the male and female subgroups. ^
DOM NON--DOM P % diff
Whole pop. (n=31)
Qtot 363 .4 (85. 1) 357 . 6 (77 .4) 0 ,23 1.6
Qtrab 181., 6 (53 .4) 179 . 6 (54..0) 0 ., 60 1.1
Qscort 500 ,.2 (113 .2) 494 . 0 (96..7) 0 .41 1.2
Qcort 528 ,. 6 (82 .7) 525 .4 (79 ,.9) 0 ., 67 0 . 6
Males (n=17)
Qtot 409 ,. 5 (76, 9) 400 , 5 (67,.5) 0 .23 2 . 3
Qtrab 210 ,. 6 (43 .9) 212 . 7 (39,.1) 0 .68 -1. 0
Qscort 556 . 6 (96. 7) 541 .1 (82 .6) 0 ,.16 2 . 7
Qcort 558 . 7 (65. 0) 545 .9 (65 .7) 0 ,.19 2.3
Females (n=14)
Qtot 307 . 4 (57 .4) 305 . 6 (54 .0) 0 . 77 0.6
Qtrab 146 .4 (42 .3) 139 .4 (40 .9) 0 .22 4.8
Qscort 431 . 7 (94 .1) 436 .9 (82 .3) 0 ,. 61 -1.2
Qcort 491 . 9 (89. 1) 500 .4 (90 .5) 0 .49 -1.7
Values are mean (SD). p value is for the paired t-test.
% difference is that between the mean dominant and non-dominant 
BMD.
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CHAPtER 5
CREAtION OF A NORMAL RANGE AND DEtERMINAtION OF IMPORtANt 
ANtHROPOMEtRIC FACtORS ON RADIAL pQCt HMD MEASUREMENtS IN 
FEMALES AGED 18-90.
5.1 Introduction
The Stratec XCT-960 pQCT bone scanner was developed in Germany. 
The manufacturers did provide a normal range for trabecular and 
total BMD values, although this was based on a German 
population aged 20-79 scanned using a precursor to the Stratec 
XCT-960 - the Stratec SCT-900 - which used a rather than X- 
ray source. There had been concern that the normal range 
provided was inaccurate, a worry which has recently been 
confirmed in a German population (1.50). Therefore, it was felt 
prudent to investigate whether the manufacturers reference 
range was representative of the population of Grampian region, 
Scotland. The best method of determining a normal range from a 
reference population would be to randomly select females from 
a population or GP register. Financial and time restraints 
meant that this was not possible, but all normal females who 
had been scanned with pQCT were analysed. Since age, height, 
weight and menopausal status are known to be important factors 
in determining Bto (1.50,5.1,5.2,5.3), their influence on pQCT 
radial BMD measurements was examined in this population,
5.2 Study Population
332 normal females who had been scanned with pQCT were studied. 
All females completed a health questionnaire. None were known 
to suffer from any condition or were taking medication known to 
influence bone mass or metabolism and none had previously 
undergone hysterectomy. They were recruited in the following 
way:
1. 61 volunteers who worked in the Osteoporosis Research Unit
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and the hospital at which the Unit was based.
2. 197 females who attended an osteoporosis screening 
programme which has been described previously (1.196). 
These females were aged 45-55 years old, lived in the 
Grampian region of Scotland and were randomly selected 
from a community register. Primary screening involved DXA 
scanning of the lumbar spine and hip. pQCT was performed 
within 2 months at an additional visit .
3. 31 volunteers selected from a previously studied random 
population who took part in an epidemiological study 
(European Vertebral Osteoporosis Study - EVOS) (5.4). They 
were known to fulfill criteria for normality 2 years 
previously, and agreed to return for further assessment. 
30 again fulfilled normality criteria and were included in 
this study population, but one had suffered a vertebral 
fracture, and was excluded. They formed part of the 
control group for the studies discussed in chapters 8 and 
11.
4. 45 volunteers who were recruited through advertising as 
normal controls for a study examining the power of 
different scanning modalities (DXA, CUBA and pQCT) to 
discriminate patients with previous hip fracture from a 
control population. This study is discussed further in 
chapter 8. One female self reported a history of 
rheumatoid arthritis and was therefore excluded, leaving 
44 females to be included in this normal population
5.3 Statistical Analyses
BMD was stratified by age into consecutive decades, and by 
menopausal status (premenopausal: regular menses still
occurring; postmenopausal: no menses for at least 12 months). 
Age specified mean and SD BMD values were compared to those 
provided by the manufacturer, and also a recently published 
German normal range. The effect of the independent variables
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age, weight, height and menopausal status was examined by 
stepwise multiple regression analyses in the whole population. 
Analyses of premenopausal and postmenopausal subgroups were 
undertaken, with years since the menopause being substituted 
for menopausal status in the postmenopausal group.
5.4 Results
119 of the population were postmenopausal. Total and trabecular 
BMD data for our normal population and that provided by the 
manufacturer are shown in table 5.1. Cortical and subcortical 
BMD data for our population are shown in table 5.2 (there were 
no corresponding manufacturers values). Our normal range 
differed from that of the manufacturer and also that recently 
published for a German population (1.50). There are data on 
only 6 females in the 30-39 age band, which unfortunately 
cannot be considered a truly representative sample of the 
normal population. This could explain why Qtot, Qtrab and 
Qscort BMD values are lower than expected in this age band. 
Mean Qtot and Qtrab BMD values were generally higher in our 
population, compared to the manufacturers and recently reported 
German population (1.50). Compared to the manufacturer's 
figures, the difference tended to be greater for Qtot (+9.5% - 
+31.1%) than for Qtrab (-1.2% - +10.6%: excluding those aged 
30-39) .
The age related changes in Qtot, Qtrab, Qscort and Qcort are 
shown in figures 5.1-5.4 respectively. Multiple regression 
equations examining the influence of the independent factors 
age, height, weight and menopausal status (years postmenopause 
in postmenopausal females) upon BMD measurements in the whole 
population, and premenopausal and postmenopausal subgroups are 
also shown in the corresponding figures.
There was an age related decrease in all BMD values. Examining
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the whole population by decades, this was not apparent until 
the 6th decade for Qtot, Qscort and Qcort and the 7th decade 
for Qtrab. Age related changes in BMD are discussed further in 
chapter 7. Important anthropometric determinants in the whole 
population were as follows: weight which was positively
correlated with Qtot, Qtrab and Qcort; age which was negatively 
correlated to all measurements; height which was negatively 
correlated to Qtot and Qtrab; menopausal status which was 
negatively correlated to Qtot and Qscort.
For premenopausal females, weight was positively correlated to 
Qtrab, and height negatively correlated to Qtot and Qtrab. The 
amount of variance explained in the premenopausal group was 
small with only 5% of the variance in Qtot, and 8% of Qtrab 
being explained. The amount of variance in Qscort and Qcort 
explained by these independent variables (age, height and 
weight) was so low that no equation was formed.
For postmenopausal females, weight was positively correlated to 
Qtot, Qscort and Qcort, whilst age was negatively correlated to 
all BMD measurements. Years since the menopause was not an 
important determinant for any pQCT BMD measurement. The degree 
of variance in BMD explained in the postmenopausal group was 
much greater than in the premenopausal group: 35% for Qcort, 
34% for Qscort, 33% for Qtot, but only 8% for Qtrab,
5.5 Discussion
These results highlight the importance of obtaining a locally 
derived normal reference range. Values supplied by the 
manufacturer were consistently lower across the decades than 
those of the local Grampian population. There were also 
differences in BMD values between the female population of 
Grampian, and the German population reported recently by Butz 
et al (1.50). These differences are probably real, but the
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following factors could also be important. Firstly, the 
recruitment methods for the study populations were different. 
The entire German population reported by Butz et al (1.50) was 
randomly selected, whilst about 100 of the 332 females in our 
population were volunteers, the remainder being randomly 
selected from the population. Secondly, our pQCT scanner 
(Stratec XCT-960) was the upgraded model from that used to scan 
the German population (Stratec XCT-900). Differences in 
performance of the scanners are not known, but are unlikely to 
result in the large BMD differences reported here. The finding 
of population differences does however support the findings of 
a recent study, which reported that normative female pQCT BMD 
data vary between a number of different European centres (5.5) . 
Mean trabecular BMD of females aged 60 years at the different 
centres varied between 101-117 mg/cm^, although this was 
statistically insignificant. Similar findings have also been 
shown for normative DXA spinal (5.6, 5.7) and hip (5.7, 5. 8) 
data. Differences between a locally derived normal range and 
that provided by the manufacturer have also been found for 
axial DXA (5.7,5.9,5.10) and pQCT measurements (1.50). Such 
difference are important as they can lead to the 
misclassification of patients as osteoporotic or not
(5.7,5.10). If must be concluded that, if possible, normative
data should be derived from the local population.
For the purposes of this thesis, the population studied in this 
chapter is referred to as a "normal" population. However there 
are several limitations of this population. Firstly,
approximately 3 0% of females were not randomly selected.
Secondly, there is a paucity of females aged 30-39 years, with 
BMD values in this age group generally being lower than their 
counterparts aged 18-29 years and 40-49 years. This suggest 
that the females in this age band are not representative of the 
population. Unfortunately, it is this age group which is used
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most often to create T-scores. Hence, during the remainder of 
the thesis, T and Z scores are quoted for DXA femoral neck and 
lumbar spine measurements, but not for pQCT measurements.
Examining the BMD values across the decades, pQCT values do not 
appear to alter greatly until the 6th decade for Qtot, Qscort 
and Qcort, and the 7th decade for Qtrab. This is a similar 
pattern to that observed previously for pQCT measurements 
(1.50,1.78) . Bearing in mind the limitations of trying to 
determine peak bone mass with a small number of females aged 
30“39 years, maximum mean BMD is achieved in the age group 40- 
49 years for Qtot, 18-29 years for Qtrab and Qscort, and 30-39 
years for Qcort (40-49 years if the 30-39 age group is 
excluded) . It is surprising that there does not appear to be a 
dramatic reduction in Qtrab during the 6th decade, bearing in 
mind that the accelerated phase of bone loss during the 5-10 
years following the menopause preferentially affects trabecular 
bone. Rates of radial bone loss are examined further in chapter 
7 .
Weight and height are generally positively related to axial hip 
and spine BMD, whilst age and postmenopausal status are 
negatively related (1.51,4.2,5.1,5.2,5.11,5.12). The results 
presented here suggest that in premenopausal females, the above 
independent variables explain only a small amount of the 
variance in the various pQCT BMD values, although other local 
and environmental factors were been examined. This is in 
keeping with the previous finding that peak bone mass at the 
radius (1.58), and hip and spine (1.59) is largely genetically 
determined, with up to 80% of variance being explained by 
genetic and familial factors.
The variance in pQCT BMD explained by age, weight, height and 
menopausal status for the normative data presented here, was
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much greater in the postmenopausal, compared to the 
premenopausal subgroup. Age was an important determinant of all 
BMD measurements, being negatively related in the whole 
population and the postmenopausal subgroup. It was surprising 
that years since the menopause was not related to any 
measurement in postmenopausal females, particularly as 
trabecular bone is preferentially affected during the earlier 
postmenopausal years, and is independently quantified by pQCT. 
However, postmenopausal status was negatively related to total 
and subcortical BMD measurements. Weight was also positively 
related to BMD measurements in the whole population, but seemed 
to have a greater influence upon BMD of postmenopausal females. 
Conversely, height was negatively related to total and 
trabecular BMD in the whole population, and more important in 
premenopausal females. This relationship of height with radial 
BMD is an unexpected and unusual finding which is difficult to 
explain, but has been noted before for trabecular BMD (1.64). 
It is possible that taller women have thinner radii.
Considering the two menopausal groups together, these results 
are similar to previously published studies. Age, has been 
s h o w n  to be n e g a t i v e l y  r e l a t e d
(1.50.1.51.1.63.1.68.1.69.1.70.1.78.1.79.5.3.5.13), and weight 
unrelated (1.50,1.64,5.13) or weakly positively related (1.51) 
to radial BMD. Height has been variably shown to be unrelated
(5.13), weakly positively (1.50,1.51,5.14) or weakly negatively 
(1.64) related. Postmenopausal status (1.51) and years 
postmenopause (5.13) have been found to be negatively related 
to radial BMD. The effect of the menopause upon radial pQCT BMD 
measurements is discussed further in chapter 7. Disparity with 
the some of the results of others could be explained by 
differing method of analysing the relationship between 
anthropometric and BMD variables, as some have used linear 
regression, others multiple regression and others a combination
80
of both. Additionally, although pQCT was used in some of the 
work quoted above (1.50,1.64), SPA was used by others
(1.51,5.13). Accordingly, the scan site and therefore 
proportion of trabecular bone differs, as do the reported BMD 
measurements.
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CHAPTER 6
COMPARISON OF RADIAL pQCT BMD MEASUREMENTS WITH MEASUREMENTS AT 
OTHER SKELETAL SITES: IMPLICATIONS FOR THE USE OF pQCT IN
SCREENING FOR LOW AXIAL BMD.
6.1 Introduction
Bone density measurements are now possible at a variety of 
skeletal sites using different techniques. At the present time 
DXA is considered the "benchmark" method of assessment. 
Therefore, in the development of pQCT, it would be important to 
document the relationship between DXA and pQCT BMD 
measurements. Similarly, it would be useful to know the 
relationship between pQCT and other emerging scanning 
techniques such as ultrasound. This is particularly important 
as regional variation in bone mass status exists within 
individuals (6.1,6.2,6.3) .
Osteo-densitometry has some well defined roles in the 
management of bone disease (1.145,1.146). However, the issue of 
screening and prevention for the general population remains 
contentious (1.101,1.194). Screening for osteoporosis has been 
discussed in more detail in the introduction (chapter 1.5) . It 
has been suggested that DXA may be of value in screening 
perimenopausal women, targeting those considered to be "at 
risk" for life style and therapeutic intervention. Selection of 
individuals in the lowest quartile (1 .88) or quintile (1 .101) 
of aged-matched DXA hip and lumbar spine measurements is one 
method proposed for identifying individuals for intervention, 
while another is to target prevention in those with 
osteoporosis (T-score of  ^ -2.5), or osteopenia (T-score of  ^
-1.0 but > -2.5) (6.4). An ideal bone density screening tool
will accurately predict subjects at risk of future osteoporotic 
fracture. As discussed in the introduction (chapter 1.4 & 1.5),
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BMD assessment is the best method of defining fracture risk 
(1.101,1,194). The best predictive power is achieved by- 
measuring BMD at the site of future fracture, ie at hip and 
spine (1.88). pQCT is probably cheaper and more portable than 
DXA, so could be used either to predict fractures or to select 
subjects for measurement with the more expensive DXA technique. 
The predictive capacity of pQCT can only be determined by long­
term prospective studies, as already done for radial SPA 
measurements in spine (6.5) and hip (1.192) fractures. Pending 
publication of such studies with pQCT, it could be used in an 
attempt to select individuals with a high risk of low hip and 
spine BMD.
The relationships between BMD measurements using different 
techniques at various sites were therefore examined by 
comparing pQCT BMD measurements with DXA (hip and spine) and 
calcaneal ultrasound measurements in a perimenopausal female 
population, and whole body DXA measurements in a postmenopausal 
female population. The potential for pQCT to be used as a 
community based screening tool preliminary to axial DXA 
measurement was examined in the perimenopausal population - 
that is, could it pre-select a group from the community who 
could be offered an axial DXA BMD measurement,
6.2 Study Populations and Bone Mass Measurements
The relationship of pQCT BMD measurements and those at other 
skeletal sites was examined in two groups:
Group 1. The relationships between the four pQCT BMD 
measurements were examined in 216 perimenopausal 
females who attended an osteoporosis screening 
programme. The method of recruitment has been 
described previously (Chapter 5.5.2-point 2). The 
relationships between pQCT and DXA hip and lumbar
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spine BMD measurements, and calcaneal ultrasound 
measurements were also studied in this population. 
DXA measurements were performed on the initial 
screening visit, whilst pQCT and ultrasound 
measurements were performed on the same day at an 
additional visit within 2 months.
Group 2. Comparison of pQCT measurements with DXA whole body 
BMD (WB-BMD)was made in 45 postmenopausal females who 
were acting as controls in a study examining the 
power of different scanning modalities (DXA, CUBA and 
pQCT) in discriminating patients with hip fracture 
from a control population. This study is discussed 
further in chapter 8 . Women within this group who had 
undergone hysterectomy had done so more than 2 years 
after cessation of their menses, and were considered 
to be postmenopausal. Further analysis of the whole 
body scan identified the non-dominant arm 
(ipsilateral to that scanned using pQCT) as an 
additional region of interest (ROD . The medial 
border of this ROI passed through the gleno-humeral 
joint and excluded all other bony areas. This is 
depicted in figure 2.5. The BMD of the whole arm was 
then derived (WB-ARM). All measurements were all done 
on the same day.
6.3 Statistical Analyses
Results for continuous variables are expressed as mean with 
standard deviation when normally distributed, median with range 
otherwise. Maximum and minimum values are shown for all bone 
density variables. The relationships between the various BMD 
measurements were examined by linear regression and Pearson 
correlation co-efficients. In the perimenopausal population 
(group 1) , quartiles of the DXA, CUBA and pQCT measurements
90
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were calculated with comparison of the proportion of 
individuals in the lowest quartiles of the different 
measurements. In view of the recently agreed WHO criteria for 
the diagnosis of osteoporosis and osteopenia based on bone 
density measurements (6.4), the proportional cut off value for 
each pQCT measurement which would be required to detect all 
women with osteopenia (T-score of  ^ -1.0) at either the hip 
(femoral neck) or spine site was determined, and compared to 
ultrasound measurements.
6.4 Results
6.4.1 Demographic and Bone Mass Data
Details of age, height and weight for all individuals (groups 
1 & 2) are shown in Table 6,1. In group 1, 101 (46.8%) of the 
study population were premenopausal, 46 (21.3%) had previously 
undergone hysterectomy and 69 (31.9%) were postmenopausal. All 
females in groups 2 were postmenopausal. Bone mass data for 
groups 1 and 2 are shown in tables 6.2 and 6.3 respectively. 
Due to scanner malfunction, it was not possible to record BUA 
and VOS results in 5 and 7 subjects respectively in group 1, 
and it proved impossible to isolate the arm as a ROI from the 
whole body scan in 1 female in group 2. Only the DXA hip and 
spine measurements have a locally acquired normal range based 
on 300 women known not to have osteoporosis. Locally derived T- 
scores are given for the group 1 study population compared to 
this normal range.
6.4.2 Intra-Technique BMD Correlations for pQCT
The relationships between the different pQCT measurements are 
shown in figures 6 .1-6.3. Qtot and Qscort correlated best 
(r=0.917). Qtot correlated less strongly with Qtrab and Qcort 
(r=0.687, r=0.551 respectively). Qscort was highly correlated 
with Qcort (r=0.739) but only moderately with Qtrab (r=0.457). 
Qtrab and Qcort were very poorly and negatively correlated (r=-
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0.152) .
6.4.3 Correlations of PQCT BMD Measurements with Bone Mass
Measurements at Other Skeletal Sites
The relationships of Qtot with hip, spine, arm and whole body 
BMD measured by DXA, and calcaneal ultrasound BUA and VOS 
measurements are shown in figures 6 .4-6.7. The correlation with 
hip measurements were all of a similar magnitude (FN: r=0.459, 
FT: r=0.443, FW; r=0.441), and slightly lower with LS
(r=0.389). Correlation were comparable with WB-ARM {r-0.456), 
and slightly higher with WB-BMD (r=0.545). The relationship 
with calcaneal ultrasound measurements were generally poor 
(BUA: r=0.272/ VOS: r=0.159).
The relationships of Qtrab with the above measurements are 
shown in figures 6.8-6.11. The relationships were similar to 
those found for Qtot, with slightly higher correlation with LS 
(r=0.41), FT (r=0.462), FT (r=0.525), WB-BMD (r=0.573) and BUA 
(r=0.306), and slightly lower correlation with FW (r=0.438), 
WBA-ARM (r=0.435) and VOS (r=0.097).
The relationships of Qscort with the above measurements are 
shown in figures 6.12-6.15. The correlations with LS (r=0.345), 
hip (r-0.406, 0.363, 0.403 for FN, FT and FW respectively), WB- 
BMD (r=0.416), WB-ARM (r=0.371)and BUA (r=0.242) were slightly 
poorer, and VOS (r=0.165) slightly greater than those found for 
Qtot.
The correlations of Qcort with other measurements (figures 
6.16-6.19) were found to be extremely poor: (r: 0.047-0.207),
and was best with WB-ARM.
6.4.4 Comparison of the Proportion of Females in the Lowest
Quartiles of the Different Measurements for the
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Perimenopausal Population (Group 1)
All women were placed in a quartile for each of the DXA (hip 
and spine), pQCT and ultrasound measurements. The percentage of 
females falling into the lowest quartiles (QU^ ) of pQCT and DXA 
measurements also in the lowest quartile of other mutually 
exclusive hip and spine measurements are shown in Figure 6.20. 
Around 50% of women in QU4 of LS, FT and FW and around 25% in 
QU4 of FN were also in QU4 of Qtot, Qtrab and Qscort. The 
corresponding figures for Qcort were around 30%. However, only 
about 60% of women in QU4 of the hip measurements were also in 
QU4 of LS, and about 70% when comparing intra-hip 
measurements. Figure 6.21 shows a similar analysis comparing 
women in QU4 of the pQCT and ultrasound measurements. 
Generally, less than 50% of women in QU4 of all pQCT 
measurements were also in QU4 of BUA, with the corresponding 
figures for VOS being lower.
6.4.5 Proportional Cut-Off Figures for pQCT Measurements in
Detecting Low Axial BMD in the Perimenopausal 
Population : Comparison with Ultrasound Measurements 
(Group 1).
In group 1, 97 (44.9%) women had a T-score  ^ -1,0 at LS, and 
108 (50%) at FN. The proportional cut off values to detect all 
women with T scores  ^ -1.0 at LS and FN and the percentage of 
women below this value for each of the other bone density 
measurements are shown in Table 6.4. The proportional cut-off 
values for all pQCT measurements were such that almost the 
whole population would have to be scanned to detect all women 
with hip and spine osteopenia. However, the findings were 
similar for ultrasound measurements. Also, to detect all women 
with spinal osteopenia based upon a FN measurement, 96.3% of 
the population would have to be scanned, and 88.4% to detect 
hip osteopenia based upon a lumbar spine measurement.
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6.5 Discussion
Intra-technique correlations of pQCT BMD measurements were 
variable. The highest correlation was found between total and 
subcortical BMD values, which can be explained by subcortical 
measurements incorporating the cortical shell and a small rim 
of trabecular bone, thus both cortical and trabecular 
components are represented in this measurement, as they are in 
the total BMD measurement. The correlations between other pQCT 
BMD measurements were only moderately high, with the 
relationship between trabecular and cortical measurements being 
negative. This suggests that radial bone at this site is 
inhomogeneous, as previously suggested (1.153). Also, rapid and 
dramatic changes in the proportion of cortical and trabecular 
bone occurs within the distal 3cm of the radius (1.17) . The 
measurement site for ultra-distal pQCT measurements falls 
within this area so small differences in the relative scan 
position between individuals will result in a large scatter of 
results, and poorer correlation between BMD values. These 
correlation coefficients are similar to previously reported 
results for the same scanner (3.1,6.6). It is worth noting that 
the relationship between trabecular and cortical BMD
measurements at the ultra-distal radial site is very poor, a 
feature which has also been noted previously (3.1). This is 
probably related to the thinness of the measurement slice 
introducing sampling errors (3.1), an age related diminution in 
both cortical bone thickness and density (6 .6), and an age 
related increase in the proportion of trabecular bone at the 
measurement site (6 .6) . However, the age range of the
population studied (group 1) to determine the correlations of
pQCT BMD measurements was narrow (45-55 years), suggesting that
a dramatic change in the proportion of trabecular and cortical 
bone over small distances at the ultra-distal site, and 
thinness of the measurement slice were the main reasons for the 
lack of correlation between pQCT cortical and trabecular BMD.
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There was also only moderate correlation between pQCT BMD 
measurements and the total BMD of the ipsilateral arm, as 
identified from the DXA whole body scan. As the radius, ulna 
and humerus are long bones consisting predominantly of cortical 
bone, it is surprising that the correlation between the pQCT 
cortical BMD and DXA arm BMD was not higher, whilst the best 
correlation was found with the pQCT total BMD measurement. Once 
again though, this is likely to be related in part to the size 
of the measurement sample, relative to the size of the upper 
limb.
The correlations between total, trabecular and subcortical pQCT 
radial BMD measurements and DXA BMD measurements of the lumbar 
spine, proximal femur and whole body are all of a similar 
magnitude and at best only moderate, whilst those for cortical 
BMD are even poorer. Similar relationships between pQCT and DXA 
hip and spine BMD measurements have been reported previously 
using similar pQCT scanners with an single energy x-ray source 
(1.50,3.1), and a predecessor using a energy source (6.7) .
To my knowledge there no reports comparing pQCT measurements to 
whole body BMD.
Similarly, correlations were poor between all pQCT
measurements and both calcaneal ultrasound measurements, 
confirming previous findings (1.50). The best correlation was 
between BUA and radial trabecular BMD, which is perhaps not 
surprising as the os calcis consists of 90-95% trabecular bone 
(1.21). This differs from the results of a previous study where 
BUA correlated better with radial mid-shaft BMD (predominantly 
cortical bone) , rather than with trabecular BMD measured at a 
distal site. The pQCT scanner which was specially built, was
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different to the Stratec 960, and the study population was much 
smaller, with only 24 females being studied (6 .8) .
These results suggest that the relationship between ultra- 
distal radial pQCT BMD measurements and those at other skeletal 
sites (ipsilateral arm, lumbar spine, proximal femur, whole 
body and calcaneus) are at best only moderate. As such, they do 
not reflect, and could not be used to predict with any 
accuracy, BMD at other skeletal sites. Whilst these results 
could be explained in part by our heterogeneous population, 
differences in the proportion of cortical and trabecular bone 
between skeletal sites, scanner precision, and thinness of pQCT 
measurement slice, it is much more likely that they further 
illustrate regional variation of bone density within 
individuals, which has been observed previously (6 .1 ,6 .2 ,6 .3) .
For females considered "at risk" in the lowest quartile of 
lumbar spine measurements, about 50% would be missed based upon 
pQCT (other than cortical BMD) measurements, and 70% missed 
based upon pQCT cortical BMD. For women "at risk" in the lowest 
quartile of femoral neck measurements, 7 0% - 80% would be
missed based upon pQCT measurements. Vice versa, basing risk 
upon quartiles of pQCT measurements would result in many women 
being wrongly categorised as "at risk" at the hip and spine. To 
detect all women with either hip or spinal osteopenia (T score 
 ^ -1.0) based upon pQCT measurements, almost the whole
perimenopausal population would have to be scanned to ensure 
all cases were detected. The results for calcaneal ultrasound 
measurements were comparable to pQCT. It is also worth noting 
that to detect all women with femoral neck osteopenia based 
upon a lumbar spine scan, 88.4% of the study population would 
have to be scanned, and vice versa, 96.3% scanned. These data 
suggest that due to the poor correlation between BMD assessment 
at various sites irrespective of scanning modality, site
96
   . _ _    . :
specific or at least two-site assessment of risk is preferable 
in those requiring fracture risk assessment. Two-site 
assessment has previously been shown to improve the predictive 
value for subsequent vertebral fracture {1.191,6.9,6.10).
These results show that pQCT would be of no value in pre­
selecting individuals for further axial DXA measurements should 
a screening program for osteopenia become reality. However, 
calcaneal ultrasound measurements have been shown to predict 
future hip fracture (see chapter 8) and there is convincing 
evidence that peripheral bone density measurements are useful 
in determining fracture risk. Although hip fracture risk is 
best determined by a site specific measurement (1.192), 
prospective studies have shown that radial BMD measurements, 
using osteo-densitometers other than pQCT, can predict fracture 
risk at the hip (1.192) and spine (6.5). Prospective studies 
are required before similar claims can be made for pQCT.
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Table 6.2. pQCT, DXA hip and spine BMD, and calcaneal 
ultrasound measurements of the perimenopausal population (Group 
1) .
Mean SD Min. Max.
pQCT (BMD, g/cm^ : n=216)
Qtot 380 .1 58.5 205.9 578 .1
Qtrab 182 .3 41. 0 56 . 8 341. 7
Qscort 521.8 69 . 0 306 . 6 697.1
Qcort 554 .4 61.2 380.4 705 . 3
DXA (BMD,g/cm2: n=216)
Lumbar spine (LS) 1. 030 0 .170 0 . 701 1. 736
T-score -0 . 81 1.46 -3 . 64 5.28
Femoral neck (FN) 0.860 0 ,130 0.580 1.222
T-score -0.90 1 . 08 -3 .25 2 . 85
Trochanter (FT) 0 . 690 0 .120 0.411 1.037
Ward’s area (FW) 0.670 0.140 0.409 1.135
Ultrasound
Attenuation (BUA) 77 .8 17.6 39.0 144.0
(dB/MHz: n=211)
Velocity (VOS) 1405 54 1151 1575
(m/s: n=209)
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Table 6.3, pQCT total (Qtot), trabecular (Qtrab), subcortical 
(Qscort) and cortical (Qcort) BMD and DXA whole body (WB-BMD) 
and arm (WB-ARM) BMD of Group 2.
Mean SD Min. Max.
pQCT (BMD, g/cm^: n=45)
Qtot 288 .8 66 .1 193 . 5 448 .1
Qtrab 151.6 54 .5 19 .5 262.7
Qscort 397.6 86.1 258.4 557.4
Qcort 455.2 77 .7 267 . 9 621.9
DXA (BMD, g/cm2)
WB-BMD (n=45) G .871 0.110 0.656 1.157
WB-ARM (n=44) 0 .723 0.112 0.473 0.982
100
Table 6.4. Cut-off value and proportion of population below 
this value for each of the DXA, pQCT and ultrasound 
measurements to detect all women with T scores  ^ -1 at lumbar 
spine (n=97) and femoral neck (n=108). Values are: bone density 
cut-off value (percentage of population)
Lumbar Spine Femoral neck
DXA (BMD, g/cm2)
LS - 1.236 (88.4)
FN 1.104 (96 .3) -
FT 0 . 835 (89.4) 0 . 751 (71.3)
FW 1. 023 (98.6) 0 . 812 (85.6)
pQCT (BMD, g/cm2)
Qtot 578.1 (100) 578 .1 (100)
Qtrab 278.1 (98.6) 278 .1 (98.6)
Qscort 688.6 (99.1) 688 . 6 (100)
Qcort 693.8 (99.5) 705.3 (100)
Ultrasound
BUA (dB/MHz) 144 (100) 122 {98.6)
VOS (m/s) 1496 (97.1) 1514 (99.0)
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CHAPTER 7
AGE RELATED CHANGES IN RADIAL pQCT BMD MEASUREMENTS: COMPARISON 
WITH OTHER SKELETAL SITES.
7.1 Introduction
Changes in bone mass throughout the lifetime of an individual I 
have been discussed in detail in chapter 1.1.3, and are 
depicted in figure 1.2. Peak bone mass (PBM) is now generally 
considered to be achieved by the end of the second decade
,(1.44,1.60-1.65), and possibly a few years later (age 25) at 
the radius (1.40). PBM is generally maintained throughout the 
following 2-3 decades before bone loss commences. Controversies 
regarding the age at which PBM is achieved, and timing of bone 
loss from PBM are also discussed in chapter 1.1.3. Generally, 
age related bone loss occurs in all individuals from all 
skeletal sites, and affects both trabecular and cortical bone.
This type of bone loss leads to what has been termed Type 2 
osteoporosis, leading eventually to hip fractures (1.67). Due 
to ovarian failure and subsequent oestrogen deficiency, women 
experience an accelerated phase of bone loss following the 
menopause. Although all skeletal sites are affected, there is 
controversy, especially at axial sites, as to the exact timing 
and degree of bone loss (1.51,1.68-1.72,1.74,1.79- 
1.82,5.1,5.2). Trabecular bone is metabolically more active 
than cortical bone, and is therefore thought to be 
preferentially affected during this phase of accelerated bone 
loss. Consequently, bone loss is greater from skeletal sites 
rich in trabecular bone. This type of bone loss leads to what
has been termed Type 1 osteoporosis, and fractures especially 
of the wrist and vertebrae (1.67).
Most of the work done to date examining patterns of radial bone 
loss have employed either SPA or DXA, which give a composite
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7.2 study Populations and Bone Mass Measurements
The following different female populations were studied
assessment of trabecular and cortical BMD at the measurement 
site. pQCT, with its ability to quantify trabecular and 
cortical BMD independently may give additional information as 
to the timing, pattern and extent of bone loss at the radius.
It should be more sensitive than radial SPA or DXA to subtle 
BMD change, particularly within the trabecular component. It 
should be borne in mind however, that for any given individual, 
a change in BMD of ±2.8 x the co-efficient of variation is I
necessary before a BMD change can be accepted as being outwith i|
precision error (1.88,7.1) . The pattern of bone loss as
determined by pQCT was therefore examined in 4 different female |
populations, which are detailed below. Changes in pQCT radial
.:Ï*
BMD were compared to axial measurements in three of the groups i
Î
I
Cross-Sectional Design
Group 1. Changes in pQCT measurements alone were obtained from
:Sanalysis of the study population used to create our 
normal range. This population was defined in chapter
5.2, and has an age range of 18-90 years. 213 females 
were premenopausal (defined as ongoing menses) and 
119 were postmenopausal (defined as no menses for at f■ft;
least 12 months)
Group 2 . Changes in pQCT BMD measurements were compared to DXA 
lumbar spine and hip BMD measurements in a 
perimenopausal group aged 45-55 years. The study 
population described in chapter 6.2 (group 1) was ianalysed further. From the original 216 females, 
those with a known history of thyroid disease, 3|ft
diabetes, asthma and inflammatory arthritis were t
excluded as were those taking drugs known to affect 
bone metabolism and those who had undergone 
hysterectomy, leaving 119 normal women. 79 women were
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premenopausal, and 40 postmenopausal.
Longitudinal Design
Group 3 . 23 normal premenopausal females who were attending an
osteoporosis screening programme (described in 
chapter 5 : 5 .2-point 2) were invited to return
approximately one year later for re-scanning. None 
were known to have any condition or were taking 
medication which could influence bone mass. pQCT was 
performed within 8 weeks of DXA lumbar spine and hip 
measurements at the baseline visit, but both were 
performed on the same day at the follow-up visit. All 
women were menstruating regularly at both baseline 
and follow-up visits.
Group 4. 26 normal postmenopausal females underwent pQCT and
DXA hip and spine measurements on the same day at 
baseline and approximately 18 months later. None 
were known to have any condition or were taking 
medication which could influence bone mass. This 
study population is derived from that described in 
chapter 5: 5.2-point 3. Of the original 31 females, 
26 females agreed to return for re-scanning, to form 
the basis of this study population.
For the follow-up pQCT measurements, the "trending" function, 
which is discussed in chapter 3, was utilised. The cut-off 
value used for the difference in voxel numbers between baseline 
and follow-up scans was set at 30. This should have ensured 
accurate positioning of the scanner in follow-up scans, thus 
minimising the influence of change in scan site on follow-up 
pQCT BMD measurements.
7.3 Statistical Analyses
Results for continuous variables were expressed as the mean 
with standard deviation if the data were normally distributed,
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otherwise as the median with ranges.
7.3.1 Cross-sectional Designs
The relationships of pQCT BMD values with age in the whole 
population aged 18-90 years (group 1) , were examined using 
linear and non-linear regression, exponential and logarithmic 
analyses. The model which best fitted the data was determined 
by minimising the residual sum of squares and improving the 
correlation co-efficient. Similar analyses were performed on 
premenopausal women as a function of age, and postmenopausal 
women as a function of years since the menopause. From the 
resultant equations, annual rates of change were determined, as 
a function of age for premenopausal women, and years 
postmenopause for postmenopausal females at 5, 10, 20, 3 0 and 
40 years postmenopause.
In group 2, between group comparisons were performed using the 
unpaired t-test. Differences between premenopausal and 
postmenopausal subgroups were expressed as percentages. Taking 
into account the differing ranges for BMD measurements, T- 
scores were also generated and compared for the postmenopausal 
group, using the premenopausal group as the young normal 
population. The differences are expressed as T-scores rather 
than Z-scores, as obviously the populations were not aged 
matched, and pQCT BMD in premenopausal women studied cross- 
sectionally showed little change (see results section of this 
chapter).
7.3.2 Longitudinal Designs
In the longitudinal designs, between group comparison of 
baseline BMD measurements were performed using the unpaired t- 
test. Annualized rates of change in BMD were calculated, and 
within group annualized percentage BMD changes from baseline 
were compared using the paired t-test.
7.4 Results
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7.4.1 Cross-sectional studies
The changes in pQCT BMD values in a female population aged 18- 
9 0 (group 1) are shown in figures 7.1 - 7.4. For the whole 
population, cubic regression was superior to other models in 
describing age related changes for all pQCT BMD measurements as 
a function of age (see figures 7.1-7.4 for regression 
equations) . There was a decrease in BMD from peak bone mass to 
that of old age of 34.3%, 31.7%, 33.7% and 24.4% for Qtot,
Qtrab, Qscort and Qcort respectively [excluding the age range 
30-39 years, which is probably not representative of the 
general population, due to the small number of subjects studied 
(n=6)j . Linear regression equations of the premenopausal 
females showed that there was little change in any of the pQCT 
BMD measurements as a function of age between the end of the 
second and fifth decades. The relationship with age was 
positive for Qtot (Qtot = 376.4 + 0.3(age), r=0.053, p=NS), and 
negative for Qtrab (Qtrab = 186.4 - 0.01(age), r=-0.003, p=NS), 
Qscort (Qscort = 545 - 0.17(age), r=-0.024, p=N8) and Qcort 
(Qcort = 567.7 - 0.11(age), r=-0.016, p=NS). The resultant
annual rates of changes in premenopausal women were small : Qtot 
(+0 . 3mg/cm^/yr / 0.08%/yr), Qtrab (-0 . Olmg/cm^/yr / -0.005%/yr), 
Qscort (-0 .17mg/cm^/yr ; -0.03%/yr) and Qcort (-0 . llmg/cm^/yr ;
-0 .02%/yr).
For postmenopausal females, all BMD measurements were
negatively related to the duration since menopause, and are 
shown in figures 7.5 and 7.6. A cubic regression model best 
fitted Qtot, Qscort and Qcort BMD data, whereas a parabolic 
model best fitted Qtrab BMD (see figures 7.5 and 7.6 for
regression equations). The annual rates of changes for
postmenopausal women at 5, 10, 20, 3 0 and 40 years
postmenopause (YPM) derived from the regression equations for 
each of the BMD measurements are shown in table 7.1. For Qtrab, 
the rate of loss gradually increased from -0.53%/yr at 5 YPM to 
-0.76%/yr at 40 YPM. The greatest rate of loss in the early 
postmenopause years (5 and 10 YPM) was found for Qscort ( -
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0.72%/yr and -1.12%/yr respectively) and Qtot (-0.79%/yr and - 
1.12%/yr respectively), with that for Qcort being less (- 
0.5%/yr and -0.95%/yr respectively). The greatest overall rates 
of loss for Qtot, Qscort, and Qcort were found at 2 0 YPM: -
1.36%/yr, -1.39%/yr and -1.39% respectively. Qtot, Qscort and 
Qcort all increased at 40 YPM: +0.85%/yr, +1.43%/yr and
+0.75%/yr respectively.
Changes in radial BMD around the menopause were further 
examined in a perimenopausal population (group 2) and compared 
to DXA spine and hip BMD. 79 premenopausal females (PRE 
subgroup) were compared to 40 postmenopausal females (POST 
subgroup). Details of the study population are shown in table
7.2. The PRE group was 4.1 years younger and 3 cm taller than 
the POST group, but were well matched for weight. The median 
duration since the menopause in the POST subgroup was 35 months 
(range 12-180). All bone mass measurements were lower in the 
POST subgroup and are shown in table 7.2, and figures 7.7 and 
7.8. There were statistically significant differences in all 
BMD measurements except Qcort and Qtrab. Percentage BMD 
differences for axial DXA measurements [-13.48%, -11%, -9.81% 
and -9.78% for FW, FT, FN and LS respectively] were greater 
than those for pQCT [-7.63%, -6.43%, -5.49% and -1.75% for
Qtrab, Qtot, Qscort and Qcort respectively]. T-score 
differences between the premenopausal and postmenopausal
subgroups (using the premenopausal subgroup as the reference 
population) followed a similar pattern to the percentage 
differences and are shown in figures 7.7 and 7.8. Differences 
[T-score(SD),p value] for axial DXA measurements: FT [-
0.81(1.29) ,p<0.001] , FW [-0.77 (1.01 ) ,p<0.001] , FN [-
0.76 (1.09),p<0.001] and LS [-0 . 61(1.26),p=0.005] were greater 
than those found for pQCT measurements: Qscort[-
0.58(1.34),p=0.018] , Qtot [-0 . 54(1.3),p=0.013 ] , Qtrab [-
0.35(1.2),p=0.1] and Qcort [-0.29 (1.24),p=0.17] .
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7.4.2 Longitudinal Studies
Demographic and BMD data for groups 3 and 4 are shown in table
7.3. At baseline, the premenopausal group (group 3) were 
younger (16.3 yrs), taller (4.7cm) and heavier (2.7kg) than 
their postmenopausal counterparts (group 4). Accordingly, BMD 
for all radial, hip and spine measurements were greater in 
group 3, although this failed to reach significance for Qtrab 
and FN. Correcting for the influence of height and weight, 
significant differences remained for all except for Qtrab 
(p=0.198), FN (p=0.065) and FT (p=0.057). The variance of all 
BMD measurements was greater in group 4 than in group 3 . There 
were no significant changes in height or weight in either group 
between baseline and the follow-up visits (group3: height 1.613 
± 0.062m vs 1.614 ± 0.06m; weight 65.9 ± 12.5kg vs 66.2 ± 
12kg)(group 4: height 1.566 ± 0.063m vs 1.568 + 0.063m; weight
63.2 ± 10.7kg vs 62.9 ± 11kg). Annualized rates of change in 
pQCT radial BMD and DXA hip and spine BMD for both groups are 
shown in table 7.4, and figures 7.9 and 7.10. There were 
statistically significant annualized decreases in Qtot in both 
groups, and in Qscort in group 3. Mean changes in other pQCT 
measurements were negative in both groups with the exception of 
Qtrab in group 4, but none reached significance. There were no 
significant changes in DXA hip or spine BMD measurements in 
groups 3 or 4 with the exception of FN in group 4. The variance 
in percentage change was large for all measurements and tended 
to be greater in group 4. As can be seen for figures 7.9 and 
7.10, very few individual changes fell outwith the 2.8 x CV 
band indicating that a real change could only be confirmed in 
very few patients. The postmenopausal group (group 4) was 
further analysed according to the duration since menopause. 
There was no difference in the annualized rates of change 
between those within 10 years of their menopause (n-9), and 
those more than 10 years from their menopause (n=15) , although 
the numbers in each subgroup were small.
The relationship between the annualized percentage rates of
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change in pQCT measurements and those of LS and FN for 
premenopausal females (group 3) are shown in table 7.5, and 
for postmenopausal females (group 4) are shown in table 7.6. 
Similar relationships were found with FT and FW BMD 
measurements, but are not shown. There were no significant 
relationships between annualized rate of change between pQCT 
and DXA LS and FN measurements in either premenopausal or 
postmenopausal groups. The relationships between changes in 
Qtot and LS in premenopausal and postmenopausal females are 
shown in figure 7.11, as are those for Qtot and FN in figure
7.12. The relationships of other pQCT measurements were similar 
but are not shown. However, the relationships between 
annualised percentage rates of change at LS and FN in both 
group 3 and 4 were also insignificant, and are shown in figure
7.13.
7,5 Discussion
All radial pQCT BMD measurements decreased with age, the, 
reduction between peak bone mass and old age being 24.4%-34.3% 
depending upon the measurement. Studying a population with a 
wide age range, as there was in group 1 (18-90 years) , a cubic 
regression model was found to best fit all pQCT BMD 
measurements. This has been found previously for trabecular BMD 
determined by QCT at the radius (7.2) and lumbar spine 
(1.74,7.2) . When the cross-sectional data derived from group 1 
were examined by decades (see tables 5.1 & 5.2), the various 
BMD values seem stable until the end of the sixth decade. This 
method of analysing data can mask the effects of the menopause 
upon BMD, as its age of onset varies between women. Dividing 
the population by menopausal status should help clarify the 
effect of the menopause upon radial BMD. In the premenopausal 
subgroup of group 1, there must be doubt whether those females 
in the age group 3 0-40 years (n=6) are representative of the 
general population. This negates any meaningful attempt to 
determine the timing of peak bone mass in this population. 
Nevertheless, fitting a linear regression model should allow
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the trend of BMD in premenopausal women to be determined, as 
the 10 year age bands on either side of the 4th decade are 
sufficiently large to be representative of the premenopausal 
population. Such a model showed that all radial pQCT BMD 
measurements were effectively stable in the premenopausal 
subgroup. This is in keeping with almost all of the published 
work done using both SPA (1.63,1.51,1.68,1.69,1.70,1.79) and 
pQCT (1.50,1.78). However, reduced radial trabecular BMD has 
been found in regularly menstruating women with evidence of 
declining ovarian function (7.3).
In contrast to the premenopausal subgroup, there was clear 
evidence of significant reductions in pQCT BMD measurements in 
the postmenopausal subgroup of group 1. A cubic regression 
model best fitted Qtot, Qscort and Qcort BMD data as a function 
of years since the menopause, whereas a parabolic model best 
fitted Qtrab. Surprisingly, the derived rate of loss for Qtrab 
gradually increased from 5 to 40 years postmenopause, which is 
contrary to the theory that an accelerated phase of trabecular 
bone loss occurs immediately following the menopause, at least 
at the radius. Additionally, derived rates of loss for Qtrab 
were much lower than those for Qtot, Qscort and Qcort in the 
early postmenopausal years (5 to 20 years postmenopause). The 
greatest rates of loss were found for Qtot, Qscort and Qcort at 
20 years postmenopause(-1.36%/yr - -1.39%/yr). These findings 
for Qtot, Qscort and Qcort can be explained by the recent 
observation that postmenopausal remodelling occurs at the inner 
aspect of the cortical shell with trabecularisation of 
endosteal cortical bone. Consequently, progressive expansion of 
the cross-sectional area of trabecular bone occurs at the 
expense of cortical area in postmenopausal women (1.75,6.6) . A 
more pronounced decrease in pQCT total BMD compared to 
trabecular BMD has been noted previously from cross-sectional 
data (1.50,6.6). The estimated rates of bone loss (from cross- 
sectional data) for the postmenopausal subgroup of group 1 in 
this thesis, are comparable to other estimated rates of loss
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(cross-sectional data) determined using pQCT (1.50,6.6), SPA 
(1.68,1.69), and DXA (7.4), and observed rates of loss 
(longitudinal data) determined using pQCT (1.75,1.78) and SPA 
(1.73). There was also evidence of ongoing loss for all pQCT 
BMD measurements in the elderly. Estimated rates of loss in 
women 30 years postmenopause were between -0.59%/yr and - 
0.93%/yr depending upon the measurement, supporting the claims 
of others that significant bone loss continues into old age 
(1.86). In contrast, the estimated rates of change at 40 years 
postmenopause, suggested that radial Qtot, Qscort and Qcort BMD 
increased in the very elderly. However, many of the women more 
than 40 years postmenopause were recruited through an 
advertising campaign requesting elderly, fracture free women to 
act as normal controls for hip fracture patients. They were not 
randomly selected from the elderly population, and were 
therefore liable to several biases, which could have falsely 
increased BMD, thus reducing or reversing estimated rates of 
bone loss (1.86) . These biases have been discussed in more 
detail in chapter 1.1.3.
Profound changes in bone metabolism occurs immediately 
following the menopause due to falling oestrogen levels. This 
results in increased bone resorption and subsequent bone loss. 
The effect of the menopause upon radial pQCT BMD was compared 
to DXA hip and spine BMD measurements, in a cross-sectional 
study. The study population was a randomly selected group of 
perimenopausal females aged 45-55 years of age, which was then 
divided into premenopausal and postmenopausal subgroups based 
upon menstrual history (group 2) . 90% of the postmenopausal 
females studied in this group were within 8 years of the 
menopause and thus represent early postmenopausal females. In 
view of the differences in mean BMD values and ranges between 
pQCT and DXA measurements, comparison of differences is best 
achieved if the differences are expressed as T-scores (using 
the premenopausal subgroup as the young normal reference 
population) rather than percentages. BMD was found to be
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significantly lower at all skeletal sites in postmenopausal 
females. The greatest differences (based upon T-scores) were 
found for the three DXA hip measurements, particularly the 
trochanteric site and Ward's area, which are the trabecular 
rich sites within the hip. Differences for all pQCT BMD 
measurements were lower than those found at the hip and spine. 
At the radius, the greatest differences (based upon T-scores) 
were found for Qtot and Qscort (both statistically 
significant), whereas those for Qtrab and Qcort were 
insignificant. This suggests that perimenopausal and early 
postmenopausal bone loss is less marked from radial compared to 
axial sites, supporting the findings of others (1.77,7.4). 
These findings also suggest that perimenopausal bone loss at 
the radius primarily occurs from the subcortical region, 
supporting the findings above derived from group 1, and 
previously reported work (1.75,6.6). A similar insignificant 
reduction in radial trabecular BMD has also been reported 
previously from a comparable study, with a population similar 
but smaller to group 2 reported here (7.5) .
Longitudinal studies should resolve the issues of timing and 
rate of bone loss. Almost all longitudinal studies have shown 
that there is no significant premenopausal loss in radial bone 
mass when assessed using SPA (1.63,1.69,1.70,1.79), The 
premenopausal females studied longitudinally in this thesis 
(group 3), are all older than 45 and are therefore likely to be 
nearing the menopause. Observed annualized rates of change 
showed mean total and subcortical BMD reductions of -1.04% and 
-1.35% respectively, both of which were statistically 
significant. Trabecular and cortical BMD changes were much 
smaller and insignificant. This suggest that there may be 
radial bone loss immediately preceding the menopause within the 
subcortical area, in a similar manner to that described in 
postmenopausal women above (Chapter 7: groups 1 & 2), and
previously (1.75,6.6). It may well be that although these 
premenopausal women were still menstruating regularly, their
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oestrogen levels were diminishing, but unfortunately they were 
not assessed as part of this study.
There is convincing evidence from longitudinal studies using 
both SPA (1.70,1.73,1.80,5.3) and pQCT (1.75) that bone loss 
occurs from the radius in postmenopausal females. The studies 
using SPA have found rates of bone loss around 1%/yr. The study 
using pQCT (1.75) found a greater annual rate of loss of 2.3% 
for total BMD and 2.8% for trabecular BMD, whilst cortical BMD 
remained stable. This latter study examined females within 4 
years of the menopause, and supports the concept of accelerated 
bone loss immediately following the menopause which 
preferentially affects trabecular bone. In comparison, there 
was no significant change in trabecular BMD ( + 0.3 ± 3.04 %/yr) 
in the group of postmenopausal females studied longitudinally 
in this thesis (group 4: table 7.4) . Although observed mean
annual rates of loss were noted for subcortical (-4.1%/yr) and 
cortical BMD (-4.1%/yr), these annual changes failed to reach 
statistical significance due to the large variances observed. 
The observed mean rate of loss for pQCT total BMD was 1.36%/yr 
which reached statistical significance. The large variance in 
rates of change found generally in the postmenopausal females 
could be related to the precision of the scanner, but also 
probably reflects inter-individual variation in rates of bone 
loss, and differing rates of bone loss in postmenopausal 
females at different time points from the menopause. The 
disparity from previous results using pQCT (1.75) can be 
explained by the different study populations as our population 
was older, and the mean duration since menopause was 13.3 years 
with a large variance.
The mean annual rates of change found at the radius using pQCT 
in all these populations (groups 1-4) would be clinically 
insignificant if found in an individual, bearing in mind a 
change of ± 2.8 times the coefficient of variation for each BMD 
measurement is necessary before it can be assumed that a
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clinically relevant change in BMD has occurred, and that the 
change is not due to scanner error (1.88) . Based upon the 
changes observed in group 3, an interval of around 3 years 
would be necessary between scans for detection of clinically 
important changes in total and subcortical BMD in an individual 
premenopausal female nearing the menopause. It is more 
difficult to be accurate about the corresponding interval in 
postmenopausal females, as this would be determined by the 
precision of pQCT in such females. Unfortunately this has not 
been formally assessed by us, but the precision is likely to be 
between that of normal young females, and that of 
postmenopausal females with severe osteoporosis and vertebral 
fracture (see chapter 3). If this assumption is accepted, then, 
based upon the observed annual rates of change in group 4 
(longitudinal data in postmenopausal women) , and the estimated 
annual rates of change in the postmenopausal subgroup of group 
1 (cross-sectional data in postmenopausal women), the 
corresponding interval in normal postmenopausal females would 
again be at least 3 years, with total and subcortical BMD 
measurements being the most useful measures of change.
Existing evidence from the literature suggests that changes in 
BMD at the radius differs from that at the axial skeleton both 
in timing and rate. Whilst radial BMD is stable until the 
menopause, there is some evidence to suggest premenopausal bone 
loss at both hip (1.63,1,68,1.72,5.1,5.2) and spine 
(1.51,1.63,1.69,1.70,1.71,1.74,1.83). Others have found spine 
(1.68,1.77,1.79,5.1) bone mass stable until the menopause with 
loss limited to postmenopausal females. An accelerated phase of 
bone loss at the hip (1.81,5.1,5.2) and spine 
(1.51,1.71,1.73,1.74,1.81,5.1,5.3) immediately after the 
menopause has been recorded, whilst others have found a linear 
decline at hip (1.72,5.3) and spine (1.68,1.69,1.70). The 
percentage difference between PBM and BMD of old age, and rates 
of loss, have been found to be greater at the hip and spine 
compared to radius in most of the previous work. Generally,
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annual rates of loss at axial sites exceed 1% and tend to be 
greater in postmenopausal females in both cross-sectional and 
longitudinal studies, with rates of loss at the spine as great 
as 6%/yr being found in the early postmenopausal years.
Hip and spine BMD in the premenopausal females (group 3) 
studied longitudinally in this thesis were found to be stable, 
with no evidence of bone loss. Similarly, there was no evidence 
of spinal bone loss in the postmenopausal group. There was 
however a significant annual decline of 2.47%/yr in femoral 
neck BMD, although changes in femoral trochanter and Ward's 
area were insignificant. The small numbers studied in each 
group, the composition of the postmenopausal group (see above), 
the interval between repeat measurements and the precision of 
the DXA scanner are likely to be responsible for the largely 
stable DXA measurments in groups 3 and 4. As for radial pQCT 
measurements, the precision of DXA and rates of change recorded 
at axial sites are such that annual changes are not outwith 
scanner error, and an interval between scans greater than that 
studied in this thesis (median value: 15 months for group 3, 18 
months for group 4) is necessary for clinically significant 
change to be detected in an individual.
The relationships between the observed rates of change in the 
longitudinal studies (groups 3 & 4) for radial pQCT BMD
measurements and changes at either lumbar spine or hip were 
very poor. In the premenopausal group, the relationships 
between radial, and lumbar spine and femoral neck BMD changes 
were all positive except radial trabecular BMD versus lumbar 
spine, but none reached statistical significance. The 
relationships in the postmenopausal group were even poorer, 
such that all changes in pQCT measurements were negatively 
related to changes at the femoral neck. Although the 
corresponding relationships with lumbar spine changes were all
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positive, none reached significance. A similar relationship has 
been found before between lumbar spine and radial BMD changes 
measured by DPA and SPA respectively (1.70). It is worth noting 
however, that the relationship between changes at the femoral 
neck and lumbar spine was equally poor in both premenopausal 
and postmenopausal populations studied in this thesis. The 
relationship was stronger in the postmenopausal compared to the 
premenopausal group, but failed to reach significance in 
either. This suggests that BMD changes occurring at one 
skeletal site are not necessarily representative of changes at 
another over the short-term. Change must therefore be 
determined from site specific measurements, and cannot be 
extrapolated from measurements at other sites.
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Table 7,3 Demographic data of group 3 {n=23) and 4 (n=26), with 
baseline pQCT and DXA spine and hip BMD data. Values are: mean 
(SD), § is median (range). YPM: is years postmenopause.
Time: is duration in months between baseline and follow-up
visit. ANOVA: is analysis of covariance controlling for height 
and weight
Group 3 Group 4 t-test ANOVA
Age (yrs) 47.2 (1.7) 63.5 (6 .8) <0 .001 -
Height (cm) 1. 613 (0.162) 1.566 (0.063) 0.011 -
Weight (kg) 65 . 9 (12.5) 63.2 (10.7) NS -
YPM (yrs) 13.3 (7.9) - -
Time (mo) § 15 (13-17) 18 (15-19) - -
pQCT (gm/cm^)
Qtot 395.2 (47.1) 349.5 (75.3) 0 . oil 0,032
Qtrab 190 . 6 (27.2) 179.1 (44.4) NS NS
Qscort 542.8 (70.8) 474.1 (99.2) 0 . 008 0 . 037
Qcort 563.2 (63.4) 503.7 (86.4) 0 . 009 0 .035
DXA (gm/cm^)
LS 1 . 08 (0.126) 0.893 (0.16) <0 . 001 < 0.001
FN 0 . 868 (0.094) 0.799 (0.15) NS NS
FT 0 . 714 (0.093) 0.631 (0.128) 0 . 014 NS
FW 0.693 (0 .101) 0.583 (0.170) 0 . 01 0 . 024
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CHAPTER 8
THE ABILITY OF pQCT TO DISCRIMINATE FRACTURE AND NON-FRACTURE 
POPULATIONS: COMPARISON WITH OTHER BONE MASS MEASUREMENTS
8.1 Introduction
Osteoporotic fracture is the ultimate event affecting 
individuals with low BMD. Accordingly, such individuals are 
categorised as suffering from severe osteoporosis (6.4). 
Osteoporotic fractures characteristically affects the distal 
radius, thoracolumbar spine and proximal femur. Such fractures 
cause significant morbidity and cost the NHS an estimated £740 
million per year (8.1). Additionally, the latter two types of 
fracture are associated with a reduced 5 year survival of 0.82 
(8.2) and 0.83 (1.94) respectively, when compared to age
matched non-fracture controls. With our increasingly aged 
population, the problems and financial burden imposed by 
osteoporotic fractures will undoubtedly rise (1.98).
One of the most important roles of osteo-densitometry is 
prediction of future fracture, as individuals considered at 
risk based upon a bone mass measurement can be targeted for 
life style and therapeutic intervention. There is convincing 
evidence that radial bone density measurements are useful in 
determining fracture risk. Although hip fracture risk is best 
determined by a site specific measurement (1.192), prospective 
studies have shown that radial BMD measurements, using 
techniques other than pQCT, can predict fracture risk at the 
hip (1.192,8.3) and spine (6 .5,8 .3). It is recognised that 
there is an overlap in BMD assessed at axial sites between age 
matched non-fracture populations and both hip (1.155,8.4,8.5) 
and vertebral (1.54,8.6) fracture populations, with the overlap 
being greater for the former type of fracture. Also, lumbar 
spine measurements can be falsely elevated by overlying aortic
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calcification (1.168,1.169,1.170), and age related spondylosis 
and osteophytosis (1.171-1.177), thus limiting its 
discriminatory power (1.177). Inspite of these problems, spinal 
BMD measurements have been shown to discriminate vertebral 
fracture and non-fracture populations (1.173), with spinal QCT 
being considered the best method (8.9,8.10). Similarly, 
prospective studies have shown spinal BMD to predict 
osteoporotic fractures (1.192,6.5,6.10,8.11), with a recent 
study showing that spinal (and hip) DXA BMD predicts fragility 
fractures in perimenopausal females (1.203).
There has been much recent interest in the value of calcaneal 
ultrasound in fracture discrimination and prediction. In the 
case of hip fracture, the discriminatory power of calcaneal 
ultrasound attenuation and velocity measurements has been 
established (8.12,8.13,8.14,8.15), and both prospective 
(8.16,8.17,8.18,8.19) and retrospective (8.20) studies have 
shown their predictive power. In the case of vertebral 
fractures, they have been shown to discriminate (8,8,8.14) and 
predict prospectively (8 .21),and retrospectively (8 .22) 
fracture populations. Generally ultrasound measurements are 
thought to be more useful in hip than vertebral fracture 
discrimination and prediction. A preliminary prospective study 
has also shown ultrasound attenuation to predict fragility 
fractures in perimenopausal females (1.204), although less well 
than DXA lumbar spine BMD.
Prospective studies in fracture prediction are required for 
pQCT. Such studies are clearly longterm, and not really 
feasible within the time scale of work for this thesis. 
However, an important related function is the discrimination of 
fracture and non-fracture populations. Almost invariably 
discriminatory studies have demonstrated approximately the same 
relationship between specific sites of BMD assessment and
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fracture risk as subsequent longitudinal studies. As the 
vertebral body is predominantly trabecular bone, as is up to 
50% of the proximal femur, independent assessment of trabecular 
and cortical bone at the radius by pQCT may allow 
differentiation of fracture and non-fracture populations by one 
or other of the pQCT BMD measurements. The ability of pQCT to 
discriminate groups of individuals who had suffered a previous 
vertebral or hip fracture from non-fracture controls was 
therefore studied, comparing the results with DXA and 
ultrasound measurements done at other skeletal sites.
8.2 Study Populations and Bone Mass Measurements
8.2.1 Vertebral fracture study
4 5 postmenopausal females with vertebral fractures proven on 
lateral thoracolumbar spine x-ray were recruited from a bone 
clinic. None had any underlying condition or were taking 
medication known to influence bone mass. 30 normal 
postmenopausal females formed the control group. The 
recruitment of these females has been discussed previously 
(Chapter 5: 5.2 point 3). Lateral thoracolumbar spine x-rays 
were performed to exclude vertebral fracture in this control 
group (1 of the original 31 females had a vertebral fracture 
and was excluded from this study). All of these females had 
radial pQCT and DXA of hip and spine performed on a single 
visit. 30 of the fracture population were scanned using a 
Norland DXA scanner, whilst the remaining 15 females were 
scanned using a Lunar DPX-a scanner. The whole control 
population was scanned using the Norland DXA scanner. Fractured 
vertebral bodies within the DXA lumbar spine region of interest 
(L2-L4) were excluded from the analysis. As two different DXA 
scanners were used in the assessment of the vertebral^ fracture 
group, and there are known to be differences in data 
acquisition between these scanners (8.23), DXA hip and spine
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BMD data were standardised using a conversion equation (8.23). 
These equations have been derived from extensive cross­
calibration experiments allowing for the expected deviations 
between the measured BMD’s on each scanner. This allows direct 
comparison of data derived from the two scanners. The following 
equations were used for both hip and spine measurements:
sBMDn = 1.0761 BMD„
SBMDl = 0.9522 BMDl
where s = standardised
N = Norland 
X, = Lunar
8.2.2 Hip fracture study
300 females who had suffered a hip fracture were recruited into 
a study designed to examine the power of calcaneal ultrasound 
and different DXA measurements in discriminating hip fracture 
patients from a control population. Patients who had suffered 
a previous hip fracture patients were obtained from a search of 
admission records to Aberdeen Royal NHS Trust for the five year 
period prior to the study. Individuals were invited by letter 
to attend for scanning. 64 postmenopausal female controls were 
recruited from advertising in the local press. None had a 
history of previous fracture, although thoracolumbar spine x- 
rays were not done to exclude asymptomatic vertebral fractures. 
All females had the following measurements done on the same 
day: (1) DXA of the left hip in the control group, and the hip
contralateral to the fracture site in the fracture group, (2) 
ultrasound of the left calcaneus. When personnel trained to 
perform pQCT were available, including myself, pQCT was also 
performed. 165 of the hip fracture group, and 45 of the control
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group had pQCT performed. These females formed the study 
populations which are reported in this thesis.
8.3 Statistical Analyses
Similar analytical methods were used for both vertebral and hip 
fracture groups. Continuous variables are expressed as mean and 
standard deviation when normally distributed, median with range 
otherwise. Comparison between groups was performed by the 
unpaired t-test. Bone mass measurements were examined having 
corrected for the influence of age, height and weight by 
analysis of co-variance. Percentage differences between 
measurements were calculated, and taking into account differing 
ranges for these measurements, Z-scores (number of standard 
deviations above or below the normal mean) were calculated. 
These z scores were generated using the control group as the 
reference population in each corresponding studies. Receiver 
operator curves (ROC) for the different bone mass measurements 
were created. These reflect sensitivity versus specificity for 
multiple cut off values. The area under the resultant curve 
(AUC) indicates the ability of that measurement to discriminate 
fracture from non-fracture populations. The greater the area 
under the curve, the more discriminatory the measurement. ROC's 
were generated, AUC's calculated, and subsequent comparisons 
made using the "ROCKER" statistical package.
8.4 Results
8.4.1 Vertebral fracture study
Details of the study populations are shown in table 8.1. The 
fracture group was 4.1 years older (p<0.05), 3.8 cm shorter
(p<0.05), 3.2 kg lighter (p=NS) and 6.5 years more
postmenopause (p<0.01) than the non-fracture group. The median 
number of vertebral fractures was 2 (range 1-8). All pQCT BMD 
values were significantly lower in the fracture group and are 
shown in figure 8.1: (Qtot: 341.8 ± 76.3 vs 269.8 ± 56.3 g/cm^;
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Qtrab: 174.7 ± 44.9 vs 114.1 ±45.8 g/cm^ , both p<0.001; Qscort:
465.1 ± 105.6 vs 390.5 ± 85.4 g/cm^ , p-0.002) with the exception 
of Qcort (498.2 ± 91.7 vs 475.9 ± 87.3 mg/cm^) . DXA measurements 
were also lower in the fracture group and are shown in figure 
8.2: (standardised (S) LS: 0.958 ± 0.174 vs 0.726 ± 0.133 g/cm^; 
SFN: 0.843 ± 0.164 vs 0.667 ± 0,089 g/cm^; SFT: 0.667 ± 0.138 
vs 0.526 ± 0.1 g/cm^; SFW: 0.616 ± 0.176 vs 0.458 ± 0.92 g/cm\ 
all p<0.001). After correcting for differences in age, height, 
weight and years postmenopause between the groups, significant 
differences in BMD remained (see figures 8 .1-8.2), with the 
exception of Qscort (AJSTOVA, p=0.063). The greatest percentage 
difference between groups (see figures 8.1 & 8 .2) was found for 
Qtrab (-34.7%), with difference in Qtot, SLS, SFN, SFT and SFW 
being of a similar magnitude (-21.1%, -24.2%, -26.4%, -21.1%
and -25.6% respectively). A smaller difference was found in 
Qscort (-16%) and Qcort (-4.5%). Taking into account differing 
measurement ranges, z-score differences between fracture and 
non-fracture groups (see figures 8.1 & 8 .2) were greatest for 
standardised LS (mean(SD): -1.37(0.78)] and Qtrab [-
1.35(1.02)]. Z-score differences were of a similar magnitude 
for standardised DXA hip BMD measurements and Qtot (-0.9 - - 
1.08), whilst that for Qscort [-0.71(0.81)] was lower, and that 
for Qcort [-0.24(0.95)] lowest.
The receiver operator (ROC) curves generated for pQCT and DXA 
measurements, with the corresponding area under the curves 
(AUC), are shown in figure 8.3. Comparisons of the AUC's for 
each of the measurements are shown in table 8.2. The largest 
AUC was for Qtrab (0.853), which was significantly greater than 
that for Qscort (0.715, p=0.035) and Qcort (0.572, p<0.002), 
but not Qtot (0.782, p=0.139). The AUC for SLS (0.847) was
greater than that for SFN, SFT and SFW (0.822, 0.787 and 0.784 
respectively). However, there were no significant differences 
between the AUC's for the DXA measurements. There was a slight
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numerical difference between the AUC for Qtrab and SLS in 
favour of the former, but this was insignificant (p=0.976). The 
AUC for Qcort was significantly less than all other pQCT and 
DXA measurements. Otherwise, there were no significant 
differences in the AUC's comparing pQCT with DXA measurements, 
except for SLS which was greater than Qscort (p=0.035).
8.4.2 Hip fracture study
Details of the hip fracture and non-fracture groups are shown 
in table 8.1, The fracture group was 1.2 years younger, 0.8cm 
shorter, 2.5 kg lighter and 1.4 year less postmenopausal than 
their non-fracture counterparts, none of which were 
statistically significant. The mean duration between fracture 
and study was 3 years. 1 of the control group, and 26 of the 
hip fracture group self-reported a history of rheumatoid 
arthritis (x^  test, p=0.02). Their exclusion did not change the 
results, so they are included in the subsequent analyses. 
Differences in bone mass measurements between groups are shown 
in figures 8 .4-8.6 . DXA hip BMD data is missing on 17 of the 
fracture group due to bilateral hip prostheses. Ultrasound data 
are missing from 1 control and 11 fracture subjects due to 
machine malfunction. All pQCT measurements were significantly 
lower in the fracture group and are shown in figure 8.4: (Qtot:
288.8 ± 66.1 vs 243 ± 60.7 g/cm^ and Qscort: 397.6 ± 86.1 vs 
334.7 ± 81 g/cm^, both p<0.001; Qcort: 455.2 ± 77.7 vs 403.4 ±
94.1 g/cm^ , p=0.001; Qtrab: 151.6 ± 54.5 vs 12 6.1 ± 47.7 g/cm^, 
p=0.002). All DXA hip measurements were significantly lower and 
are shown in figure 8.5: (FN: 0.686 ± 0.106 vs 0.576 ± 0.095
g/cm"; FT 0.549 ± 0.114 vs 0.458 ± 0.113 g/cm^; FW: 0.462 ±
0.105 vs 0.39 ± 0.096 g/cm^, all p<0.001), as were ultrasound 
measurements which are shown in figure 8 .6 : (BUA: 62.3 ± 15.8
vs 52.1 ± 19.6 dB/MHz, p=0.002; VOS: 1485 ± 49 vs 1423 ± 64 
m/s, p<0.001). Correction for differences in age, height, 
weight and years postmenopause between the groups did not alter
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the results. The percentage differences were of a similar 
magnitude for all pQCT (-16.8%, -15.8% -15.6% and -11.4%, for 
Qtrab, Qscort, Qtot and Qcort respectively), DXA hip (-16.6%, 
-16% and -15.6% for FT, FN and FW respectively) and BUA (- 
16.4%) measurements. There was only a -4.2% difference for VOS. 
Again, taking into account differing measurement ranges, z- 
score differences between fracture and non-fracture groups (see 
figures 8.4 - 8 .6) were greatest for FN [-1.04 (0.86)] and VOS 
[-0.91(4.68)], followed by FT [-0.83 (1.03)] and Qscort [-0.73 
(0.94)] . Those for the remaining pQCT measurements, FW and BUA 
were all of a similar magnitude [-0.64 - -0.68], with Qtrab 
differences being lowest [-0.48 (0.88)].
The receiver operator (ROC) curves generated for pQCT, DXA and 
ultrasound measurements, with the corresponding area under the 
curves (AUC), are shown in figure 8.7. Comparisons of the AUC's 
for each of the measurements are shown in table 8.3. The AUC 
for the ROC curve was greatest for FN (0.796), which was 
significantly greater than those for all pQCT measurements: 
(Qtot: AUC=0.693, p=0.028; Qtrab: AUC=0.648, p<0.002; Qscort: 
AUC=0.698, p=0.037; Qcort: AUC=0.675, p=0.027), FW (AUC=0.738, 
p=0.01) and BUA (AUC=0.663, p=0.007). Although the AUC for FN 
was greater than those for FT (0.751, p=0.062) and VOS
(AUC=0.783, p=0.818), the differences were statistically
insignificant. The AUC for Qscort was greater than other pQCT 
measurements, but not statistically superior. The AUC for VOS 
was greater than all of the pQCT measurements, but this reached 
significance only against Qtrab (p=0.026) . The AUC for BUA was 
similar to those for pQCT, but significantly less than that for 
VOS (p=0.009).
8.5 Discussion
These results show that trabecular BMD measured by pQCT at the 
ultra-distal radial site was the most powerful measurement in
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discriminating patients with vertebral fracture from non­
fracture controls, by virtue of the greatest AUC of the ROC 
curve. However there was no statistical superiority over the 
discriminatory power of DXA lumbar spine and hip measurements 
for which the AUC's were only slightly less. In contrast, the 
discriminatory power of the cortical BMD measurement was low, 
and significantly poorer than all other pQCT, as well as DXA 
hip and spine measurements. When the discriminatory power of 
pQCT measurements were compared, that for trabecular BMD was 
significantly better than that of cortical and subcortical, but 
not total BMD measurements. These finding largely mirror the z- 
score differences between fracture and non-fracture groups for 
each of the BMD measurements - the greatest difference being 
found for radial trabecular BMD, and the smallest for radial 
cortical BMD.
In contrast, the power of pQCT to discriminate a hip fracture 
population from a non-fracture population was less than it was 
for a vertebral fracture population, as shown by the smaller 
AUC's. This was true for all individual pQCT BMD measurements 
comparing the AUC's in the vertebral fracture and hip fracture 
populations, with the exception of the cortical BMD. The most 
discriminatory pQCT measurement in the hip fracture study was 
subcortical BMD, whilst the least was trabecular BMD. Overall, 
the best discriminatory measurement for hip fracture was DXA 
femoral neck BMD, which was statistically superior to all pQCT 
measurements, and calcaneal ultrasound attenuation, but not 
velocity. In general, the discriminatory power of the pQCT and 
DXA was poorer for hip fractures than it was for vertebral 
fractures. This could be explained in part by the smaller z- 
score differences between fracture and non-fracture groups for 
corresponding BMD measurements in the hip fracture study 
compared to the vertebral fracture study (except for Qscort and 
Qcort) . It also suggests that although BMD is an important
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discriminant of fracture, it is more important in vertebral 
fracture than in hip fracture.
It is apparent that factors other than BMD are important in 
determining fracture risk. More recently, other features of the 
proximal femur have been cited as being important in fracture 
predisposition - namely femoral neck length 
(8.24,8.25,8.26,8.27,8.28), and distribution and architecture 
of bone (8.24,8.28,8.29,8.30), as assessed on x-ray and DXA 
images. Bone turnover rate also predicts hip fracture 
independently of BMD (8.31). The mechanics of a fall are also 
important for hip fracture (1.26,1.27,1.94,8.32,8.33). The 
orientation and energy of the fall, the location of impact, and 
protective mechanisms are all important in determining whether 
a hip fracture will occur or not (8.32). The importance of 
falls, which is the most important risk factor for hip 
fracture, is less important in vertebral fractures (1.94,8.1). 
For the latter type of fracture, architectural factors have 
also been found to be of some importance. A smaller cross- 
sectional area of unfractured vertebrae results in an increased 
mechanical strain for equivalent loads (8.34), and morphometric 
differences in spinal trabecular bone predispose to fracture 
(8.35).
To date, very little data has been published on the 
discriminatory or predictive power of pQCT in fracture 
populations, especially hip fracture. The superiority of pQCT 
derived trabecular BMD over DXA lumbar spine BMD in the 
discrimination of a vertebral fracture population has been 
cited previously (8.36) . In contrast, Grampp et al (8.37) found 
pQCT to be inferior to spinal BMD measured by QCT, and radial 
total BMD superior to radial trabecular BMD. The cross- 
sectional area of radial cortical bone was found to be equally 
discriminatory as total radial BMD. Several workers have
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reported pQCT BMD in vertebral fracture populations 
(1.78,3.1,6.7,8.38). Grampp et al (3.1) found differences of 
10% for trabecular, 8% for total and 1.5% for cortical BMD, 
which are lower than those reported in this thesis. There was 
also a greater age difference between their groups than ours. 
Schneider et al (6.7) found a difference of 21% between groups, 
but they compared a postmenopausal fracture group (mean age 5 9 
years) with a premenopausal control group (aged 20-40) which 
are clearly not comparable. However, Ruegsegger et al have 
found differences of 15-33% in age matched controls (1.78, 
8.38) which are comparable to those reported in this thesis.
To date, no prospective cohort study exist in which fracture
risk has been determined by pQCT. Numerous studies have shown
that radial BMD, as measured by SPA, has predictive value for
hip (1.192,8.3,8.39,8.40) and vertebral (6.5,6.10,8.3)
fractures. One standard deviation decrease in radial BMD
results in a 1 .6-2.6 increased risk of hip fracture
(1.192,8.3,8.11), and a 1.3-2.4 increased risk of vertebral
fracture (6.5,6.10,8.3,8.11). It is however generally accepted
that fracture risk is best determined by a site specific
measurement (1.192,8.11,8.41). If this applies to the radius, .
then radial pQCT measurements should be useful in predicting
distal forearm fracture, although this was not formally
assessed as part of the work for this thesis. The
discriminatory power of pQCT trabecular and total BMD 
.measurements in vertebral fracture suggests that pQCT may also
be of value in the prediction of vertebral fracture. pQCT may
be of particular value when lumbar spondylosis is evident, when
the discriminatory power of spinal DXA is diminished (8.52).
The power of pQCT to discriminate hip fracture was less than 
that of hip DXA and calcaneal ultrasound, suggesting that pQCT 
would be of less value in the prediction of hip fracture.
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Prospective studies are now required to determine the clinical 
usefulness of pQCT in fracture prediction.
The fact that BUA was a poor discriminator of hip fracture was 
surprising and difficult to explain, as it is contrary to the 
findings of others (8.12-8.15), who found differences between 
groups of a similar magnitude to that presented here. BUA has 
also been shown to predict future hip fracture (8.16-8.19), and 
correlate with the failure load of human cadaveric femurs 
during simulation of a fall onto the trochanter (8.42). The 
finding that ultrasound velocity discriminates hip fracture 
from non-fracture populations as well as hip BMD, inspite of 
smaller percentage differences, is in keeping with previous 
work (8.12,8.14). When the differences in mean values and the 
range of absolute values are taken into account, and fracture 
and non-fracture groups are compared using z-scores, 
differences in DXA femoral neck BMD [-1.04 (0.86)] and VOS [- 
0.91(4.68)] are not dissimilar. The power of ultrasound 
velocity was superior to all pQCT measurements in the 
discrimination of hip fractures, although this reached 
statistical significance only against pQCT trabecular BMD. The 
finding that ultrasound attenuation was no better than pQCT, 
and significantly poorer than DXA hip and ultrasound velocity 
was surprising, and contrary to previous findings comparing DXA 
and BUA. One possible explanation is the interval between 
fracture and scanning in the work presented in this thesis 
(mean: three years), as the fracture and subsequent immobility, 
could have resulted in greater bone loss at the hip than at the 
calcaneus. A recent, large, prospective study showed that 
calcaneal ultrasound attenuation and velocity predicted hip 
fracture as well as, and independently of, DXA femoral neck BMD 
in 7575 (5662 underwent ultrasound assessment) community
dwelling, elderly (at least 75 years of age) women (8.19). Of 
the ultrasonic measurements, BUA was found to be the most
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independent of femoral neck BMD, yet the most predictive of hip 
fracture. Additionally, for women in whom both BUA and femoral 
neck BMD was low (less than the median) , the fracture risk was 
much greater than in those with only one low measurement. This 
suggests that fracture risk is best determined by measuring 
both femoral neck BMD and calcaneal BUA.
There are several confounding factors in the studies presented 
in this thesis. In the vertebral fracture study, the groups 
were not entirely comparable, with the fracture group being 
older, shorter and further beyond the menopause than the non­
fracture group. However, correcting for these differences did 
not greatly change the highly significant differences for most 
BMD measurements between groups. Also, as discussed in chapter 
7, age related rates of bone loss are greater at the spine and 
hip compared to the radius. Therefore any age difference 
between groups would affect DXA more than pQCT measurements, 
and as such should not detract from the finding that pQCT 
trabecular BMD discriminates best between vertebral fracture 
and non-fracture groups. An additional problem was performing 
axial measurements on two DXA scanners manufactured by 
different companies, which is less than ideal. However, 
correction equations have been extensively validated to allow 
comparison of data acquired from these different scanners 
(8.23) . Additionally, there was no quantification of lumbar 
spondylosis on the spinal x-rays. If significant osteoarthritic 
changes were present, this would have diminished the 
discriminatory power of the DXA lumbar spine measurement.
In the hip fracture study, the control group is much smaller 
than the fracture group, whilst the reverse is the ideal. 
Unfortunately it proved impossible to recruit more non-fracture 
controls. Also, only a subgroup of the population originally 
recruited underwent pQCT as discussed in chapter 8.2.2. There
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was no preselection of this subgroup, as pQCT was performed 
whenever personnel trained in pQCT were available, and this is 
unlikely to have biased the subgroup which formed the 
populations presented here. The differences in bone mass 
measurements between hip fracture and non fracture groups for 
hip DXA and ultrasound measurements are comparable to those 
previously published (8.12,8.13,8.15), which supports the 
concept that both groups were representative.
Finally, the ability of pQCT to predict hip, vertebral and 
distal forearm fractures must now be determined by prospective 
studies.
170
■g-HIP4mQ)Uu
0  
U
(Urc;4J
4-)-ri
m1to
(U
3
U24-)
g
mI4J
ïI
ffi
0) I—Ig
raIUtJ)
S
4J
aA o
"H
4J
IM
0  
n34-)
L)
-Ht
to1Q
H
U
Ui
rH
ftiSh■34J
>
OS
UIPu
00 H
W
a-HrCl
nS LO JUO 04 ,—VCT) 00O OLO H LOPu CO1 CT) rH 1H ro 04 ro i> 00 rHI • LO • • —'M 00 CT) rH> LO rH lO 04 04
LOO H
rH • • mO O[> ■— H CT)U O1 o CT)H ro rH LO CT) rodl I • LO • .M n '=ÿ • 04 LO> LO H LO H
PuIPuH
m
IX) kO 1—i
u LnI
d) IlS 5
rH
rH
<y\
m
m
i>
[>o
o
I>
Lf)LO
lf)
r-"
VDo
LOLO
LO
rH
04
HH
CT)
00LO
LO
CT)
HLO
%^^UlU 4J 4Jf!tn m(U -H -iHtn Q) (D<< m &
OH
CT)CM
O'
CT)
O
ro
LO
H
O
PO
0 ta 4Ja4J 0 0U 0 Ü0 U XSh 04H 4JUa s, 00 •rH 0 Sh pW Sh 4H co
Ü !>1rd 1—1a 0 0 ü0 0 Sh 0c T3 rQ 00 4J 0 0 Bg 0 XJ 4J4J 0 Sh 00 0 Sho rH 0) > 0Pu 0 5:1> 0 4H 00 U O 0u 0 00 4-1 a0 Sh 0 0M H >
(Ug'rd
ÎH3•H
g
H
XIu-H
4J
Üm
O■H4H
■Hg,■Hm
4J
O
a
Q)m
-HeQ)
Æ4J
O
W I—I
OU4Jg
0  
mp5Ul
k
>
4_)m
(U4J14J
tJQ)U-H
fd
0
Sho4H
rH
O
O
O
A
aA
rHO
O
S'
H
O
O
A
aALO
O
O
oXJ
p
0
ucxa
4-1o
uQ)g
§
00
<
CN
00
0 I—I
>■Hm
rHu
004-)i
4Jma■Ha  0tn0
S=!w, O tj) m!=1■H
4J0U•H
-H
Os
0
Epiu
ShO4J0Sh0
&
Sh
>•H0U0Sh
0XU4J
Sh0
•HSh0
IU
0Ü0■H
4J0rH
1a
0Sh04JU0Sh4HI
§
1Sh4H
2pi4JU0ShTJ 4H p;
^  rH 0
g 4^-4 Sh
>
04J0
-HB"HShU0-H•d
I0
0  0 I—I 0
0Sh0
0
4J1Shpi00
e
00[>IS •
Ph o
o CM00 LO1> O)•
pH o O
04 LO 00CM CT\ LO00 ro ro|2S •PH o O O
l> 04 LDCO ro00 LD 04 CMCO
P o O O O
CM CM CM4J CM O O O roSh o O o O o0 LO • • • oU o o oO O V V V o
u04J CM d lSh LO O in l> O)o H O ro LO LO LO 4Hu l> o O H CM 00 Od O V o o O 0 un
<
4HCM 0ro in O LO rH 000 LO ro O i> ro 0) 0 PISh 00 o O) LD CM ro 04J O 0d o o V o O O 0 -H
Sh0a
eCM 0CM m O H LT) 04 LO u4J 00 ro ro O rH O) 0o rH  rH • CM ro 00 0) Sh4J • • o • * • . 0d o O  O V O o o 0 4H
00pja0>u !
p a< 0Sh0
4J 0X^  Sh 4J 00 O Sh pjSh U O 1—14J 0 u CO J2J IS 0d  d d p pH pH pH >
' "f-
S
I
*
î>i
I— I I—1 0 0 4J 
0
4J0
-S
S)0
d0 0 
•H Sh1a o
XH 0 4-» Üotn -H d -d ■H 0I!-H Ss i4H
S g
i i Sh
Sh ^s i
< . 4 H
m
a0
§_ o4J x:] 0 0
1ShO0■Htj
04-J1024-4
H
0
i
Üt-H0Ü
0 0 H  0
0Sh0
0
4J1Sh
000i
>-HCfl0rHÜg
CO
>
gffl
g
g
4-1gÜa
4JShOu0d
0Sh4-4
d
4-4O
4-4
d
ro00
roLOLO
O
00roi>
rH
LDl>
LOO)l>
inl>LO
§
moo
H
O o
CM CMCM 00 00LO O LO
O O O
CM l> 00LO rH O HO O o 00
O O o O
LO [> roCM 00 LO CT)O H CM 00 O
O O O o o
00 CM CM ShCT) CT) ro 00 CM d* LO OLO ro o CM LO rH 4H
O O o O O O O u5
4HCM 000 H CT) o CM i> LO1> 00 o M* l> 00 CM dLO CM LO O O o O oo 0O O O V O o o O •rHSh0aBoro rH rH ro 00 00 CT) CM üCT) O LO CM LO lO 00 "vfLO CM 00 LO O CM ro LO rH Sh* • • • « • • • • Oo O O O O O o O O 4H
Sh4J
4-4ÎHOÜ0
4JShOU
d  d  d g HPh Ph W CO>
US
00dr—I
>Ia
0Sh0
00drH
>
m
&32o>
01coc"Oc(00
O(0Ia§cI
aCIiEasÛQia.
8Ië
00
.2*LL
Q.
m §•
2 23 O)II
I S
'ë C § g
.a
fc
s??
lOCO
8 2 o 8V <n o. N h€H
□
s
ë T3CNI8 go 8 I (/) CL N I □--1
r
Ô
s
1 1 1
(O Q. N
in
o
-Q
0 ^ 6 8  U  «> II «"Ÿ a. N5 -a-
I § §CO ooU) o ooCO oo
I
SL3
D)I
0jaI0
a.,1Ig> (1)E5
g sQ. g 2#II
XS Q. C 3 0 p 
JC o)ÎIîlws **—0 O
S’ S
0IIdeo
20i2oQ.
I*IIi|I f
l ll|0) E
l lg 8Q.N
( luo/B) aiAig
wa.32D)0
0
1C
oc
■o
c00
uffi
2Ii
0JD
42cIiEos0Û
o
8
1£
(y003)
CL
D> §■IIÜ 0III i> c
□
<o oR "CL N
6
COoIIIT- II Ü) 
^  Cl. N
O
zu. d 8II w 
CL N o
CO
0
Î3
o° o
, V  «  
^  CL N
CM O
-o-
CM O 00d COo o CMd
830a.081CL
2I
Q.I£c8
0s z
l iD)
O)
0
i|I III
1 1
8.8liP 0C  0
g1
Cl323)0
uCO
0 3
Os0J=
8CI
c0  %3 01T3
28C1
Qeic2 E
2o%
lO
a. O.N
Ic
*T3
S§a.■oc(Q
O
0
1a. (/) c (D O
D)C
«3I I0)
g #
ililil
g  ^
g  g
ëîoôO)ÎZ
Èo
r \ _ o
D. n \
00 otooT“ o
§  8
d  d
LL IL LL
00 to CM OT~
AwAiMSuos
00o
(A umm
Nd
CDN
00d
s |
s |
CV|
OO •B
0?3
1«
ü
<
&32O)
£IIcg■ocCB
0>
Cg
(UJQ
42ciiED
S
m
I
00
.5>LL
| lOï O
II
Ï É  
■ □ a
t:
ê
!ÈT3
00KO
8 £ o 8V ü> 
Q. N
tI
CM
Ë9
8 2
V 8 
Q. N
•a
co
KO
XiI
Sis.S9
S
8
Q. N
Ë■o
8
CD00 O 
(d ti 8 (A
Q. N I □ 1
I— O— I
I— □— I
I-- O — —I
oo00 I i i i oco OO
(gU io/B ) a w a
I(0ID)I8îië&
45I
dc/)
iI
42o
CL
Q .
2D>
C8
(D
i lIII O)II
E g
.5 <D
CD O
8*8 k c £ 2IIII8|
1 1ü  45 «  (0
i li|w E
ï l(ü o >  «O.N
NN
ï
,r..
8.32O)
2Icoc■oc(0Q>
OCO
Cg
IIO) û)
IIk. I
oJZ c ll<o o
tfi Va. N
1
•>£i
I □ ----1
ë
42ci3iI
Q
.5
g
£iQ
«>00
D)
LL
t
§(d
S
ss
a. N
(O00ds
# 8 2  
g :  8T  Q. N
CM
ro
[ [] 1
I □---1
00d
1— '— r
CD Tfd  d
_T
CMd
(^ luo/B) aiAia
o
(0
a 45(0 (A
(A
00N
■ ...
(AOL32D)ICO
•ocCO
23oCO
g
ë
3cIIET3c
gI
8Ë
££
«Î00
■SPLL
(s/Lu) SOAI OoCM s00 I
s
9
CO§ &« h"Ÿ Q. N
|-°i
Ui
0
D)0
3
“ illIIx: c
i □
oCD 8 8 O
(zHiAimp) vns
Q.IÎc
8
0
li■° a3If.Ill111
f iwp 2
illi|iIfi" (0(As l - -
illSI IO > (A O.Q.N
m
•f
Hd p 00d
(Od
o
CNjdQ.
oa. 00d (Dd o (Nd oT"
00O) 00o
CL o 3 < < (£>d
O ) (Q 5  a  a CLo
0 4  > CNd
Q. o
cod co o CMd o
00dtS "U cod
LL LL.
d x:
CMd ■o
o
OOd oO)
■ -i _____
CHAPTER 9
CHANGES IN RADIAL pQCT HMD MEASUREMENTS IN RESPONSE TO DRUG 
THERAPY: COMPARISON WITH MEASUREMENTS AT OTHER SKELETAL SITES.
9.1 Introduction
One of the most important functions identified for bone 
densitometry is monitoring of drug therapy 
{1.145,1.146,1.153,1.154,9.1). This is as equally applicable to 
drugs which have a beneficial effect upon bone mass and are 
used in the treatment of osteoporosis, as it is to those which 
have an adverse effect upon bone mass, such as corticosteroids. 
Both hormone replacement therapy (HRT) and cyclical etidronate 
with calcium are used in the treatment of osteoporosis. HRT has 
been shown to reduce fracture rates at the hip, spine and 
radius in postmenopausal women (1.198,1.199,9.2-9.5), increase 
axial (9.6-9.13) and maintain radial (9.8,9.11,9.14) HMD. 
Cyclical etidronate and calcium increase spinal BMD and is of 
proven value in the treatment of established postmenopausal 
osteoporotic vertebral fracture by reducing vertebral fracture 
rates (9.15,9.16,9.17) and increasing spinal BMD 
(9.7,9.13,9.15,9.16,9.17). The desired interval between repeat 
measurements for monitoring response is largely determined by 
the precision of the scanner and the expected rate and 
magnitude of change. As the precision of pQCT is comparable to 
DXA lumbar spine and femoral trochanter measurements, and 
better than femoral neck and Ward's area measurements (see 
chapters 2 and 3) , the response to these treatments may be 
better monitored at the radius by following changes in 
trabecular BMD. This is especially attractive as both HRT and 
etidronate preferentially affect trabecular bone which has an 
increased metabolic rate. As DXA measures a composite of 
trabecular and cortical bone unlike pQCT which allows direct 
quantification of trabecular BMD, DXA may be less sensitive to
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smaller changes in trabecular bone than pQCT. Whilst spinal QCT 
is also a technique which allows measurement of trabecular bone 
independently, its use, especially when repeat measures are 
necessary, is limited by radiation considerations (see chapter 
1) . The use of pQCT for monitoring purposes would however be 
dependent upon drug induced change at the radius being of a 
similar timing and magnitude to that at other skeletal sites. 
At present, BMD assessment every 2 years is recommended
(1.145) . A hypothesis can be raised pQCT will allow earlier 
detection of responders, and equally importantly, non­
responders to HRT and etidronate. The work in this chapter 
addresses this hypothesis, the issue of timing of bone mass 
changes at different skeletal sites in response to HRT and 
etidronate during the first year of treatment, and whether 
changes in radial trabecular BMD measured by pQCT can predict 
axial changes measured by DXA.
9.2 Study Populations and Bone Mass Measurements
11 postmenopausal women (defined as no menses for at least 2 
years) were treated by their general practitioners with HRT 
preparations (Prempak-C, n=4 ; Livial and Estracombi n=2 ; 
Trisequens, Estraderm and Cycloprognova each n-1) for the 
prevention of osteoporosis (HRT Gp) . 6 of these women were
identified from the ongoing osteoporosis screening programme 
which has been described previously (Chapter 5: 5.2-point 2). 
They either had lumbar spine or femoral neck BMD in the lowest 
quartile of age matched controls and were targeted for 
intervention with HRT assuming no contra-indications, a cut-off 
point which has been proposed previously (1.88). The remaining 
women were referred directly by their general practitioner's 
for a DXA scan and were also found to have low bone mass for 
which HRT was recommended. All women were either osteopenic (T- 
score  ^ -1; n= 1) or osteoporotic (T-score  ^ -2.5; n= 10) as 
defined by the WHO (6.4), at either the femoral neck or lumbar
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spine. None of these women had suffered an osteoporotic 
fracture and none had vertebral fractures on lateral 
thoracolumbar spine x-ray.
10 older postmenopausal women were referred by their GP ' s to a 
specialised bone clinic because of symptomatic osteoporotic 
vertebral fractures for which cyclical etidronate and calcium 
supplements was prescribed (ETD gp) . All women were 
osteoporotic (T-scores  ^ -2.5 at either lumbar spine or femoral 
neck) with atraumatic vertebral osteoporotic fractures.
None of the women in either group had other conditions or were 
taking other medications which could affect bone mass or 
metabolism. Baseline pQCT and DXA of hip and spine measurements 
were made before treatment was started, and then 4, 8 and 12 
months thereafter. All measurements were done on the same day 
except the baseline visit, where DXA preceded pQCT by no more 
than 8 weeks in some women - DXA was repeated if a longer 
delay was encountered. For the follow-up pQCT measurements, the 
"trending" function, which is discussed in chapter 3, was 
utilised. The cut-off value used for the difference in voxel 
numbers between baseline and follow-up scans was set at 30, 
thus ensuring accurate re-positioning of the scanner in follow- 
up scans and minimising the influence of change in scan site on 
repeat pQCT BMD measurements.
The co-efficients of variation (CV) for pQCT (see chapter 3) 
are generally poorer in postmenopausal women with vertebral 
osteoporotic fractures compared to young normal women (Qtot: 
1.73% vs 1.24%, Qtrab: 2.96% vs 1.33%, Qscort: 1.57% vs 1.58%, 
Qcort: 5.18% vs 1.88%). The precision of axial DXA measurements 
was determined in 6 postmenopausal women [median (range) age: 
68 (60 -71) years, and years postmenopause; 21 (13 - 25) years] 
with vertebral fractures on lateral thoracolumbar x-ray [median
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(range) number of fractures; 2.5 (1-3)], by performing repeat 
hip and spine measurements on the same day with repositioning 
of the subject between scans. These women were different to 
those studied to determine the precision of pQCT in the a 
vertebral fracture group, and those studied in the etidronate 
treatment group. The CV's in the vertebral fracture group 
compared to young normals were; LS ; 2.32% vs 0.9%, FN ; 1.3% vs 
2.8%, FT; 1.42% vs 1.3%, FW; 2.16% vs 4.8%. Fractured vertebral 
bodies within the DXA lumbar spine region of interest (L2-L4) 
were excluded from all relevant analyses.
9.3 Statistical Analyses
Results for continuous variables are expressed as median with 
ranges. Baseline lumbar spine and femoral neck BMD results are 
also expressed as T-scores and Z-scores (number of standard 
deviations above or below the mean relative to young, and age 
matched normal controls respectively). Between group comparison 
at baseline are performed using the Mann-Whitney U test. Within 
group percentage changes in bone mass measurements from 
baseline are compared using the Wilcoxon matched pairs test and 
one factor repeat measurement analysis. The relationships 
between annual rates of changes in BMD at different sites were 
examined using linear regression and correlation co-efficients.
9.4 Results
Baseline clinical and bone mass details of both groups are 
shown in Table 9.1. Although 4 women had undergone hysterectomy 
(hyst) previously [HRT gp; n=l(age 63,hyst 20 yrs previously)], 
[ETD gp : n=l(age 71,hyst 16 yrs previously), n=2 (aged 60 & 73, 
hyst 30 yrs previously)], none had FSH, LH or oestradiol levels 
done to confirm their assumed postmenopausal status. The HRT 
group were younger and fewer years postmenopausal than the ETD 
group. Consequently all baseline BMD measurements were greater
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in the HRT group with the exception of LS.
There were no significant changes in median height or weight 
values during the 1 year follow-up period in either HRT or ETD 
groups (see table 9.2). Percentage BMD changes for the pQCT 
radial and DXA hip and spine BMD measurements are shown in 
tables 9.3 and 9.4 respectively, and depicted in figures 9.1 
and 9.2. There were no overall significant changes in any pQCT 
BMD measurements for either group. There was however a trend 
towards a fall in BMD at month 8 in the HRT group, which 
reached significance for Qtot and Qscort, with some recovery by 
month 12. Significant overall increase was found at LS in both 
groups, which was statistically significant within 4 months, 
and further increased after 12 months of treatment. Although 
there was a trend for all hip BMD measurements to increase, 
overall significance was only achieved for FN in the HRT group. 
The results remained unchanged after correction for changes in 
height and weight. There were no significant relationships 
between the percentage changes in any of the pQCT BMD 
measurements and DXA hip or spine BMD changes with either 
treatment. Comparisons of the percentage changes in pQCT 
measurements with LS BMD after 12 months of treatment with HRT 
(r = 0.19, -0.35, 0.26 and 0.19 for Qtot, Qtrab, Qscort and
Qcort respectively; p = NS for all) and etidronate (r = 0.14, 
0.35, 0.01 and -0.01 for Qtot, Qtrab, Qscort and Qcort
respectively; p = NS for all) were typical of comparisons.
9.5 Discussion
These results shows that changes in BMD induced by both HRT and 
etidronate during one year of treatment varies between skeletal 
sites. The most significant and greatest changes occurred at 
the lumbar spine for both treatments, although there was 
considerable inter-individual variation. Also, for several
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.women in either group, lumbar spine BMD did not increase during 
the first year of treatment. Median increases of +6.6% and 
+ 5.3% after one year of treatment with HRT 
(9.6,9.9,9.10,9.11,9.18) and etidronate (9.15,9.16)
respectively are in keeping with previous work. The work 
presented here suggests that statistically significant changes 
were detectable at the lumbar spine after only 4 months of 
treatment with either HRT or etidronate. Present 
recommendations are that BMD measurements should not be 
repeated until a patient has been on therapy for 1-2 years
(1.145) . This is based upon a change 2.8 times that of the co­
efficient of variation (CV) being necessary before it can be 
regarded as real and not due to measurement error (1.88,9.1).
The CV for DXA lumbar spine measurements in our centre is 0.9% 
in young healthy women, but 2.32% in older osteoporotic women.
The median change in lumbar spine BMD after 4 months of 
treatment with HRT was +3.3% which could only be accepted as 
significant if the precision value for young normal women was 
applied (ie CV = 0.9% with significant change greater than + 
2.52%) . If this figure was applied, then a repeat lumbar spine 
DXA scan as early as 4 months may indicate response to therapy. 
However, although the HRT group did not suffer from vertebral 
fractures, and major spondylosis was not a problem, it is 
unlikely that the precision value would be as low as 0.9%, due :
to the lower BMD values which would result in a higher CV. If 
the higher CV figure was applied, then a follow up scan after 
1 year would be the earliest possible to detect significant 
change. In the etidronate group, the higher CV for DXA lumbar 
spine scans would have to be applied (CV = 2.32%, with
significant change greater than ± 6.4%). Consequently, a repeat 
scan no earlier than 1 year would be indicated. This implies 
that the optimum length of time between scans when assessing 
the response to therapy is dependent upon both the age of the 
patient (which can affect the precision of the measurement),
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and the expected magnitude and timing of the response to 
treatment.
It is surprising that the baseline lumbar spine BMD of the ETD 
group was greater than that of our HRT group bearing in mind 
they were older and more years postmenopausal. This could be 
due to age related spinal osteoarthrosis (1.171-1.177) and 
aortic calcification (1.168,1.169,1.170) elevating spinal BMD 
results in the ETD group. This should not influence the rate of 
response at the lumbar spine, although a state of low bone 
turnover has recently been observed in patients with lumbar 
spondylosis and osteoarthritis (1.174,1.178,1.179,9.19). Also, 
we cannot exclude a spurious rise in BMD from further fractures 
occurring within the area of interest (L2-4) during the first 
year of treatment, as lumbar spine X-rays were not repeated.
This was an attempt to minimise radiation exposure, 
particularly as the purpose of this work was not to examine the 
effect of treatment upon fracture rates. I:
Although there was a trend towards an increase in all hip 
measurements for both groups, this only achieved overall 
significance for femoral neck BMD in the HRT group. Similar 
changes in proximal femur BMD have been documented previously 
with HRT (9.6,9.10,9.11,9.18) and etidronate (9.20,9.21), and 
tend to be lower than those found at the lumbar spine, 
presumably due to a smaller proportion of trabecular bone at 
the former site. Bearing in mind the poorer precision of DXA 
hip measurements, they would be of less value than spinal 
measurements for detecting early response to HRT and 
etidronate. If however, certain situations prevailed, such as ,ïheavy overlying aortic calcification, severe spondylosis or 
multiple vertebral fractures within the spinal region of 
interest, then hip measurements may be the better choice for 
monitoring response, with an appropriately longer interval
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Î
i
between scans.
Previous work has shown that radial BMD, as measured by single 
photon absorptiometry (SPA) is maintained but not increased 
significantly with HRT (9.8,9.11,9.14) and etidronate 
(9.7,9.15). Theoretically, by quantifying trabecular BMD 
independently, pQCT should be more sensitive than SPA in 
detecting change at appendicular sites, and may mirror or even 
antedate axial changes measured by DXA. Although radial BMD was 
maintained, there was no significant increase, even in 
trabecular BMD in either treatment group. This, and the fact 
that there were no meaningful relationships between percentage 
changes at the radius and spine or hip, suggests that the 
response to treatment at the radius, even within the trabecular 
component, is different from that at the lumbar spine. It is 
possible that trabecular BMD may change after more than 1 year 
of treatment, but previous studies using SPA have shown no 
significant increase in radial BMD after treatment with HRT for 
2 years (9.22), and etidronate for 3 years (9.15).
Early demonstration of response to treatment is important 
because it may help improve patient compliance
(1.201,1.202,9.1), and allow early detection of non-responders 
which have been found previously with both etidronate 
(9.20,9.23) and HRT (9.10,9.18,9.22). For such non-responders, 
compliance with therapy could be checked, the importance of 
treatment emphasised, or the treatment changed if necessary. 
Also, proof of response to therapy is important as there is now
some evidence that the anti-fracture efficacy of treatment is
determined by both a reduction in bone turnover and an increase 
in BMD (9.24) . The work presented in this thesis suggests that 
a repeat measurement after one year would evaluate response to 
treatment with HRT and etidronate in the majority of cases. 
When changes smaller than 2. 8x the CV are recorded, such
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changes could also be interpreted as showing an improvement if 
there was a consistent upward trend, although this would have 
to be judged in the context of a given individuals treatment
(9.1) . In clinical practice, the interval between follow up 
scans is likely to be determined largely by individual clinical 
situations and resources. In most instances, due to the 
differential effect of HRT and etidronate on axial and 
appendicular bone, response to treatment would be best 
determined by a spinal BMD measurement.
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Table 9.1 Baseline clinical, pQCT and DXA data for hormone 
replacement therapy (HRT) and etidronate (ETD) groups.
HRT gp (n=ll) ETD gp (n=10)
Age 53 (46-63) 71 (60-79)
Years Postmenopause § 4 (2-10) 23 (14-30)
No. of fractures - 2 (1-4)
pQCT (g/cm^ )
Qtot 340.0 (261.6-389.1) 279.6(198.3-397.8)
Qtrab 147.8 (102.1-200.4) 125.1(87.8-225.7)
Qscort 476.3 (383.9-562.3) 376.6(288.6-538.3)
Qcort 523.0 (466.7-627.0) 463.3(399.1-565.3)
DXA (g/cm^ )
LS 0.755(0.632-0.959) 0.783(0.526-0.934)
T-score 3.17(-4.23 - -1.41) -2.93(-5.02 - -1.63)
2-score 1.46(-1.84 - -0.43) -0.70 (-2.55 - +0.36)
FN 0.723(0.540-0.905) 0.606(0.471-0.858)
Tscore 2.06(-3.58 - -0.54) -3.03 (-4.16 - -0.94)
2-score 1.01(-1.88 - +0.69) -1.26 (-2.09 - +0.89)
FT 0.577(0.441-0.813) 0.497 (0.276-0.619)
FW 0.533 (0.373-0.760) 0.387(0.304-0.554)
•i
I
Î
*
aT.
Î
"■'! I
Values are median (range) unless otherwise stated.
§ for non-hysterectomized women.
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CHAPTER 10
THE EFFECT OF LONGTERM WARFARIN THERAPY ON RADIAL AND AXIAL 
BMD.
10.1 Introduction
It is well recognised that heparin can cause bone loss (10.1) . 
Warfarin is known to affect the development of foetal bone with 
stippled epiphyses and hypoplasia of the nose and extremities 
being observed in the off-spring of mothers treated during 
pregnancy (10.2,10.3). The effect of warfarin on adult bone is 
less well documented, but there is a suggestion that courmarins 
do have an adverse effect (10.4,10.5). In these previous 
studies reduced bone mass was found, but assessment was limited 
to the radius using SPA, and the more clinically important 
sites of hip and spine were not examined. Warfarin is thought 
to affect bone metabolism through its effect on osteocalcin, 
the non-collagenous bone matrix protein which is synthesised by 
osteoblasts and considered to be a marker of bone formation. 
Osteocalcin contains gamma-carboxyglutamic acid (gla), which is 
derived from glutamate through enzymic carboxylation (10.6), a 
process which requires vitamin K as a co-factor. Warfarin, by 
antagonising this vitamin K dependent process, results in 
increased decarboxylated osteocalcin, which is not incorporated 
into the bone matrix, but released into the circulation (10.7) .
As warfarin is a commonly prescribed drug, any adverse effect 
on bone deserves further investigation. As previously stated, 
metabolic changes affect trabecular bone more rapidly than they 
do cortical bone. Therefore any effect of warfarin should be 
greatest within the trabecular component, and skeletal sites 
rich in trabecular bone. pQCT should therefore be valuable in 
assessing its effect on bone. The influence of warfarin upon 
BMD at the radius, was compared to that at the hip and spine in
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a group of men taking longterm warfarin.
10.2 Study Population and Bone Mass Measurements
4 0 men taking longterm warfarin were recruited from the 
hospital anticoagulant clinic (WARFARIN group). The indications 
for anticoagulation were as follows: prosthetic heart valve 
replacement (HVR; n=16), atrial fibrillation (AF; n=13), bypass 
surgery for peripheral vascular disease (PVD; n=7), and 
recurrent venous thrombo-embolism (VTE; n=4) . The degree of 
anticoagulation was determined by averaging the INR values at 
the anticoagulant clinic visits before and after the day of 
study. Controls were obtained from a search of hospital 
discharge summaries, clinic lists and surgical registers 
(CONTROL group). Each individual in the WARFARIN group was 
matched to a control for age (within 5 years). They were also
f
matched for underlying disease so that individuals in the 
WARFARIN group with AF and PVD were matched to controls with 
the same condition but not requiring warfarin. Likewise those 
taking warfarin for HVR were matched to controls with HVR not 
requiring warfarin, although a small number of controls had 
undergone open heart coronary artery by-pass grafting rather 
than HVR. Those taking warfarin because of VTE were matched to 
controls who had undergone lower limb varicose vein surgery. 
All men were Caucasian and ambulatory. Individuals with 
underlying conditions or who were taking drugs (with the
exception of thiazide diuretics) known to influence bone 
metabolism or bone mass were excluded. The controls for 
individuals in the WARFARIN group taking thiazide diuretics 
(n=4) were also matched for thiazide diuretic use. Thus the 
WARFARIN and CONTROL groups were stringently matched for 
factors which could influence BMD other than warfarin therapy.
I
All individuals attended for assessment on a single visit 
within a three week period. At this visit all medications,
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including warfarin dose, were checked. Height, weight, smoking 
habit and alcohol consumption were recorded. A questionnaire 
about physical activity was completed which gave a composite 
score with a range of 5 (most active) to 20 (least active) . All 
men had BMD measurements at the radius by pQCT, and hip and 
spine by DXA.
10.3 Statistical Analyses
Results for continuous variables were expressed as the mean 
with standard deviation if the data were normally distributed, 
otherwise as the median with ranges. Between group comparison 
was performed using the unpaired t-test. Within group 
comparison of BMD data was performed using the Kruskal-Wallis 
test to examine the influence of indication for 
anticoagulation. In the WARFARIN group, the relationships 
between bone mass measurements and duration and degree of 
anticoagulation were examined using univariate regression 
analyses.
10.4 Results
Anthropometric, lifestyle and warfarin related data are shown 
in table 10.1. As might be expected from the matching process, 
there were only slight, and insignificant differences between 
the groups for anthropometric and lifestyle variables. One man 
had received warfarin therapy for 4 months, the remainder for 
more than 12 months. LS (1.061 ± 0.182 vs 0.95 ± 0.13 9 g/cm^, 
p=0.003) and Qtrab (219.8 ± 37.1 vs 200 ±39.8 g/cm\ p=0.024) 
were significantly lower in the WARFARIN group. Whilst the 
remaining pQCT (Qtot: 398.7 ± 64.2 vs 376.7 ± 61.3 g/cm\
Qscort: 533.3 ± 86.5 vs 509.8 ± 77.3 g/cm^, and Qcort; 529.6 ± 
70 vs 527.6 ± 61.3 g/cm^) and DXA hip (FN: 0.817 ± 0.122 vs
0.801 ± 0.142 g/cm\ FT: 0.794 ± 0.147 vs 0.748 ± 0.13 g/cm\ 
and FW 0.587 ± 0.106 vs 0.571 ± 0.139 g/cm^ ) were also lower in 
the WARFARIN group, the differences failed to reach statistical
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significance. Figures 10.1 and 10.2 show the pQCT and DXA BMD 
data for both groups respectively. There were mean percentage 
differences of -10.4% and -9.0% for LS and Qtrab respectively. 
The percentage differences for all other measurements were 
lower: -5.5%, -4.4% and -0.4% for Qtot, Qscort and Qcort
respectively; and -2%, -5.8% and -2.9% for FN, FT and FW
respectively. Controlling for height, age and weight 
differences between groups did not significantly change the 
findings. There were no differences in BMD measurements within 
the subgroups of the WARFARIN group based upon indication for 
warfarinisation. Linear regression analyses of the WARFARIN 
group showed that there were no significant relationships 
between any of the BMD values and dose or duration of warfarin 
therapy, or with the degree of anticoagulation as indicated by 
the INR. These relationships with Qtrab and LS BMD are shown in 
figures 10.3 and 10.4 respectively. Unexpectedly, the slopes of 
the regression lines of duration of warfarin therapy versus LS 
and Qtrab BMD were both positive, but failed to reach 
statistical significance.
10.5 Discussion
These results show that males treated with longterm warfarin 
have lower BMD at the radius, spine and hip than age matched 
male counterparts. The greatest difference was found at the 
lumbar spine, where trabecular bone accounts for about 65% of 
the vertebral body bone mass (1.20). Trabecular BMD at the 
radius was affected to a similar extent, whilst there was very 
little difference in radial cortical BMD. This suggests that 
trabecular bone is preferentially affected by warfarin, no 
doubt due to its increased metabolic rate compared to cortical 
bone. This is in keeping with the effects of other drugs which 
have an adverse effect upon bone such as corticosteroids
(10.8), and those which have a beneficial effect, such as HRT 
and etidronate (see chapter 9) . Bearing in mind that the DXA
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lumbar spine measurement is a composite measure of both 
trabecular and cortical bone, it is surprising that the 
difference at the spine was greater than that for the purely 
trabecular measurement at the radius. Differences in trabecular 
bone at the lumbar spine, which could be measured by QCT, would
200
probably be greater than the difference detected by DXA in this 
thesis, and therefore also greater than that found at the 
radius. This suggest that bone at the radius is affected less 
than that at the spine. At the hip, the greatest difference was 
found for the femoral trochanter site which has a greater 
proportion of trabecular bone than the femoral neck (1.20). 
Whilst the femoral Ward's area is supposed to represent the 
most trabecular rich area within the proximal femur, poorer 
precision would explain why the difference at this site is less 
than other hip sites.
I
Î
s
There were no significant relationships between duration or 
dose of warfarin, or degree of anticoagulation with BMD 
measurements at any site. The relationship between duration of 
warfarin therapy and lumbar spine and radial trabecular BMD 
appears to be a positive. However, the majority of men had been 
on warfarin for less than 160 months (range 4-302 months), with 
only 6 being on treatment for longer. It is possible that these 
6 individuals are not representative of this population and may 
have skewed the data and resultant regression slope. 
Alternatively, the bone losing effect of warfarin may occur 
early in the course of treatment, as it does with 
corticosteroids (10.8). There are differences between the 
vitamin K antagonism on carboxylation in bone and liver (10.9) 
and it is possible that the antagonistic effect on bone occurs 
at doses lower than is necessary for anticoagulation. This may
,explain the lack of relationship between dose and INR with BMD 
measurements. The issues relating to duration, dose and INR 
would be better addressed in a prospective study with larger
201
numbers of subjects.
Men were chosen for the study group because the matching of 
individuals in the warfarin group with controls (for age, 
thiazide diuretic use and underlying disease) was considered to 
be very important. This would have been much more difficult had 
women been studied, as it would have been necessary to match 
for menopausal status and duration since the menopause as well. 
Matching individuals for underlying condition proved to be 
imperfect, as is illustrated by men taking warfarin for venous 
thromboembolism being matched to controls who had undergone 
varicose vein surgery. Such difficulties are probably of minor 
importance in this work, and are inevitable in cross-sectional 
designs. fI
The clinical importance of these findings are unclear at the
'present time, as there is no fracture incidence data available 
to date. However, a 10% reduction in BMD is equivalent to about 
10 years of age related bone loss (8.40), and around 50% of the 
difference between postmenopausal and premenopausal women
(10.10). It is also comparable to a fall in BMD of almost ISD 
within the general population (10.11), which is associated with 
up to a three fold increase in fracture risk 
(6.10,10.12,10.13). In view of the increasing indications for 
anticoagulation, such as non-rheumatic atrial fibrillation and 
poor left ventricular function, perhaps the adverse effect on 
bone should also be considered when deciding to anticoagulate 
individuals, particularly those already at increased risk of 
osteoporosis, such as postmenopausal women.
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CHAPTER 11
The effects of disease and corticosteroids on appendicular bone
MASS IN POSTMENOPAUSAL WOMEN WITH RHEUMATOID ARTHRITIS: 
COMPARISON WITH AXIAL MEASUREMENTS
11.1 Introduction.
Reduced bone mass is a well recognised feature of rheumatoid 
arthritis (RA), with many studies showing reductions at both 
axial and appendicular sites (11.1)» The effect of oral 
corticosteroid therapy on bone mass in RA is contentious 
especially at appendicular sites (11.2,11.3). There is evidence 
to support the concept of generalised bone loss (11.4,11.5), 
but controversy exists about the distribution and degree of 
bone loss, and the relative contribution of immobility, low 
dose corticosteroids and the systemic effects of RA (11.3- 
11.8).
The pQCT measurement scan occurs at the ^ultra-distal radius in 
close proximity to the carpus. As the carpus is frequently 
involved in RA, and periarticular bone loss is a characteristic 
feature, pQCT seems an ideal technique to study periarticular 
bone changes related to RA. Additionally, trabecular bone is 
metabolically more active than cortical bone, and therefore may 
be more responsive to stimuli such as corticosteroid therapy
(11.9), which is used to treat a proportion of patients with 
RA. Accordingly, by quantifying trabecular bone, pQCT may be 
able to differentiate the effects of RA disease activity and 
corticosteroid therapy on bone at the radial site.
The ankle and subtalar joints are also frequently involved in 
RA. One might therefore expect the os calcis, which is also a 
trabecular rich bone (1.21), to be affected in a similar manner 
to the distal radius by local inflammatory processes and
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corticosteroid therapy. It would of interest to determine how 
calcaneal ultrasound measurements are affected by RA, and how 
such changes relate to those found with pQCT.
The relative importance of corticosteroids, disease parameters 
and life style on bone mass in postmenopausal women with RA, 
were examined using pQCT, and compared with ultrasound, and DXA 
of hip and spine.
11.2 Study Population, Clinical Assessments and Bone Mass 
Measurements I
11.2.1 Study Population
75 ambulatory, Caucasian, postmenopausal women were studied.
The control group comprised of 29 previously normal 
postmenopausal women, the recruitment of which is discussed in 
chapter 5 (5.2.point 3). The remaining 46 women had suffered
from RA (as defined by the American College of Rheumatology) j:
(11.10) for at least 6 months and were recruited from out­
patient clinics and a casenote review. 25 of the RA women had 
been on longterm low dose prednisolone therapy (^  lOmg/day) for 
at least 6 months (RA+P group) . The remaining 21 had never 
received oral corticosteroids (RA group). Patients who had 
received intra-articular steroid were not excluded. Subjects 
with abnormal renal function (serum creatinine >140 //mol/1) or
other conditions known to affect bone metabolism were excluded 
as were individuals taking drugs such as HRT and
bisphosphonates. Patients on thiazide diuretics were not 
excluded. Each individual had all assessments performed on the 
same day.
11.2.2 Clinical Data
Data collected included age, height, weight, years since
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menopause, smoking history (cigarettes/day) and alcohol 
consumption (units/week). Dietary calcium intake (mg/day) was 
determined by a locally derived questionnaire, and level of 
physical activity by the Framingham questionnaire. All 
individuals underwent lateral thoracolumbar spine x-ray (T4-L5) 
and fractures were noted (defined as a reduction of 25% in 
anterior, mid or posterior vertebral body height).
RA patients completed a health assessment questionnaire (HAQ). 
Articular index (painful joint count only), mean grip strength 
of three measurements of right and left hands (mm Hg), visual 
analogue pain score (150mm horizontal line) and the time taken 
to walk 15 meters on level ground were recorded. X-rays of 
hands and wrists were scored using the Larsen method. Serum C- 
reactive protein and rheumatoid factor were measured using 
standard laboratory methods.
11.2,3 Bone Density Measurements
pQCT was performed at the ultra-distal radius of the non­
dominant forearm. The effect of RA on in-vivo short-term 
precision is discussed in chapter 3. Briefly, precision 
measurements [expressed as the coefficient of variation (CV)] 
are poorer in the RA population compared to young normals 
(1.24% vs 1.6%, 1.33% vs 4%, 1.58% vs 1.84% and 1.88% vs 2.8% 
for Qtot, Qtrab, Qscort and Qcort respectively). pQCT was not 
possible in one RA subject due to bilateral wrist surgery. 
Ultrasound of the non-dominant os calcis was performed, but due 
to machine servicing, ultrasound data is missing from 7 
controls and 1 RA subject. DXA hip and spine measurements were 
performed using a single scanner. Hip measurements were not 
possible on one RA+P subject due to bilateral hip replacements. 
Fractured vertebrae within the DXA spinal region of interest 
were excluded from the analysis. The effect of RA upon 
precision values of ultrasound and DXA hip and spine
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measurements was not studied.
11.3 Statistical Analyses
Results for continuous variables were expressed as the mean 
with standard deviation if the data were normally distributed, 
otherwise as the median with ranges. Categorical data were 
examined using the Chi squared (%/) test. Variables common to 
all three groups were compared using the oneway analysis of 
variance (ANOVA) or Kruskal-Wallis where appropriate. 
Subsequent comparisons among groups were performed through the 
use of Scheffe's multiple comparison test. Variables relevant 
only to the RA groups were compared using the unpaired t-test 
or Mann-Whitney U test. Bone measurements across groups were 
examined having corrected for the influence of age, height, 
weight and years postmenopause by analysis of covariance with 
subsequent multiple comparison testing among groups. The 
independent relationships between corticosteroid use, RA 
variables, life-style variables and bone mass measurements were 
examined using Pearson correlation co-efficients and stepwise 
multiple regression analysis.
11.4 Results
Detailed clinical data for the three groups are given in Table 
11.1. There were no significant differences in age, years 
postmenopause, height, weight, smoking habit or dietary calcium 
among groups, although the RA+P group was slightly heavier and 
more years postmenopause than the others. A greater proportion 
of the control group consumed alcohol than either RA group, 
although the amount consumed was not significantly different 
(p=0.16; Kruskal-Wallis). The physical activity index was 
significantly higher in the control group compared to either RA 
group, but not significantly different between RA groups. 
Thiazide diuretic use was similar for the combined RA groups 
and control group. 17 (81%) of the RA group and 19 (76%) of the
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RA+P group were taking disease modifying agents 
(sulphasalazine, auranofin, hydroxychloroquine, penicillamine, 
myocrisin, methotrexate or azathioprine). The median disease 
duration was 4 years greater in the RA+P group (p=0.24, Mann- 
Whitney U test) and although there was a trend toward worse 
disease parameters in the RA+P group, significance was reached 
only for the HAQ. There were more vertebral fractures in the RA 
groups than controls, although the difference was not 
significant. ■•%'fIBone mass measurements are shown in figures 11.1 - 11.3. There f
were significant reductions in both RA groups compared to the if
control group for all measurements except the lumbar spine and s|
forearm subcortical and cortical BMD. Although Qscort was lower |
Jin both RA groups compared to the control group, this reached if:fsignificance only for the RA+P group. pQCT BMD measurements 
were (control vs RA vs RA+P; overall ANOVA p value: Qtot: 340.6 
+/- 67.1 vs 289 +/- 67 vs 285.9 +/- 89.7 g/cm^; p=0.016, Qtrab:
174.2 +/- 40 vs 111.8 +/- 52.6 vs 111 +/- 63 g/cm^; p=0.001, 
Qscort: 466.9 +/- 92.8 vs 413.4 +/- 72.6 vs 393 +/- 102.3
g/cm^; p=0.009, Qcort: 495.2 +/- 89.3 vs 518.6 +/- 66.8 vs 498 
+ /- 97.2 g/cm^; p=NS) . Ultrasound measurements were (control vs f-
RA vs RA+P; overall ANOVA p value: BUA: 68.7 +/- 13 vs 49.5 +/- |
17 vs 44.6 +/- 20.5 dB/MHz; p=0.001, VOS: 1517 +/- 51.2 vs 1428 f
+ /- 36.9 vs 1408 +/- 40.8 m/s ; p=0.001) . DXA BMD measurements
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were (control vs RA vs RA+P ; overall ANOVA p value: LS : 0.89
I
+/- 0.16 vs 0.85 +/- 0.21 vs 0.82 +/- 0.18 g/cm^; p=NS, FN:
0.78 +/- 0.14 vs 0.68 +/- 0.15 vs 0.65 +/- 0.11 g/cm^ ; p=0.002, 
FT: 0.61 +/- 0.12 vs 0.55 +/- 0.15 vs 0,52 +/- 0.11 g/cmf;
p=0.012, FW: 0.56 +/- 0.14 V S  0.45 +/- 0.14 vs 0.47 +/- 0.08
q/crc?} p=0.007). Differences persisted after adjustment for the 
influence of age, height, weight and years postmenopause. There 
were no significant differences between the RA groups for any 
bone mass measurement. Combining the RA groups, the percentage
I
difference in bone mass compared to controls was -36.1%, 
“15.6%, -8.4% and +2.4% for forearm trabecular, total,
subcortical and cortical measurements respectively, -31.7% and 
-6.6% for calcaneal BUA and VOS respectively, -15,4%, -13.1%
and -17.9% for femoral neck, trochanter and Ward's area 
respectively, and -6.7% for the lumbar spine.
Stepwise multiple linear regression analyses on the whole 
population are shown in table 11.2. Weight was positively 
correlated with lumbar spine and hip BMD, radial trabecular BMD 
and ultrasound measurements. Physical activity was positively 
correlated with lumbar spine and hip BMD. The independent 
variable RA (coded 0=no, l=yes) was negatively correlated to 
radial total, trabecular and subcortical BMD, calcaneal 
ultrasound measurements and femoral neck and trochanter BMD. 
Years postmenopause was negatively correlated with radial 
total, subcortical and cortical BMD. Age was negatively 
correlated with femoral trochanter BMD. Introducing RA disease 
variables into the regression analyses for the combined RA
group showed that the Larsen score (LARS) was negatively 
correlated with BUA [BUA = 86.25 - 1.04 (LARS); 1^^0.485, F Sig 
<0.0001], VOS [VOS = 1472.1 - 1.45 (LARS); 1^  = 0.185, F Sig = 
0.0037], Qtot [Qtot = 347.2 - 1.852 (LARS); R^=0.093, F Sig
= 0.0348] and Qtrab [Qtrab = 205.6 - 2.21 (LARS) - 0.06(RhF), 
R2=0.503, F Sig <0.0001], with rheumatoid factor titre (RhF) 
being negatively correlated with Qtrab. Table 11.3 shows the
correlation coefficients of individual RA disease variables
with pQCT and ultrasound measurements for the combined RA \
groups. The Larsen score for the non-dominant wrist and whole 
hand (wrist + MCP's + PIP's) was negatively correlated with 
Qtrab, BUA and VOS, whilst the Larsen score of the non-dominant 
wrist was positively correlated with Qcort. Rheumatoid factor 
titre was negatively correlated with Qtrab, BUA and VOS, whilst 
grip strength was positively correlated with Qtrab and BUA. The
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significant linear regression relationships of Qtrab, BUA and 
VOS with RA disease variables are shown in figures 11.4 - 11.6 
respectively.
11.5 Discussion
This study has demonstrated marked reductions in appendicular 
bone mass measurements in patients with RA using both pQCT and 
ultrasound. Some appendicular measurement changes were more 
marked than those noted at the femoral neck and lumbar spine, 
with the changes at the latter site being insignificant in this 
small study.
pQCT measurements were difficult in a small number of patients 
with RA, and the precision of pQCT is poorer in this 
population. There are several reasons for this, which are 
discussed in chapter 3 - namely a lower mean BMD value in RA 
patients, and difficulty visualising the radio-carpal joint 
during the scout scan in patients with more severe RA where the 
normal anatomical landmarks are distorted. However, unless 
there is severe destruction and resorption of the distal radius 
and ulnar, measurement scans in the RA population should be in 
a position similar to those of the control group. In this 
study, pQCT trabecular and total BMD measurements were marked 
reduced in the RA groups (36.1% and -15.6% respectively) 
compared with controls, with very little difference between the 
RA groups. These data are in keeping with previous studies 
examining radial bone loss in patients with non-steroid treated 
RA using pQCT (11.11,11.12). There are however some important 
differences between the studies. The previous longitudinal 
studies examined premenopausal and postmenopausal women with 
early (< 3 years) RA, whilst the cross-sectional study
population reported in this thesis is purely postmenopausal 
with longer and variable disease duration. The pQCT scanners 
used also differed. An ^^ I^ rather than x-ray radiation source
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was used previously, trabecular BMD was measured at the 8-10%, 
and cortical BMD at the distal 1/3 site (rather than the 4% 
site here). As the proportion of trabecular and cortical bone 
changes dramatically over short distances at the distal radius 
(1.17,1.19), these are important differences. Nevertheless, 
annual rates of loss up to 25% were recorded for trabecular 
BMD, whilst cortical BMD changes were similar to the control 
group (11.11), results similar in distribution and magnitude to 
ours. Rapid trabecular bone loss at the radius occurs early in 
the disease process with subsequent slowing (11.12). In view of 
the substantially lower trabecular BMD found in the RA groups, 
the data presented here would suggest that there is 
considerable ongoing bone loss beyond this initial period of 
rapid loss, although this would be better addressed by a 
longterm longitudinal study. The strong correlation of whole 
hand and wrist Larsen scores with trabecular BMD suggests that 
local inflammatory mechanisms responsible for joint damage, and 
resultant wrist immobility have important adverse effects on 
ultra-distal radial bone mass, as found previously (11.13) . An 
increasing rheumatoid factor titre was negatively correlated to 
trabecular bone, which may be related to more aggressive local 
disease in such individuals. The correlation of grip strength 
with trabecular BMD supports the concept that mechanical 
loading and stimulation has a beneficial effect upon local bone 
mass (4.2) . In this case, it is detectable within the 
trabecular component, which being more metabolically active, is 
more responsive to such stimuli.
As corticosteroid induced bone loss preferentially affects 
trabecular bone, one might expect pQCT to be a sensitive 
technique for detecting such an effect. However, it is apparent 
that there is no significant corticosteroid effect on any of 
the forearm BMD measurements, even within the trabecular 
component. The subcortical measurement was significantly lower
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in the steroid treated RA group, but not the non-steroid 
treated RA group compared to controls, but there was no 
significant difference between the RA groups. The lack of 
corticosteroid effect is almost certainly due to the juxta- 
articular, inflammatory driven bone loss (11.14) overwhelming 
other mechanisms affecting trabecular bone at this site. The 
radial measurement site is therefore an important 
consideration. That for SPA is more proximal than pQCT, and as 
such is further removed from the inflammatory process occurring 
at the wrist. The effect of corticosteroid could therefore be 
more pronounced at a more proximal site, which might explain 
why some have found significantly lower radial bone mass in 
patients with corticosteroid treated RA (11.2). In keeping with 
the results reported above, others found no significant 
corticosteroid effect at the radius (11.3,11.15).
Similarly, immediate postmenopausal bone loss preferentially 
affects trabecular rather than cortical bone, yet the duration 
since menopause was negatively correlated with total, 
subcortical and cortical, but not trabecular BMD. Presumably 
this is also due to the periarticular inflammatory process 
overwhelming menopausal effects on trabecular bone, but having 
much less effect upon cortical bone, which is metabolically 
less active. Cortical bone comprises 55% of the pQCT total BMD 
measurement which explains the relationship of duration since 
the menopause with the latter BMD. Cortical bone is also known 
to undergo postmenopausal as well as age related change (1.51), 
as is the pQCT subcortical measurement as discussed in chapter 
7 .
There were no difficulties in performing ultrasound of the os 
calcis in these RA patients as the foot recess was wide enough 
to accommodate broad feet, and application of the transducers 
was not impaired by the degree of subtalar deformity. There
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were reductions in ultrasound attenuation and velocity of - 
31.7% and -6.6% respectively in the combined RA group, again 
with no additional significant steroid effect. Weight was an 
important determinant of ultrasound measurements as was the 
Larsen index in the RA groups. The latter finding is 
particularly intriguing as the Larsen index was measured at the 
hand and wrist. The same inflammatory mechanisms causing bone 
loss at the wrist may well effect the trabecular rich os 
calcis, explaining the correlation between the Larsen index at 
the wrist and the ultrasound measurements at the os calcis. As 
for radial trabecular BMD, and presumably for the same reason, 
both calcaneal ultrasound measurements were negatively 
correlated with a rising titre of rheumatoid factor. It is 
difficult to explain the correlation between grip strength and 
BUA, but this may well reflect similar long-term disease 
activity in the hands and feet in this group of patients.
There have been many previous studies addressing axial BMD in 
RA, and these have been reviewed recently (11.1). DXA 
measurements were included here to allow comparison with pQCT 
and ultrasound within the same population. A significant 
reduction in femoral neck BMD of 12.8% (0.71 SD) and 15.4% 
(0.93 SD) in the RA and RA+P groups respectively, with no 
significant corticosteroid effect is in keeping with most of 
the present literature (11.6,11.7,11.8,11.15,11.16). Such 
reductions are associated with an increased risk of future hip 
fracture (1.192), which has been recently demonstrated in the 
RA population (11.17). Weight and physical activity were 
important determinants of hip BMD in keeping with previous work
(11.7,11.8), suggesting that patient mobility helps maintain 
hip BMD.
The 4.5% and 7.9% reductions in lumbar spine BMD for the RA and 
RA+P groups respectively failed to reach significance and are
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smaller than those recorded at the hip, radius and calcaneus. 
Although the groups were well matched for age, we cannot 
exclude age and fracture related spinal osteoarthrosis 
influencing our spinal BMD results (1.171-1.177). 
Interpretation of the lumbar spine results in the light of 
previous work has to be cautious because of differences in 
measurement techniques, study populations and dose of 
corticosteroid. In those studies which examined postmenopausal 
women. Hall et al studied larger numbers and found a larger and 
significant difference of 7.5% between control and non-steroid 
treated RA groups (11.8). Although a significant difference of 
6.5% was found between steroid and non-steroid treated RA 
groups, the difference was smaller (4.3%), and non-significant 
when a subgroup with a lower cumulative dose of corticosteroid 
was examined. Verstraetaen et al studied the effect of higher 
dose prednisolone in women with much longer disease duration 
than their non-steroid treated counterparts (11.3). Also, 
rather unusually, lumbar spine BMD was much higher in the non­
steroid RA group compared to control group, suggesting that 
either the RA or control group was non-representative. Using 
QCT, Laan et al found a reduction of 34.7% in lumbar spine 
trabecular BMD in a low dose steroid-treated RA group compared 
to a non-steroid treated group (11.18), which is much greater 
than that reported here. However, QCT measures purely 
trabecular bone, whereas DXA measures a composite of cortical 
and trabecular bone, and as such, the techniques are clearly 
not comparable. In patients with RA, one would not expect 
differences in radial trabecular BMD (as measured by pQCT) to 
be comparable to differences in spinal trabecular BMD (as 
measured by QCT) , as the spine is far removed from the 
periarticular inflammatory process which profoundly influences 
radial trabecular BMD. Also, there is poor correlation between 
radial and axial BMD in the general population (11.19, see 
chapter 6). Compared to controls. Lane et al (11.15) found DXA
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lumbar spine BMD 8.4% lower in non-steroid treated RA patients, 
but a non-significant difference for steroid treated patients, 
although the steroid treated group was small (n=13 for LS BMD 
measurements). The greater difference in lumbar spine BMD for 
the non-steroid treated group in comparison to the results 
presented here, can be explained by the longer duration of RA 
(mean: 24.5 yrs) in the group studied by Lane et al. Others 
have examined populations which differed in gender and 
menopausal status (1.131,11.6,11.7,11.16), or studied the 
effect of higher dose corticosteroid (11.3,11.7,11.8,11.16) 
which makes direct comparison with the results reported here 
difficult. An increased prevalence of vertebral fracture has 
been demonstrated in steroid treated postmenopausal women with 
RA (11.20), although there was no non-steroid treated RA group 
for comparison. The increased prevalence was greater than 
expected from DXA spinal BMD differences, suggesting a steroid 
effect on bone architecture as well as mass.
I.I,:
This study has highlighted important changes in appendicular 
bone mass in RA. There is now good evidence that bone loss 
occurs early in RA at the radius (11.11,11.12), hip and spine 
(11.4), with axial bone loss being related to disease and 
physical activity (11.4). Recently there has been interest 
expressed in measuring appendicular BMD as a method of 
monitoring disease activity in RA (11.1,11.21). pQCT and 
calcaneal ultrasound, by quantifying trabecular bone adjacent 
to the carpus and ankle respectively, offer novel and unique 
opportunities to study the effect of RA on periarticular bone, 
and may be valuable methods of monitoring response to 
treatments such as disease modifying anti-rheumatic drugs and 
corticosteroid. Further work is necessary to examine the 
clinical use of pQCT and ultrasound in RA.
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CHAPTER 12
OVERALL CONCLUSIONS AND DISCUSSION.
Briefly, the aims of this thesis were to examine the use of 
pQCT in the field of osteoporosis. The precision of pQCT was 
studied in different populations. The effect upon precision of 
minimising the difference between scan voxel numbers in follow- 
up scans was also investigated. The effect of dominance in 
individuals of normal day-to-day activity was studied. 
Normative data from the local female population was obtained, 
from which, important anthropometric determinants were 
determined, and estimated rates of change derived. pQCT was 
variably compared to DXA measurements and calcaneal ultrasound 
in a number of different situations. These were: perimenopausal 
changes in HMD; the relationships with other bone mass 
measurements and the implications for screening; discrimination 
of vertebral and hip fracture populations from non-fracture 
controls; the effect of HRT and etidronate therapy upon HMD and 
the implications for monitoring treatment; the effect of 
warfarin upon HMD; and the effect of disease and low dose 
corticosteroid in postmenopausal women with rheumatoid
arthritis.
The precision of the Stratec XCT 960 pQCT scanner was 
comparable to other scanning modalities such as DXA with 
precision values of 1-2%. Although less precise than the multi- 
slice pQCT technique, it is cheaper and more ubiquitous. The 
precision was found to be poorer in older postmenopausal women 
with vertebral fracture, and in women with rheumatoid arthritis 
It is likely that the precision of the Stratec XCT 960 pQCT 
system could be improved by increasing the number of scan 
slices, thus increasing the measurement sample size. However, 
this would result in a longer scan time, and consequently a 
greater chance of movement artifact. The local radiation dose
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would also be increased, although this is unlikely to be a 
problem, as the radiation dose associated with the present 
system is so low.
Precision was shown to be influenced by the difference between 
voxel numbers of repeat scans, suggesting that scan voxel 
numbers can be used as a surrogate marker of cross-sectional 
area, and an aid to positioning during repeat scanning. This is 
an important consideration in repeat scanning of the ultra- 
distal radius, as absolute BMD, and the proportion of cortical 
and trabecular bone change significantly over short distances 
(1.16-1.19). With the present Stratec system, beyond 
standardization of the scanning technique, further improvement 
in precision is possible by limiting the difference in voxel 
numbers between repeat scans. At the present time, a difference 
of 30 voxels or less is recommended from the work presented in 
chapter 3. However, this should be further validated, for 
example, by an in-vitro cadaveric study. Dominance influenced 
radial BMD by only 1-2% in individuals of normal physical 
activity. Although not statistically significant, it does have 
important clinical implications. A lack of consistency with 
respect to which forearm is scanned, would introduce a further 
1-2% variance in BMD measurements. It was our policy therefore, 
to always scan the non-dominant forearm unless there had been 
a previous Colles fracture, and to always scan the same forearm 
in longitudinal studies.
The importance of acquiring a normal range based upon the local 
population was shown in chapter 5. BMD values of the normal 
range derived from the Grampian region of Scotland were greater 
than those of the manufacturers and a previously reported 
German population (1.50). The population sample was somewhat 
lacking in numbers in the 30-3 9 years age group, which 
unfortunately negates any meaningful attempt to address the
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issue of timing of peak bone mass. Not surprisingly, age was 
negatively correlated with all pQCT BMD measurements in 
multiple regression analyses. Weight was found to be positively 
correlated, inspite of the radius being a non-weight bearing 
site. The negative correlation for height with total and 
trabecular BMD measurements is surprising, but may indicate 
that taller women have thinner radii.
The cross-sectional pQCT data presented in this thesis 
indicates that radial BMD was stable from the age of 18 years 
until the menopause, which is inkeeping with almost all of the 
previous literature(1.50,1.51,1.63,1.68,1.69,1.70,1.78,1.79). 
However, the longitudinal data from 23 normal premenopausal 
women (mean age 47.2 year, range 46-54 years) showed a 
significant decrease in total and subcortical BMD (-1.04% and 
-1.35% respectively) after follow up for one year, inspite of 
ongoing regular menses. The differences in results between 
estimated and observed rates of change illustrate that 
population variability hides small changes in BMD in cross- 
sectional data, which can be better determined in precise, 
longitudinal studies. Premenopausal changes in radial BMD 
should be clarified with more long term, prospective studies 
involving greater numbers of participants.
The menopause is considered to induce profound bone loss. The 
pQCT data in chapter 7 of this thesis, derived from the cross- 
sectional studies supports this finding in part. When all 
postmenopausal women were considered as a single group, 
estimated rates of bone loss up to -1.39%/yr were found. 
Surprisingly however, the rate of trabecular BMD loss for 
postmenopausal women was generally lower than that of other 
pQCT BMD measurements. It also gradually increased with the 
duration since the menopause, which is contrary to the accepted 
theory that trabecular bone is preferentially affected
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immediately following the menopause (1.49,1.64,1.66,1.67,1.74-
1.77), at least at the radius. In contrast, the work in chapter 
7 showed that subcortical bone was preferentially affected in 
the early postmenopausal years. This supports the recent 
observation that during this period, remodelling results in 
trabecularization of endosteal cortical bone and expansion of 
the intramedullary radial cavity at the expense of the cortical 
shell, whilst there is little change in trabecular BMD (6.6). 
This was confirmed when changes in pQCT BMD around the 
menopause were examined further by comparing early 
postmenopausal and late premenopausal women in a cross- 
sectional study, where a greater difference was found in 
subcortical than trabecular BMD. In this perimenopausal group, 
it was also apparent that difference in radial BMD measurements 
were less than those found at the hip and spine as measured by 
DXA.
It is appreciated that bone mass at one skeletal site does not 
necessarily reflect that of another. This was borne out in the 
work presented in chapter 6, where there was at best, only 
moderate correlation between radial pQCT BMD measurements, 
calcaneal ultrasound and axial hip and spine measurements. 
Additionally, the longitudinal studies which examined 
annualized rates of change in premenopausal and postmenopausal 
women in chapter 7, albeit in small numbers, and only after 12- 
18 months of follow-up, showed that there was no relationship 
between changes at the radius and those at either the hip or 
spine. Further study of these relationships involving a greater 
number of individuals followed for a longer duration are 
required. Pending these studies and prospective studies 
addressing fracture prediction using pQCT, these preliminary 
findings suggest that pQCT has little role as either a 
screening or pre-screening tool (eg. for axial DXA assessment), 
should population based screening for osteoporosis risk ever
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become a reality. Essentially a single radial measurement did 
not adequately predict axial BMD, and serial measurements did 
not reflect changes in axial BMD in the short-term.
At the present time, fracture prediction is best achieved by 
BMD assessment. In chapter 8, a retrospective study comparing 
axial DXA with radial pQCT measurements showed that radial 
trabecular BMD was superior to all other measurements in 
discriminating vertebral fracture from non-fracture 
populations. In contrast, the discriminatory power of all pQCT 
measurements was poor in a retrospective study of hip 
fractures, and significantly worse than DXA femoral neck BMD. 
This suggest that pQCT may be useful in the prediction of 
vertebral fractures, but less so for hip fractures. Prospective 
studies are now required to confirm this suggestion.
Monitoring response to drug therapy is an established 
indication for BMD assessment (1.145,1.146,1.153,1.154,9.1). 
Preliminary work presented in chapter 9 compared changes in J;'
■3
radial pQCT BMD measurements with DXA hip and spine 
measurements in response to HRT and cyclical etidronate during 
the first year of treatment. The results showed that the 
response to both drugs follows a similar pattern, with a 
significant increase in spinal BMD evident within 4 months and 
further increase thereafter. In contrast, there was a more 
gradual increase in hip BMD, while radial BMD, including the 
trabecular measurement, remained virtually unchanged. This 
suggests that in the majority of cases, response to these 
therapies is best assessed at the lumbar spine. This needs to 
be confirmed by larger studies with longer follow-up. It should 
be borne in mind however, that as lumbar spine DXA measurements 
can be influenced by severe spondylosis (1.171-1.177), multiple
fractures and overlying aortic calcification 
(1.168,1.169,1.170), it is not always the best measurement for
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monitoring purposes. Based upon the data presented here, there 
is no suggestion that pQCT could be used as an alternative, 
although further work, as suggested above, is necessary before 
its use in this area can be completely discounted.
Ï
Monitoring the effect of drugs with an adverse effect upon bone 
is equally important. Such an effect is epitomised by 
corticosteroid therapy. Unfortunately, it was not possible to 
examine the role of pQCT in monitoring steroid induced bone
loss per se, but this area is undoubtedly deserving of future 
study. It was however possible to examine the potential adverse
effect of warfarin upon bone, a side-effect seldom considered.
In a case control study of males presented in chapter 10, 
lumbar spine and radial trabecular BMD were almost one standard 
deviation lower at each site in those men on longterm warfarin 
compared to the control group. Bearing in mind the increasing 
use of warfarin, this is an important adverse effect to be 
aware of. In considering the effect of HRT, etidronate and 
warfarin on radial BMD, there appears to be disparity in the :results. It seems strange that radial trabecular BMD was 
unchanged with both HRT and etidronate, yet significantly 
decreased by warfarin. The study designs must be borne in mind 
however. The HRT/etidronate effects were studied for only one 
year in a longitudinal study, whereas the warfarin effect was 
examined in a cross-sectional design where the drug had been 
given for a median duration of 40.5 months (range 4-302). The 
disparity in results could be related to the duration of drug 
therapy, warfarin having had a much longer time to exert its 
effect upon radial bone, than HRT or etidronate. With longer
follow up, a significant increase in radial BMD may have been 
found with HRT and etidronate.
Rheumatoid arthritis (RA) is one of the many conditions which 
is known to induce bone loss and cause osteoporosis (11.1,11.4-
,1
11.8,11.11,11.12,11.15-11.17,11.20). The pathogenesis is 
multifactorial, and the effect of low dose prednisolone^at all 
sites controversial. In chapter 11, the effect o^^A and/ low 
dose prednisolone upon radial pQCT BMD measurements was 
investigated in a case control study, with comparison of BMD at 
other skeletal sites. Trabecular BMD was reduced by more than 
30% in patients with A compared to controls, with very little 
additional corticosteroid effect. In contrast cortical BMD was 
unaffected. A similar significant difference was detected at 
the 08 calcis, a smaller but significant difference at the hip, 
and an insignificant difference at the lumbar spine. This study 
supports the growing body of evidence suggesting that the use 
of low dose corticosteroid in patients with A does not have a 
deleterious effect upon BMD. The effect upon periarticular 
trabecular BMD at the wrist in this study (as measured by pQCT) 
was dependent upon articular damage, which is the longterm 
consequence of uncontrolled inflammatory joint disease. 
Previous work by others has shown loss of radial trabecular BMD 
(as measured by pQCT) early in the natural history of the 
disease (11.11,11.12), and the data presented here suggests 
further loss in the longer term. This begs the question, could 
assessment of trabecular BMD by pQCT be used to monitor disease 
progression, and possibly response to therapy? Further work, 
preferably in interventional, prospective studies of early A 
are needed to address this issue.
It is apparent from the work presented here that radial BMD 
behaves differently from that at the hip and spine. There was 
poor correlation between radial and axial measurements. There 
was no correlation between the rate of change at the radius and 
that at the hip or spine. The response to drugs such as HRT and 
etidronate differed between sites. Although pQCT has the 
advantage of assessing trabecular and cortical BMD 
independently, radial bone seems less active, and responds
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differently and more slowly than does axial bone. This may well
be due to differences in remodelling at the radius as discussed 
above in this chapter, and in differences in the bone marrow 
present between sites. Yellow marrow is present in the radial 
medullary cavity throughout adulthood, whereas haematopoietic 
marrow predominates at the spine and proximal femur. 
Osteoclasts and osteoblasts are derived from haematopoietic 
marrow. The signalling and control of osteoclasts/osteoblasts 
and remodelling is extremely complex and not fully 
characterised, but thought to involve numerous cytokines, 
hormones and matrix factors (1.2,1.3,1.8,12.1). The close 
proximity to, and interaction with haemopoietic rather than 
yellow marrow may well explain some of the different behaviour 
of axial and radial bone which was apparent from the work 
presented in this thesis.
Osteo-densitometry is a relatively new concept and significant 
advances have been made in this field in recent years. Although 
present day osteo-densitometers are the best method of 
assessing "osteoporosis" in its broadest context, research into 
pQCT and other modalities, both established and novel, must 
continue to ensure future progress. Two and three dimensional 
QCT systems have been developed (1.149,1.150,8.35,12.2-12.8) '
which allow structural analysis of trabecular bone, providing 
in effect, a non-invasive bone biopsy. This structural 
information along with BMD may further improve the performance 
of pQCT (12.7). Scanners with a higher spatial resolution than 
that of the Stratec XCT-960 system have largely been used for 
this, although an attempt at structural analysis by enhancing 
the Stratec system has been reported to show an increased 
number of perforations in early postmenopausal compared to late 
premenopausal women inspite of an insignificant difference in 
BMD (7.5) .
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The work for this thesis evaluating the role of pQCT in 
osteoporosis was done within a limited timescale. Consequently 
it has its limitations and is far from being all inclusive. 
However, it has addressed some of the important issues which 
must be covered in the development of an osteo-densitometer, 
and has highlighted areas where pQCT may, and may not have a 
role in the management of patients with osteoporosis. Further 
work is necessary to confirm some of these findings, and 
address areas not covered by this work. Like most research, 
issues hitherto not realised, or poorly documented, have been 
raised which are worthy of future investigation. The most 
likely fruitful areas for further research and development into 
pQCT would be :
► The use of scan voxel numbers to improve precision,
and aid repositioning in repeat scanning.
► The use of pQCT to study age related changes in BMD
and bone remodelling.
► The use of pQCT in fracture prediction, more
especially vertebral fracture. It may have additive 
predictive value in conjunction with axial DXA, as 
has calcaneal ultrasound in hip fracture prediction 
(8.19) .
► The use of pQCT in determining BMD changes in
response to corticosteroid therapy
► The use of pQCT as an assessment tool for monitoring
disease progression and response to therapeutic 
intervention in rheumatoid arthritis, and possibly 
other inflammatory arthritides.
► Further assessment of structural considerations, both 
radial geometric indices, and trabecular 
microstructure.
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APPENDIX 1 Glossary of Abbreviations
ACTH
AP
ANOVA
AP
AUC
BMD
BMU
BUA
X"
CAMP
CM
CT
CV
dB/MHz
DHEA
DPA
DXA
ETD
FN
FSH
FT
FW
g
HRT
HVR
kg
LARS
L2-L4
LH
LHRH
LS
Adrenocorticotrophic Hormone 
Atrial Fibrillation 
Analysis of Variance 
Antero-posterior 
Area Under the Curve 
Bone Mineral Density 
Basic Multicellular Unit
Broadband Ultrasound Attenuation (calcaneal site) 
Chi square
Cyclic Adenosine-3',5'-monophosphate
centi-meter
Computed Tomography
Co-efficient of Variation
Decibel / Mega Hertz
Dehydroepiandrosterone
Dual Photon Absorptiometry
Dual Energy X-Ray Absorptiometry
Etidronate
DXA Femoral Neck BMD 
Follicle Stimulating Hormone 
DXA Femoral Trochanter BMD 
DXA Femoral Ward's Area BMD 
grammes
Hormone Replacement Therapy 
Heart Valve Replacement 
Kilogram 
Larsen Score
2nd to 4th lumbar vertebrea 
Luteinizing Hormone
Luteinizing Hormone Releasing Hormone 
DXA Lumbar Spine BMD
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m
m/s
MCP
MXA
NS
1-CTP
1-NTP
PBM
PICP
PINP
PIP
POST
PRE
pQCT
PVD
Qcort
QCT
Qscort
Qtot
Qtrab
RA
RA+P
RhF
ROC
ROI
SD
SPA
T4-L5
T-Score
Meter
Meter / Second 
Metacarpo-Phalangeal Joint 
Morphometric X-ray Absorptiometry 
Statistically Non-Significant
Cross-linked Carboxyterminal Telopeptide of 
Type 1 Collagen
Cross-linked Aminoterminal Telopeptide of Type 
1 Collagen 
Peak Bone Mass
Carboxyterminal Propeptide of Type 1 Collagen 
Aminoterminal Propeptide of Type 1 Collagen 
Proximal Inter-Phalangeal Joint 
Postmenopausal Women 
Premenopausal Women
Peripheral Quantitative Computed Tomography 
(ultra-distal radial site)
Peripheral Vascular Disease
pQCT Cortical BMD
Quantitative Computed Tomography
pQCT Subcortical BMD
pQCT Total BMD
pQCT Trabecular BMD
Rheumatoid Arthritis
Steroid Treated RA group
Rheumatoid Factor
Receiver Operator Curve
Region of Interest
Standard Deviation
Single Photon Absorptiometry
4th thoracic to 5th lumbar vertebrae
The number of standard deviations above or
below the mean value of young normals
,
II
i
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VN Voxel Number
VN-diff Difference in voxel numbers
VOS Ultrasonic Velocity {calcaneal site)
VTE Recurrent Venous Thrombo-embolism
WB DXA Whole Body
WB-ARM DXA Arm BMD (derived from the whole body DXA
scan image)
WB-BMD DXA Whole Body BMD
YPM Years Postmenopause
yr Year
Z-Score The number of standard deviations above or
below the sex and age related normal mean
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